Rapid diagnostic tests for diagnosing uncomplicated P.

falciparum malaria in endemic countries (Review) by Abba, Katharine et al.
Rapid diagnostic tests for diagnosing uncomplicated P.
falciparum malaria in endemic countries (Review)
Abba K, Deeks JJ, Olliaro PL, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2011, Issue 8
http://www.thecochranelibrary.com
Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
10RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Figure 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Figure 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Figure 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
29DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
31AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
31ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
31REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
53CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
227DATA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Test 1. Paracheck-Pf. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 228
Test 2. ParaSight-F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 229
Test 3. ICT Malaria Pf. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
Test 4. ParaHIT-F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
Test 5. PATH. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
Test 6. Determine Malaria Pf. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
Test 7. Rapid Test Malaria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Test 8. Diaspot Malaria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Test 9. New Pf-1 mini. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
Test 10. Hexagon Malaria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
Test 11. Type 1 (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
Test 12. CareStart Malaria Pf/Pan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Test 13. ICT Malaria Pf/Pv. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236
Test 14. NOWmalaria ICT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236
Test 15. Type 2 (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
Test 16. SD Malaria Antigen Bioline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
Test 17. First Response Malaria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
Test 18. OptiMAL/ OptiMAL 48. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
Test 19. Parascreen. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 239
Test 20. Type 3 (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 239
Test 21. OptiMAL-IT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240
Test 22. Parabank. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240
Test 23. Type 4 (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
Test 24. Carestart Pf/Pv. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
Test 25. ParaSight Pf/Pv. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
Test 26. Type 5 (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
Test 27. HRP-2 based tests. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243
Test 28. pLDH based tests. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246
Test 29. Type 1 (paired comparison with Type 4). . . . . . . . . . . . . . . . . . . . . . . . 247
Test 30. Type 4 (paired comparison with Type 1). . . . . . . . . . . . . . . . . . . . . . . . 247
Test 31. PCR adjusted microscopy, Type 1, Paracheck-PF (All). . . . . . . . . . . . . . . . . . . . 248
Test 32. PCR adjusted microscopy, Type 4, Parabank (All). . . . . . . . . . . . . . . . . . . . . 248
iRapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Test 33. PCR, Type 1, ParaSight-F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
Test 34. PCR, Type 1, ParaHIT-F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249
Test 35. PCR, Type 1 (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249
Test 36. PCR, Type 3, SD Malaria Antigen (All). . . . . . . . . . . . . . . . . . . . . . . . . 249
Test 37. HRP-2 based tests paired data. . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
Test 38. pLDH based tests paired data. . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
Test 71. PCR, Type 6, PALUTOP (All). . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
Test 72. PCR, Type 4, OptiMAL-IT (All). . . . . . . . . . . . . . . . . . . . . . . . . . . 251
251APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258
Figure 9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259
Figure 10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 260
Figure 11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261
Figure 12. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262
Figure 13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263
Figure 14. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264
Figure 15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265
268WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
268HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
269CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
269DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
269SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
269DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
269NOTES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iiRapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Diagnostic Test Accuracy Review]
Rapid diagnostic tests for diagnosing uncomplicated P.
falciparum malaria in endemic countries
Katharine Abba1 , Jonathan J Deeks2, Piero L Olliaro3, Cho-Min Naing4, Sally M Jackson1, Yemisi Takwoingi2 , Sarah Donegan1 , Paul
Garner1
1International Health Group, Liverpool School of Tropical Medicine, Liverpool, UK. 2Public Health, Epidemiology and Biostatistics,
University of Birmingham, Birmingham, UK. 3UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in
Tropical Diseases (TDR), WorldHealthOrganization, Geneva, Switzerland. 4Division of Community Medicine, International Medical
University, Kuala Lumpur, Malaysia
Contact address: Katharine Abba, International Health Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool,
Merseyside, L3 5QA, UK. K.abba@liverpool.ac.uk.
Editorial group: Cochrane Infectious Diseases Group.
Publication status and date: Edited (no change to conclusions), published in Issue 8, 2011.
Review content assessed as up-to-date: 13 January 2010.
Citation: Abba K, Deeks JJ, Olliaro PL, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P. Rapid diagnostic tests for
diagnosing uncomplicated P. falciparummalaria in endemic countries. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.:
CD008122. DOI: 10.1002/14651858.CD008122.pub2.
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Rapid diagnostic tests (RDTs) for Plasmodium falciparum malaria use antibodies to detect either HRP-2 antigen or pLDH antigen,
and can improve access to diagnostics in developing countries.
Objectives
To assess the diagnostic accuracy of RDTs for detecting P. falciparum parasitaemia in persons living in endemic areas who present to
ambulatory healthcare facilities with symptoms suggestive of malaria by type and brand.
Search strategy
Weundertook a comprehensive search of the following databases: Cochrane InfectiousDiseasesGroup SpecializedRegister;MEDLINE;
EMBASE; MEDION; Science Citation Index; Web of Knowledge; African Index Medicus; LILACS; IndMED; to January 14, 2010.
Selection criteria
Studies comparing RDTs with a reference standard (microscopy or polymerase chain reaction) in blood samples from a random or
consecutive series of patients attending ambulatory health facilities with symptoms suggestive of malaria in P. falciparum endemic areas.
Data collection and analysis
For each study, a standard set of data was extracted independently by two authors, using a tailored data extraction form. Comparisons
were grouped hierarchically by target antigen, and type and brand of RDT, and combined in meta-analysis where appropriate.
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Main results
We identified 74 unique studies as eligible for this review and categorized them according to the antigens they detected. Types 1 to 3
include HRP-2 (from P. falciparum) either by itself or with other antigens. Types 4 and 5 included pLDH (from P. falciparum) either
by itself or with other antigens. In comparisons with microscopy, we identified 71 evaluations of Type 1 tests, eight evaluations of Type
2 tests and five evaluations of Type 3 tests. In meta-analyses, average sensitivities and specificities (95% CI) were 94.8% (93.1% to
96.1%) and 95.2% (93.2% to 96.7%) for Type 1 tests, 96.0% (94.0% to 97.3%) and 95.3% (87.3% to 98.3%) for Type 2 tests, and
99.5% (71.0% to 100.0%) and 90.6% (80.5% to 95.7%) for Type 3 tests, respectively.
Overall for HRP-2, the meta-analytical average sensitivity and specificity (95% CI) were 95.0% (93.5% to 96.2%) and 95.2% (93.4%
to 99.4%), respectively.
For pLDH antibody-based RDTs verified with microscopy, we identified 17 evaluations of Type 4 RDTs and three evaluations of Type
5 RDTs. In meta-analyses, average sensitivity for Type 4 tests was 91.5% (84.7% to 95.3%) and average specificity was 98.7% (96.9%
to 99.5%). For Type 5 tests, average sensitivity was 98.4% (95.1% to 99.5%) and average specificity was 97.5% (93.5% to 99.1%).
Overall for pLDH, the meta-analytical average sensitivity and specificity (95% CI) were 93.2% (88.0% to 96.2%) and 98.5% (96.7%
to 99.4%), respectively.
For both categories of test, there was substantial heterogeneity in study results. Quality of the microscopy reference standard could only
be assessed in 40% of studies due to inadequate reporting, but results did not seem to be influenced by the reporting quality.
Overall, HRP-2 antibody-based tests (such as the Type 1 tests) tended to be more sensitive and were significantly less specific than
pLDH-based tests (such as the Type 4 tests). If the point estimates for Type 1 and Type 4 tests are applied to a hypothetical cohort of
1000 patients where 30% of those presenting with symptoms have P. falciparum, Type 1 tests will miss 16 cases, and Type 4 tests will
miss 26 cases. The number of people wrongly diagnosed with P. falciparum would be 34 with Type 1 tests, and nine with Type 4 tests.
Authors’ conclusions
The sensitivity and specificity of all RDTs is such that they can replace or extend the access of diagnostic services for uncomplicated
P. falciparum malaria. HRP-2 antibody types may be more sensitive but are less specific than pLDH antibody-based tests, but the
differences are small. The HRP-2 antigen persists even after effective treatment and so is not useful for detecting treatment failures.
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B A C K G R O U N D
Target condition being diagnosed
Malaria is a life-threatening illness, caused by the asexual form
of the parasitic protozoan Plasmodium. Most cases of malaria are
uncomplicated, commonly presenting with fever and sometimes
with other non-specific symptoms including headache, and aches
and pains elsewhere in the body (Gilles 1991;WHO 2003). A few
people develop severe malaria, with confusion, weakness, coma
and other life-threatening complications. Malaria is curable, and
early, prompt and accurate diagnosis followed by appropriate treat-
ment helps to reduce illness and death, (WHO 2003) and is cen-
tral to current malaria control policy (Bell 2006; WHO 2005).
The two most common species of malaria parasite are Plasmodium
falciparum and Plasmodium vivax. P. falciparum malaria is by far
the most common type of malaria in Africa, and is also endemic in
parts of Asia and South America. It is the most common cause of
severe malaria, is responsible for almost all malaria deaths, and can
cause other complications such as anaemia and, in pregnancy, low
birth-weight babies. Vivax malaria is a relapsing form, which is
rarely fatal but can cause serious anaemia in children. Less common
human malaria parasite species include P. malariae and P. ovale.
In 2008, there were between 190 million and 311 million cases
of malaria worldwide (WHO 2009a). Around 85% of these cases
were in Africa; 10% were in South East Asia; 4% were in the
Eastern Mediterranean region; and 1% were in South America
(WHO 2009a). In the same year, there were between 708,000 and
1,003,000 deaths frommalaria; 89%were in Africa and 85%were
children under the age of five years (WHO 2009a).
People who are repeatedly exposed to malaria infection develop a
partial and incomplete immunity. In highly endemic areas, those
most at risk are children under the age of five, who have not yet had
the chance to develop immunity. In less endemic areas, or areas of
seasonal or epidemic transmission, older children and adults are
also at risk due to less developed immunity. Travellers from non-
endemic to endemic countries are at highest risk because they have
no immunity at all.
Index test(s)
Rapid diagnostic tests (RDTs) (WHO 2003) detect parasite-spe-
cific antigens in a drop of fresh blood through lateral flow im-
munochromatography (WHO 2006). TheWorldHealthOrgani-
zation (WHO) currently lists 96 commercially-available test kits
meeting ISO13485:2003manufacturing standards (WHO 2009).
RDTs do not require a laboratory or any special equipment (WHO
2006); they are simple to use and can give results as a simple posi-
tive/ negative result, within 15 minutes (Talman 2007). RDTs are
therefore, in general, suitable for remote areas with limited facil-
ities and relatively untrained staff. However, they have a limited
shelf life, and need to be kept dry and away from extremes of
temperature. They may also fail to detect malaria in cases where
there are low levels of parasites in the blood, and false positives are
possible due to cross reactions or gametocytaemia (infection with
the sexual stage of the parasite only) (Kakkilaya 2003).
RDTs use antibodies to detect one or several antigens. The most
commonly used antibodies react to histidine-rich protein-2 (HRP-
2), aldolase and plasmodium lactate dehydrogenase (pLDH)
(Talman 2007). HRP-2 is a marker for P. falciparum, while pLDH
antibodies can be specific for P. falciparum, or P. vivax, or may
detect all species (including P. ovale and P. gambiae) or other com-
binations of these species. Aldolase antibodies are pan-specific, de-
tecting all types of malaria parasite but not differentiating between
them.Until recently, there were sevenmain types of commercially-
available test, using different antigen combinations as described
in Table 1 below (Bell 2006).
Table 1. Types of malaria RDTs by antibody combination and parasite species detected
Type of Test Antibody Combinations Possible Results
Type 1 HRP-2 (P. falciparum specific) No Pf; Pf; invalid
Type 2 HRP-2 (P. falciparum specific) and aldolase (pan-specific) No malaria; Pf or mixed; Pv, Pf and/or Pm; invalid
Type 3 HRP-2 (P. falciparum specific) and pLDH (pan-specific) No malaria; Pf or mixed; Pv, Pf and/or Pm; invalid
Type 4 pLDH (P. falciparum specific) and pLDH (pan-specific) No malaria; Pf or mixed; Pv, Pf and/or Pm; invalid
Type 5 pLDH (P. falciparum specific) and pLDH (P. vivax-spe-
cific)
No malaria; Pf; Pv; Pf and Pv; invalid
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Table 1. Types of malaria RDTs by antibody combination and parasite species detected (Continued)
Type 6 HRP-2 (P. falciparum specific), pLDH (pan-specific) and
pLDH (P. vivax specific)
No malaria; Pf and Pv =/- Po and/or Pm; Pf +/- Po and/
or Pm; Pv +/- Po and/or Pm; Po and/or Pm; invalid
Type 7 Aldolase (pan-specific) No malaria; Pf, Pv, Po and/or Pm; invalid
Pf P. falciparum; Pv P. vivax; Pm P. malariae; Po P .ovale
Since this classification was developed, the following test types
have also become available.
• Pan pLDH antibodies only, with the following possible
results: no malaria; P. falciparum, P. vivax, P. ovale and/or P.
malariae; and invalid (as for Type 7 tests).
• P. vivax-specific pLDH antibodies only.
• pLDH antibody lines detecting P. vivax, P. ovale and P.
malariae in combination.
The different test types detect different malaria species and com-
binations of species; the choice of RDT used will therefore depend
on which species are endemic in the area. Table 2 shows the type
of tests that are appropriate for use in the different malaria ’zones’
of the world.
Table 2. Malaria ’zones’ by endemic parasite species and RDT type appropriate for each
Zone Endemic malaria parasites Geographic area Appropriate test type
1 P. falciparum only or other species almost
always as a mixed infection
Most of sub-Saharan Africa; lowland
Papua New Guinea
Tests using HRP-2 to detect P. falci-
parum only
(Type 1)
2 Both P. falciparum and P. vivax, most
commonly as a single species
Asia and the Americas; Ethiopian high-
lands
Combination RDTs which detect all
species and distinguish between P. falci-
parum and P. vivax
(Types 2 to 6)
3 Non-falciparum only Vivax only areas of East Asia andCentral
Asia; some highland areas elsewhere
Pan-specific or vivax-specific RDTs
(Type 7; Pan-pLDH only; vivax-pLDH
only)
HRP-2 can stay in the blood for up to 28 days after starting anti-
malarial therapy (Kakkilaya 2003). Because of this ’persistent anti-
genaemia’, it is not possible to use these tests for assessing parasite
clearance following treatment, and false positive results may be
found in patients who have recently been treated for malaria. In
contrast, pLDH is rapidly cleared from the blood following para-
site death; in fact, it may clear more rapidly than the dead parasites
(WHO 2009), but may persist in the presence of gametocytes.
Reference tests
Microscopic examination of Giemsa-stained thick and thin blood
films remains the conventional laboratory method for malaria di-
agnosis, but needs to be conducted by microscopists with ade-
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quate training and equipment. Microscopic examination displays
a good sensitivity and specificity, and allows species and stage dif-
ferentiations and quantification of parasites, all of which are im-
portant in assessing the disease severity and prescribing appropri-
ate therapy. Intensive examination is more likely to reveal par-
asitaemia, so the test is carried out by examining a fixed num-
ber of fields; infections may be missed if slides are not examined
carefully (Wongsrichalanai 2007). Very low parasitaemia may be
missed even by good quality microscopy; the limit of detection
of thick smear microscopy has been estimated at between around
four and 20 asexual parasites per µl, although under field con-
ditions a threshold of between 50 and 100 asexual parasites per
µl is more realistic (Wongsrichalanai 2007). On the whole, false
positive results are the result of poor slide preparation or reading
(Wongsrichalanai 2007).
Molecular DNA amplification via polymerase chain reaction
(PCR) is the most accurate method of detecting parasites in the
blood. It eliminates observer error and is more sensitive at low
levels of parasitaemia, with limits of detection as low as 0.004
asexual parasites per µl (Hanscheid 2002; Snounou 1993). How-
ever, whether this increased ability to detect low level parasitaemias
makes it a better diagnostic test is uncertain, as sub-microscopic
parasitaemias are of unknown clinical significance and the preva-
lence of asymptomatic sub-microscopic infection is high in some
areas (May 1999). In addition, PCRmay be prone to false positive
results due to contamination of samples if laboratory standards are
not sufficiently high. PCR is currently not widely available outside
of research settings, as it needs specially-trained technicians and a
well-equipped laboratory.
Alternative test(s)
Microscopic examination of Giemsa-stained thick and thin blood
films remains the conventional laboratory method for malaria di-
agnosis and is the gold standard, but needs to be conducted by
microscopists with adequate training and equipment.Microscopic
examination displays a good sensitivity and specificity, and allows
species and stage differentiations and quantification of parasites,
all of which are important in assessing the disease severity and pre-
scribing appropriate therapy. Intensive examination is more likely
to reveal parasitaemia so the test is carried out by examining a fixed
number of fields; infections may be missed if slides are not ex-
amined carefully (Wongsrichalanai 2007). Very low parasitaemia
may be missed even by good quality microscopy; the limit of de-
tection of thick smear microscopy has been estimated at between
four and 20 asexual parasites per µl, although under field con-
ditions a threshold of between 50 and 100 asexual parasites per
µl is more realistic (Wongsrichalanai 2007). On the whole, false
positive results are the result of poor slide preparation or reading
(Wongsrichalanai 2007).
Rationale
Diagnostic tests for malaria in endemic areas are now recom-
mended as routine by theWHOin all patients suspected ofmalaria
before any treatment begins (WHO 2010). This is due to a shift
in drug treatment policy away from cheap, often relatively inef-
fective, drugs, towards artemisinin-based combination treatment
(ACTs), which are highly effective, expensive, and need to be used
properly to prevent resistance developing.
There is a long-standing recognition that good quality, standard
malariamicroscopy is relatively expensive and difficult to deliver in
many basic, primary health care settings in developing countries,
while RDTs for malaria have now become widely available and
affordable.
RDTs in malaria could dramatically increase access to prompt
diagnosis in primary health care. The question of how a package of
care (diagnosis using RDTs with positive cases treated with drugs
versus presumptive treatment of all caseswith symptoms suggestive
of malaria) impacts on health outcomes is to be addressed in a
separate forthcoming review (Odaga 2011). However, important
policy questions remain to be answered
a) How well do RDTs perform compared to the previous standard
of microscopy in diagnosing symptomatic patients?
b) What are the differences in accuracy between different types of
commercial test, and individual brands of commercial tests?
This information will help to inform choice, although factors,
such as price, product consistency, stability and shelf life will also
influence those decisions.
This review is the first of a series of three reviews: the second will
examine the accuracy of RDTs for diagnosing uncomplicated P.
vivax and other non-falciparum malaria; and the third will assess
trials that incorporate RDTs into treatment protocols (Odaga
2011). Previous published reviews have examined travellers only
(Marx 2005) or just one particular test (Cruciani 2004).
O B J E C T I V E S
To assess the diagnostic accuracy of RDTs for detecting clinical
P. falciparum malaria (symptoms suggestive of malaria plus P. fal-
ciparum parasitaemia detectable by microscopy) in persons living
in malaria endemic areas who present to ambulatory healthcare
facilities with symptoms of malaria, and to identify which types
and brands of commercial test best detect clinical P. falciparum
malaria.
Investigation of sources of heterogeneity
We planned to investigate heterogeneity in relation to the index
test (by commercial test, test type and grouped byHRP-2/pLDH)
and reference tests (microscopy vs PCR), as well as the study par-
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ticipants’ age, endemicity of malaria, and geographic area (by con-
tinent).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Studies evaluating one or more RDTs in a consecutive series of
patients, or a randomly-selected series of patients, were eligible.
Where the report did not explicitly state that sampling was con-
secutive, but consecutive sampling was judged most probable, the
study was included. Studies were excluded if they did not present
sufficient data to allow us to extract or calculate absolute numbers
of true positives, false positives, false negatives, and true negatives.
Studies were also excluded if they were not available in English,
or if they presented insufficient information to fully assess their
eligibility.
Participants
Studies recruiting people living in P. falciparum malaria endemic
areas who attended ambulatory healthcare settings with symp-
toms of uncomplicated malaria. This included patients attending
malaria clinics with self-assessed symptoms.
We excluded studies if participants:
1. were non-immune persons returning from endemic countries
or were mainly recent migrant or displaced populations from non-
endemic or very low endemicity areas;
2. had been treated formalaria and the test was performed to assess
treatment outcome;
3. had symptoms suggestive of severe malaria;
4. did not have symptoms suggestive of malaria;
5. were recruited through active case finding (for example, door-
to-door surveys).
In studies with broader inclusion criteria but which presented
results stratified by subgroups, we included the data relevant to
our inclusion criteria. If studies included some participants with
severe malaria, and data specific to a subgroup of participants
with uncomplicated malaria could not be extracted, the study was
included if 90% or more of the participants had uncomplicated
malaria.
Index tests
Studies evaluating any immunochromatography-based RDTs
specifically designed to detect P. falciparum malaria.
Commerical tests no longer available were included because they
may use the same antibodies, and very similar technology, to tests
that are currently available or may become available in the future.
Older and more recently available versions of the same test, and
tests available in both dipstick and cassette format, were included
separately. Late prototype tests corresponding to one of the com-
mercially-available types were also included.
Comparator tests
Studies were included regardless of whether they made compar-
isons with other RDT tests.
Target conditions
Studies aimed to detect P. falciparummalaria parasitaemia. Studies
that presented RDT results relating only to all types of malaria
without distinction by species, but where over 98% of malaria
infections by reference standard were associated with P. falciparum,
were included in this review and analysed as for P. falciparum.
Reference standards
Studies were required to diagnose P. falciparum malaria using at
least one of the following two reference standards.
1. Conventional microscopy of thick blood smears, thin blood
smears or both. Presence of asexual P. falciparum parasites of any
density was regarded as a positive smear.
2. PCR test.
We required that the reference standard was carried out on blood
samples taken at the same time and from the same person as the
index tests. Where studies used more than one reference standard,
we presented data relating to comparisons with each.
Search methods for identification of studies
We used a single search strategy for all reviews in the series.
Electronic searches
To identify all relevant studies, we searched the following databases
using the search terms and strategy identified in Appendix 1. The
date of the last search was 14 January 2010.
Cochrane Infectious Diseases Group Specialized Register; MED-
LINE; EMBASE; MEDION; Science Citation Index; Web of
Knowledge; African Index Medicus; LILACS; IndMED. We
used the following MeSH, full text and keyword terms: malaria,
Plasmodium, reagent kits, diagnosis, diagnostics, RDT, dipstick,
MRDD, OptiMal, Binax Now, Parasight, Immumochromatogra-
phy, antigen detection, antigen test, Combo card. We restricted
the searches to human studies. We did not limit the search by
language or publication status.
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Data collection and analysis
Selection of studies
A single selection procedure was initially used to identify studies
for inclusion in either of the two diagnostic test accuracy reviews
in the series. The inclusion criteria between the reviews differed
only in the target condition and parasite species. Parasite species
was therefore the last aspect of the study characteristics to be as-
sessed. One author (KA) initially assessed the titles identified by
the search, excluding those obviously irrelevant to the diagnosis of
malaria using RDTs.
Letters, review articles, and articles clearly irrelevant based on ex-
amination of the abstract and other notes were next excluded and
the eligibility of the remaining potentially relevant articles was
judged on full text publications independently by two authors
(KA SJ) using a proforma. These excluded studies are listed in
Characteristics of excluded studies. Any discrepancy was resolved
by discussion. Where agreement could not be reached, we con-
sulted a third author (PG or PO). Where it remained unclear
whether a study was eligible for inclusion, it was excluded, and we
excluded study reports in non-English language reports for logis-
tical reasons.
Studies were named according to the surname of their first author
and the year of publication. The study naming used in this re-
view uniquely identifies multiple study cohorts from within each
study report (for example as ’Bell 2001a’ and ’Bell 2001b’), each
of which use different reference standards or present data sepa-
rately for more than one population with different characteristics.
A slightly different notation (for example, ’Singh 1997(a)’ and
’Singh 1997(b)’) was used to refer to completely separate studies
published by an author of the same name in the same year. Note
that more that one RDT may be evaluated in each study cohort,
thus the number of test evaluations exceeds the number of study
cohorts, which exceeds the number of study reports.
Data extraction and management
A standard set of data was extracted from each study cohort, us-
ing a tailored data extraction form. Two authors from a pool of
three (KA SJ CMN) independently extracted data, and any dis-
crepancies were resolved by discussion. In cases of studies where
only a subgroup of participants met the review inclusion criteria,
data was extracted and presented only for that particular subgroup.
Where two versions of one reference standard or index test were
used, for example local clinic and expert standard microscopy or
field versus laboratory testing, only the one most likely to yield
the highest quality results was included in the review.
For each study, we systematically extracted data on the character-
istics of the study, as shown in Appendix 2.
For each comparison of index test with reference test, data were
extracted on the number of true positives, true negatives, false pos-
itives and false negatives in the form of a two by two table. RDT
results are dichotomous; microscopy results were deemed positive
at any level of asexual P. falciparum parasitaemia; and PCR results
used the cut-off points presented by the study authors. Gameto-
cyte-only parasitaemia was considered negative; where a study was
unclear on how they had classed gametocyte-only parasitaemia,
they were assumed to have used the same classification as ourselves
and the data were included in the study. In cases of minor dis-
agreement (within 2%) between two by two table data presented
in a study report and reported study sample sizes or calculated ac-
curacies, the data in the table were taken as correct. In cases where
there was a large discrepancy, the data were not included in the
review.
Data were extracted (Smidt 2008) using current manufacturers’
instructions in interpreting theRDTresults.P. falciparum only and
P. falciparum as part of a mixed infection were not distinguished
and were classed as positive. Non-falciparum malaria only was
classed as negative for this review.Where study authors interpreted
test results or presented data differently, we used all the information
presented in the paper to extract data consistent with our own
methods; if we were unable to do this, we did not include the data
in the analyses.
Reference standard positive was defined as ’P. falciparum or mixed
infection’ and reference standard negative as ’no malaria para-
sitaemia or non-falciparum malaria parasitaemia only’.
Assessment of methodological quality
Two authors from a pool of three (KA SJ CMN) independently
assessed the quality of each individual study using the checklist
adapted from the QUADAS tool (Whiting 2003). Each question
on the checklist was answered with a yes/no response, or noted as
unclear if insufficient information was reported to allow a judge-
ment to be made, and the reasons for the judgement made were
documented. The criteria used are summarized in Appendix 3.
Statistical analysis and data synthesis
The comparisons made in this review can be considered in a hi-
erarchy. The highest level comparison groups tests by antibody
type (HRP-2 versus pLDH) and is formed by combining the test
types into two groups: HRP-2 antibody-based (Types 1, 2, 3 and
6) and pLDH antibody-based (Types 4 and 5). However, the data
on each test type is classified in the primary studies according to
commercial brands. In order to provide a coherent description of
the studies contributing to each analysis, the results are structured
first by grouping studies according to their commercial brand,
then grouping brands to form test types, and finally grouping test
types by antibody.
The analytical strategy thus compared the test accuracy of com-
mercial brands within each test type before making comparisons
between test types, and then between antibodies. Comparative
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analyses first included all studies with relevant data, and were then
restricted to studies that made direct comparisons between tests
with the same participants, where such studies existed.
For each test type, we plotted estimates of the observed sensitivi-
ties and specificities in forest plots and in receiver-operating char-
acteristic (ROC) space. These plots demonstrate the variation in
accuracy between studies.
Meta-analyses were undertaken where adequate data were avail-
able.Hierarchical summaryROCmodels (HSROC) that included
a random-effects term for variation in accuracy and threshold be-
tween studies, and non-symmetrical underlyingROC curves, were
fitted. The average operating point for each test was identified on
each curve, and average sensitivities and specificities computed.
Comparisons between tests were made by adding a covariate for
brand, test type or antigen to the accuracy and threshold param-
eters, assuming a common underlying shape. The impact of test
type and antibody on the variability of random-effects of accu-
racy and thresholds was also investigated and separate variance
terms included where required. The significance of the difference
in test performance was assessed by a likelihood ratio test com-
paring models with and without covariate terms for accuracy and
threshold. Where inadequate studies were available to estimate
all parameters, the HSROC model was simplified by assuming
a symmetrical shape to the summary ROC curve or fixed-effect
estimates.
Where more than one commercial test of the same type was tested
on the same patients against the same reference standard, we se-
lected one type at random from the analysis by test type, in order
to avoid bias due to inclusion of the same participants more than
once in the analysis. We included both types in any analyses com-
paring commercial brands.
Investigations of heterogeneity
We investigated heterogeneity for Type 1 tests because this was the
only test category for which there were sufficient studies available.
We investigated variation in sensitivity and specificity by adding to
the meta-analysis models covariates indicating the following char-
acteristics: age group; P. falciparum endemicity; continent where
the study took place; and adequacy of the reference standard.
Age groupwas classified as: children only; adults only;mixed adults
and children; and ’not stated’. Studies including, for example, all
ages over the age of five years were classified as ’mixed adults and
children’. The age cut-off between adults and children was as used
by the study authors.
Endemicity was divided into two categories: high and low.We clas-
sified endemicity as ’high’ if described by the authors as ’holoen-
demic’, ’hyperendemic’ or ’high’; and ’low’ if described as ’hypoen-
demic’, ’mesoendemic’, ’low’ or ’epidemic-prone’. In the case of
studies where a reported endemicity was not available, we imputed
endemicity using geographical location information provided in
the report. This involved mapping the location using ’Google
Earth’ onto country maps of mean parasite rate in children aged
two to ten years in 2007 (Hay 2009) provided by theMalaria Atlas
Project (www.map.ox.ac.uk). An example map produced during
this process is shown in Figure 1. Study sites with a mean par-
asite rate of less than 50% were classified as ’low’ endemicity to
correspond with endemicities of hypoendemic and mesoendemic;
study sites with a mean parasite rate of 50% and above were classi-
fied as ’high’ (Hay 2008). Where the endemicity was unclear and
borderline between ’high’ and ’low’ we assigned it ’high’. Where
multiple sites of differing endemicity class were included, and sep-
arate results by site were not available, the endemicity assigned to
that study was ’mixed’.
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Figure 1. Example map showing P. falciparum malaria endemicities and study locations
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For continent classification, where multi-site studies were con-
ducted across continents and results were not available for different
sites separately, the location of the study was classified according
to the continent with the largest number of participants.
Sensitivity analyses
Sensitivity analyses were undertaken to investigate the impact
of the reference standard method (PCR and PCR-adjusted mi-
croscopy) on the results obtained by microscopy alone.
R E S U L T S
Results of the search
The search identified 3971 titles, of which 3418 were excluded
on the basis of title alone. A further 168 were excluded without
obtaining full-text articles; 29 were excluded because they were
letters; and 139 were excluded on the basis of their abstract. We
were unable to obtain one article in full-text form. Full-text ar-
ticles were retrieved for 384 titles, of which 307 were excluded:
254 because they were initially assessed as ineligible; 17 because
the reports did not present sufficient detail for us to be sure of
their eligibility or ineligibility; 18 because they were available only
in non-English languages; 12 because we were unable to extract
absolute numbers of true positives, false positives, false negatives
and true negatives; and six because they did not present data on P.
falciparum malaria, although they were eligible for other reviews
in this series.
Two further studies were included as theywere identified as eligible
during an earlier, scoping stage of the review process but were not
identified by the final search.
A total of 74 unique studies described in 79 study reports are
therefore included in the review. However, as some of these studies
were divided for the purposes of the review (for example, because
they used two different reference standards or were conducted in
two communities with differing characteristics), 89 separate study
cohorts are identified. Fourteen of the 89 study cohorts evaluated
more than one test: one compared seven tests, three compared
three tests and ten compared two tests. Thus, there are a total
of 111 test evaluations reporting a total of 60,396 test results.
Microscopy was the reference standard for 104 test evaluations,
PCR-adjusted microscopy for two and PCR alone for five,
Sixty-five study cohorts (40,062participants) assessed the accuracy
of Type 1 tests using microscopy as the reference standard; 16
study cohorts (13,010 participants) did the same for a Type 4 test,
eight for a Type 2 test (3397 participants), five for a Type 3 test
(958 participants) and three for a Type 5 test (1777 participants).
Seventy-five cohorts (43,307 participants) assessed the accuracy of
HRP-2 antibody-based tests and 19 cohorts (14,787) assessed the
accuracy of pLHD antibody-based tests. Only four studies used
PCR and one used PCR-adjusted microscopy. A summary of the
numbers of studies assessing each RDT type using microscopy,
PCR or PCR-adjusted microscopy is shown in Table 3.
Table 3. Number of studies verifying each RDT type with reference standard
Type of RDT Number of study cohorts (test evaluations if different) by reference standard
Microscopy PCR PCR-adjusted microscopy
Type 1 65 (71) 2 1
Type 4 16 (17) 1 0
Type 2 8 0 0
Type 3 5 1 1
Type 5 3 0 0
Type 6 0 1 0
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Methodological quality of included studies
The overall methodological quality of all included study cohorts
is summarized in Figure 2. Just over 50% clearly included a repre-
sentative spectrum of participants attending ambulatory care set-
tings with symptoms suggestive of malaria; the majority of the
remaining studies were unclear, in most cases because they had
not described the sampling methods. Around 40% reported an
acceptable reference standard, 40% were unclear about the mi-
croscopy method, and 20% reported an unacceptable quality ref-
erence standard (heterogeneity relating to this criteria is investi-
gated below). As expected, almost all the included studies reported
avoidance of partial verification and differential verification, and
all reported avoidance of incorporation bias. Around 65% of study
cohorts reported blinding of the reference standard to the results
of the index test, and around 70% reported blinding of the index
test to the results of the reference standard. Only around 25%
of studies reported on uninterpretable results while around 60%
either explained any withdrawals or were clear that there were no
withdrawals.
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Twenty-four of the included studies gave details of the number of
uninterpretable or invalid RDT results. Eight reported no unin-
terpretable RDT results; one reported that 14% of tests needed
to be repeated; and 15 reported small numbers of uninterpretable
test results (<1% to 5%), which were excluded from the analy-
sis. Four studies reported small numbers of uninterpretable mi-
croscopy slides, which were excluded from the analysis.
Four key quality items (representative spectrum, adequate refer-
ence standard, blinding of reference test, and index test) are used
to evaluate each RDT type in Table 4. A lower proportion of those
studies assessing Type 1 and Type 4 RDTs reported an adequate
reference standard than those assessing other RDT types (P=0.05)
(only 25% of Type 1 evaluations and 29% of Type 2 evaluations
were judged to be adequate).
Table 4. Methodological quality by RDT type







Type 1 71 38 (54%) 18 (25%) 44 (62%) 50 (70%)
Type 2 8 2 (25%) 4 (50%) 6 (75%) 7 (88%)
Type 3 5 4 (80%) 2 (40%) 4 (80%) 4 (80%)
Type 4 17 9 (53%) 5 (29%) 10 (59%) 12 (71%)
Type 5 3 1 (33%) 3 (100%) 2 (67%) 3 (100%)
Test for difference
between types
P = 0.54 P = 0.05 P = 0.93 P = 0.84
Findings




There were 71 evaluations of Type 1 RDTs verified with mi-
croscopy (based on data from 40,062 individuals in 65 cohorts
described in 55 publications); forty-one were conducted in Africa,
28 in Asia and two in South America. The median sample size
was 269 (range 30 to 7000), and the median prevalence of falci-
parum malaria parasitaemia was 30% (range 1% to 92%). Only
nine of the 71 evaluations were undertaken exclusively in children
under the age of five. Ten different RDT brands were evaluated:
Paracheck-Pf (27), ParaSight (17), ICTMalaria Pf (16), ParaHIT-
F (4), PATH (2), Determine Malaria Pf (1), Rapid Test Malaria
(1), Diaspot Malaria (1), New mini-Pf (1), and Hexagon Malaria
(1). The earliest study was published in 1996, with the majority
published between 1999 and 2007.
Sensitivities of the tests ranged from 42% to 100%, specifici-
ties from 65% to 100% (Figure 3). The meta-analytical aver-
age sensitivity and specificity (95% confidence interval (CI)) were
94.8% (93.1% to 96.1%) and 95.2% (93.2% to 96.7%), respec-
tively, but heterogeneity was noted between studies. Comparing
the ten RDT brands in an analysis of the 71 evaluations revealed
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no statistically significant differences (P = 0.18), although differ-
ences may be masked by the high between study heterogeneity
(Table 5, see Appendix 4 for extra figures). In an analysis restricted
only to the four brands evaluated in more than 1000 patients
(Paracheck-Pf, ParaSight, ICT Malaria Pf, ParaHIT-F), pairwise
comparisons indicated that ICTMalaria Pf was significantly more
sensitive than Paracheck-Pf and ParaSight-F (97.7% compared
to 93.3% and 94.2%, respectively), whilst ParaHIT-F was sig-
nificantly more specific than Paracheck-Pf, ParaSight-F, and ICT
Malaria Pf (98.9% compared to 95.7%, 94.5% and 94.5%, re-
spectively) (see Appendix 5).However, these differences were small
and are based on between-study comparisons, so may have been
due to differences between the studies rather than true differences
between the test brands.
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Figure 3. Study results of Type 1 RDTs plotted in ROC space (by RDT brand)
Table 5. RDT types and brands verified with microscopy
RDT Brand Study cohorts
(n)








Paracheck-Pf 27 22,319 6929 93.2 (89.7, 95.6) 95.6 (92.8, 97.3) P = 0.15
ParaSight-F 17 12,521 3261 94.1 (89.9, 96.6) 94.6 (90.4, 96.8)
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Table 5. RDT types and brands verified with microscopy (Continued)
ICT Malaria-Pf 16 2955 1200 97.6 (95.5, 98.8) 94.5 (90.5, 96.9)
ParaHIT-F 4 1119 192 92.3 (74.9, 98.0) 98.9 (94.9, 99.8)
Determine
Malaria-Pf
1 526 262 98.2 (85.4, 99.8) 86.8 (35.1, 98.8)
PATH 2 378 180 96.6 (83.8, 99.3) 93.3 (68.6, 98.9)
Rapid Test
Malaria
1 306 36 97.8 (70.1,
100.0)
96.1 (65.6, 99.7)
DiaSpot Malaria 1 153 63 71.8 (23.1, 95.6) 82.6 (27.3, 98.4)
Hexagon
Malaria
1 119 32 100.0 (.) 65.7 (13.4, 96.0)
New Pf-1 mini 1 10 6 100.0 (0, 100.0) 100.0 (.)




6 2255 600 96.0 (93.6, 97.5) 95.6 (86.1, 98.7) P = 1.0
Now Malaria
ICT
2 1142 190 96.0 (91.6, 98.1) 94.1 (66.6, 99.2)
Combined 8 3397 790 96.0 (94.0, 97.3) 95.3 (87.3, 98.3)
Type 3 (too few studies to stratify by brand)




OptiMAL 10 3393 833 90.1 (86.3, 92.9) 99.3 (98.0, 99.8) P = 0.009
Carestart Pf/Pan 2 537 240 97.8 (94.1, 99.2) 92.2 (72.4, 98.1)
OptiMAL-IT 3 1356 280 87.4 (79.9, 92.4) 97.0 (88.4, 99.3)
Parabank 2 7918 2992 87.9 (82.0, 92.0) 98.8 (90.9, 99.9)
Combined3 16 13,010 4274 91.5 (84.7, 95.3) 98.7 (96.9, 99.5)
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Table 5. RDT types and brands verified with microscopy (Continued)
Type 5 Brands (too few studies to stratify by brand)
Combined4 3 1777 400 98.4 (95.1, 99.5) 97.5 (93.5, 99.1)
1 Likelihood ratio test for evidence of a difference between brands.
2 65 study cohorts evaluated 71 different tests. Only one test (selected randomly) from each cohort is included in the combined analysis.
3 16 study cohorts evaluated 17 different tests. Only one test (selected randomly) from each cohort is included in the overall analysis.
4 HSROC model fitted assuming no correlation between sensitivity and specificity.
Type 2 tests
There were eight evaluations of Type 2 RDTs verified with mi-
croscopy (based on data from 3397 individuals in eight cohorts
described in seven publications); seven were conducted in Asia and
one in South America. The median sample size was 347 (range
113 to 896), and the median prevalence of falciparummalaria par-
asitaemia was 21% (range 6% to 46%). None of the evaluations
were undertaken exclusively in children under the age of five. Two
different RDT brands were evaluated: ICT Malaria Pf/Pv (6) and
NOW ICTMalaria (2). The earliest study was published in 1999,
with the majority published between 2000 and 2005.
Sensitivities of the tests ranged from 86% to 100%, specificities
from 74% to 100% (Figure 4). The meta-analytical average sen-
sitivity and specificity (95% CI) were 96.0% (94.0% to 97.3%)
and 95.3% (87.3% to 98.3%), respectively. Comparing the two
RDT brands in an analysis of the eight evaluations showed no
statistically significant differences (P = 1.0) (Table 5, see Appendix
4 for extra figures).
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Figure 4. Forest plot of study results of Type 2, 3 and 5 RDTs (by RDT brand)
Type 3 tests
There were five evaluations of Type 3 RDTs verified with mi-
croscopy (based on data from 958 individuals in five cohorts de-
scribed in five publications); three were conducted in Africa and
two in Asia. The median sample size was 194 (range 30 to 291),
and the median prevalence of falciparummalaria parasitaemia was
37% (range 25% to 57%). One of the evaluations was undertaken
exclusively in children under the age of five. Three different RDT
brandswere evaluated: SDMalaria AntigenBioline (2), Parascreen
(2), and First Response Malaria (1). The earliest study was pub-
lished in 2004.
Sensitivities of the tests ranged from 86% to 100%, specificities
from 65% to 100% (Figure 4). The meta-analytical average sensi-
tivity and specificity (95% CI) were 99.5% (71.0% to 100%) and
90.6% (80.5% to 95.7%), respectively. There were inadequate
data on each RDT brand to make formal statistical comparisons
(see Appendix 4 for extra figures).
Type 6 tests
No studies assessed the accuracy of Type 6 RDTs verified with
microscopy.
All HRP-2 antibody based tests
There were 84 evaluations ofHRP-2 tests verifiedwithmicroscopy
(based on data from 43,307 individuals in 75 cohorts described in
64 publications); forty-two cohorts were conducted in Africa, 31
in Asia and two in South America. The median sample size was
291 (range 30 to 7000), and the median prevalence of falciparum
malaria parasitaemia was 26% (range 1% to 84%). Nine of the
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evaluations were undertaken exclusively in children under the age
of five. Sensitivities of the tests ranged from 42% to 100%, and
specificities ranged from 65% to 100%. The meta-analytical av-
erage sensitivity and specificity (95% CI) were 95.0% (93.5% to
96.2%) and 95.2% (93.4% to 99.4%), respectively.
pLDH antibody based tests
Type 4 tests
There were 17 evaluations of Type 4 RDTs verified with mi-
croscopy (based on data from 13,010 individuals in 16 cohorts de-
scribed in 14 publications); eight were conducted in Africa, eight
in Asia and one in South America. The median sample size was
305 (range 75 to 7000), and the median prevalence of falciparum
malaria parasitaemia was 32% (range 2% to 61%). Only four of
the 17 evaluations were undertaken exclusively in children under
the age of five. Four different brandswere assessed:OptiMAL (10),
OptiMAL-IT (3), Parabank (2) and Carestart Malaria Pf/Pan (2).
The earliest study was published in 1999, with the majority pub-
lished between 2003 and 2007.
Sensitivities of the tests ranged from 80% to 100%, specificities
from 90% to 100% (Figure 5). The meta-analytical average sensi-
tivity and specificity (95%CI) were 91.5% (84.7% to 95.3%) and
98.7% (96.9% to 99.5%), respectively. Comparing the four RDT
brands in an analysis of the 17 evaluations revealed statistically
significant differences (P = 0.009) (Table 5). Carestart Malaria Pf/
Pan was observed to have a higher sensitivity and lower specificity
than either OptiMAL, OptiMAL-IT or Parabank (sensitivity of
97.8% compared with 90.1%, 87.4% and 87.9%, respectively;
specificity of 92.2% compared with 99.3%, 97.0% and 98.8%,
respectively). See Appendix 4 for extra figures. These differences
are based on between-study comparisons, so may have been due
to differences between the studies rather than true differences be-
tween test brands.
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Figure 5. Study results of Type 4 RDTs plotted in ROC space (by RDT brand)
Type 5 tests
There were three evaluations of Type 5 RDTs verified with mi-
croscopy (based on data from1777 individuals in three cohorts de-
scribed in three publications); two were conducted in Africa, one
in Asia and none in South America. The median sample size was
668 (range 240 to 869), and the median prevalence of falciparum
malaria parasitaemia was 23% (range 20% to 25%). None of the
evaluations were undertaken exclusively in children under the age
of five. Two different RDT brands were evaluated: Carestart Pf/
Pv (2), and ParaSight Pf/Pv (1). The earliest study was published
in 2003.
Sensitivities of the tests ranged from 96% to 99%, specificities
from 93% to 100% (Figure 4). The meta-analytical average sen-
sitivity and specificity (95% CI) were 98.4% (95.1% to 99.5%)
and 97.5% (93.5% to 99.1%), respectively. There were inadequate
data on each RDT brand to make formal statistical comparisons.
See Appendix 4 for extra figures.
All pLDH antibody based tests
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There were 20 evaluations of pLDH antibody-based tests verified
with microscopy (based on data from 14,787 individuals in 19 co-
horts described in 17 publications); nine cohorts were conducted
in Africa, nine in Asia and one in South America. The median
sample size was 343 (range 75 to 7000) and themedian prevalence
of falciparum malaria parasitaemia was 28% (range 2% to 58%).
Four of the evaluations were undertaken exclusively in children
under the age of five.
Sensitivities of the tests ranged from 80% to 100% and specifici-
ties ranged from 90% to 100%. The meta-analytical average sen-
sitivity and specificity (95% CI) were 93.2% (88.0% to 96.2%)
and 98.5% (96.7% to 99.4%), respectively.
Comparisons between RDT types
Statistical comparisons could only be made between Type 1 and
Type 4 tests, as the number of studies evaluating other test types
was inadequate to provide stable estimates of comparisons in the
meta-analytical models. Models were fitted allowing for different
degrees of heterogeneity for the two test types: results for Type 1
were more heterogeneous than Type 4. Significant differences in
test accuracy (P = 0.009) were noted between Type 1 and Type 4
RDTs: Type 4 tests tended to have slightly lower sensitivity (P =
0.34) but significantly higher specificity (P < 0.001) than Type 1
tests in the comparisons based on all data (shown graphically in
Figure 6). When the analysis was restricted to the seven studies
with direct comparisons, the same patterns were evident, but none
were statistically significant (Table 6). Based on estimates from all
studies, Type 1 tests detect on average three more cases out of every
100 people with malaria than Type 4 tests (P = 0.20), but give on
average three more false positive diagnoses for every 100 people
without malaria (P < 0.001).
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Figure 6. Summary ROC Plot comparing different RDT types verified with microscopy (points are meta-
analytical estimates, regions are 95% confidence regions, no regions could be computed for Type 2 and 5 due
to small numbers of studies)
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Antibody-based test: indirect comparison (using all studies)
HRP-2 based 75 43,307 12,857 95.0 (93.5, 96.2) 95.2 (93.4, 96.6)
pLDH based 19 14,787 4674 93.2 (88.0, 96.2) 98.5 (96.7, 99.4)
Ratio 0.98 (0.94, 1.02)
, P = 0.34
1.03 (1.02, 1.05)
, P < 0.001
P = 0.01
Antibody-based test: direct comparison (using only studies that directly compared the two)
HRP-2 based 9 10,626 3672 95.6 (90.0, 98.1) 95.8 (84.7, 98.9)
pLDH based 9 10,623 3672 94.8 (84.1, 98.2) 98.1 (87.8, 99.7)
Ratio 0.99 (0.94, 1.04)
P = 0.60
1.02 (0.98, 1.07)
, P = 0.22
P = 0.35
Test type: indirect comparison (using all studies of Type 1 and 4)
Type 1 65 40,062 11,966 94.8 (93.0, 96.1) 95.2 (93.2, 96.7)
Type 4 16 1,3010 4274 91.5 (84.7, 95.3) 98.7 (96.9, 99.5)
Ratio 0.96 (0.91, 1.02)
, P = 0.20
1.04 (1.02, 1.06)
, P < 0.001
P = 0.009
Test type: direct comparison (using only comparative studies of Type 1 and 4)
Type 1 7 9764 3433 94.5 (88.6, 97.4) 95.7 (72.2, 99.5)
Type 4 7 9761 3433 92.0 (85.7, 94.8) 98.6 (80.0, 99.9)
Ratio 0.97 (0.87, 1.09)
, P = 0.51
1.03 (0.95, 1.11)
, P = 0.31
P = 0.26
1Likelihood ratio test for evidence of a difference between test accuracy estimates between antigen and RDT types.
Four further studies provided direct comparisons between tests
(Appendix 6). One study showed Type 2 to have higher sensitivity
than Type 4, but lower specificity than both Type 4 and Type 1;
another study showed that Type 3 tests had higher sensitivity than
Type 1. The remaining studies showed no significant differences
between types. As these comparisons are based on single small
studies, their results should be interpreted with caution.
22Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparisons between HRP-2 and pLDH antibody
based RDT Types
RDT types 1 to 3 are all based on HRP-2 antibodies, while types
4 and 5 are related to detection of pLDH antigen. The process of
grouping types based on this antibody classification is dominated
by the results of the Type 1 tests (which constitute 65 out of 75 of
the included HRP-2 antibody-based test studies) and Type 4 tests
(which constitute 16 out of 19 of the included pLDH antibody-
based test studies). Nine studies provide direct within-participant
comparisons of HRP-2 and pLDH test types, eight of which are
comparisons of a Type 1 test with a Type 4 test. As for Type 1 and
Type 4 tests, it was necessary to allow for different heterogeneity
between the test types in the meta-analytical model.
On average, HRP-2 antibody-based tests tend to have slightly
higher sensitivity (P = 0.34) but significantly lower specificity
(P<0.001) than pLDH antibody-based tests, based on analysis of
all data (Table 6; Figure 7). Differences based on direct compar-
isons showed the same pattern, but none of the differences were
statistically significant. For every 100 malaria cases, around two
more are detected with HRP-2 antibody-based tests than pLDH
antibody-based tests (P = 0.34 in analysis based on all data, P=0.60
in analysis based on within-study comparisons), but this is at the
cost of four false positives for every 100 people without malaria
(P < 0.001 in analysis based on all data, P = 0.22 in analysis based
on within-study comparisons).
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Figure 7. Summary ROC Plot comparing HRP-2-based and pLDH-based RDTs across all studies verified
with microscopy (points are meta-analytical estimates, regions are 95% confidence regions)
Investigations of heterogeneity
Heterogeneity investigations were undertaken to test for differ-
ences in RDT performance related to age, endemicity, geograph-
ical location and the use of an adequate reference standard. Anal-
yses were restricted to the 65 test cohorts in which RDTs of Type
1 were evaluated. Results are presented in Table 7.
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Mixed ages 29 23,967 7536 93.8 (90.6, 96.0) 94.2 (90.7, 96.5) P = 0.41
Children only 9 2261 907 94.1 (87.2, 97.4) 93.4 (84.6, 97.3)
Not stated 27 13,834 3523 95.9 (93.4, 97.5) 96.2 (93.7, 97.8)
Endemicity
Low 51 29,305 7671 95.1 (93.1, 96.6) 95.9 (94.1, 97.2) P = 0.22
High 10 1824 806 93.7 (87.0, 97.1) 89.6 (78.3, 95.3)
Mixed 4 8933 3489 93.2 (81.1, 97.8) 92.5 (76.5, 97.9)
Adequate reference standard
No 15 5499 1869 93.7 (88.6, 96.6) 95.5 (91.1, 97.7) P = 0.34
Unclear 32 13,481 3439 95.4 (92.8, 97.1) 96.2 (93.9, 97.7)
Yes 18 21,082 6658 94.6 (90.9, 96.9) 92.1 (86.0, 95.7)
Continent
Africa 39 21,958 7445 94.0 (91.3, 95.9) 93.0 (89.8, 95.3) P = 0.01
Asia 24 1,5810 4060 96.7 (93.7, 97.8) 96.7 (94.4, 98.1)
South America 2 2294 461 88.7 (61.9, 97.4) 99.4 (96.4,
100.0)
Continent (South America excluded)
Africa 39 21,958 7445 94.0 (91.2, 96.0) 93.1 (89.7, 95.3) P = 0.03
Asia 24 15,810 4060 96.4 (93.7, 97.9) 96.6 (94.0, 98.1)
1Likelihood ratio test for model with and without the covariate.
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Nine study cohorts only recruited children aged five years or under,
28 recruited mixed age groups, and in 27 age distributions were
not described. No difference in test accuracy was noted by age
category (P = 0.41).
Fifty-one study cohorts were in low endemicity areas, 10 in high
areas, and three were categorized as being in areas of mixed en-
demicity. Although specificity appeared to be lower in high en-
demicity areas, the differences were not statistically significant (P
= 0.22).
Significant differences were seen by continent, with lower sensi-
tivity (by 2.7%) and specificity (by 3.7%) in Africa than Asia (P
= 0.01). Results from the South American studies showed very
high specificity (99.4%) and low sensitivity (88.7%), but should
be judged with caution due to only two studies being available.
Fifteen of the Type 1 study cohorts used inadequate reference stan-
dards and in 32 the reference standardwas unclear, but their results
did not differ significantly from the 17 with adequate reference
standards (P = 0.34).
Sensitivity analysis
For all the above analyses, a sensitivity analysis was undertaken by
including the one study in the review (Hopkins 2008b) that used
PCR-adjusted microscopy as the reference standard; its inclusion
made no difference to any of the findings.
OTHER ANALYSES
Use of PCR as a reference standard
Five study cohorts (from four studies) used PCR as a reference
standard: two Type 1 RDTs (ParaSight-F and ParaHIT-F), one
Type 3 RDT (SD Malaria Antigen Bioline), one Type 4 RDT
(OptiMAL-IT) and one Type 6 RDT (PALUTOP). Comparisons
were made with the corresponding microscopy evaluations for the
first four of these tests (Appendix 7). Use of PCR as a reference
standard reduced estimates of the sensitivity of the RDTs but in-
creased estimates of specificity compared with the microscopy-
based reference standard for three of the four studies in which
comparison was possible.
For two studies, results are available separately using microscopy
and PCR reference standards (Banchongaksorn 1996b; Nicastri
2009b). In one study (Banchongaksorn 1996a; Banchongaksorn
1996b), both sensitivity and specificity for PCR and microscopy
were within 1% of each other. In the other (Nicastri 2009a;
Nicastri 2009b), specificities were 99% when verified by mi-
croscopy and 100%when verified by PCR; sensitivity verifiedwith
microscopy was 47% (95% CI 29% to 65%) compared with 72%
(95% CI, 51% to 88%) for PCR. In this study with 336 partici-
pants, 26 were positive for malaria by PCR, 32 by microscopy and
18 by RDT, suggesting a relatively high rate of false positives for
microscopy in the context of a low prevalence.
Five of the included studies presented data, in addition to the
comparisons included in the review, on the accuracy of their mi-
croscopy reference standard against PCR (excluding one study
with only two microscopy positive cases). In three studies, where
the quality of the microscopy was unclear (Gaye 1999; Mens
2007b; Nicastri 2009b), sensitivity of microscopy against PCR
varied between69%and89%; in two studieswith adequate quality
microscopy (Banchongaksorn 1996b; Rakotonirina 2008), sen-
sitivity varied between 90% and 96%. Specificity of microscopy
against PCR was high in all five studies, varying between 96% and
100%.
Comparing the accuracy of RDTs and local standard
microscopy
In addition to the comparison of RDT against the ’gold stan-
dard’ microscopy, seven of the included studies presented a
comparison of local microscopy against reference standard mi-
croscopy. These studies reportedwidely differing results: one study
showed local microscopy services to be slightly more accurate
than RDTs (Kolaczinski 2004); three studies showing local mi-
croscopy to be extremely inaccurate, with very low specificities of
0% (A-Elgayoum 2009) to 25% (Tagbo 2007), or a sensitivity
so low that only around half of cases were detected (De Oliveira
2009); and the others were intermediate but favouring RDTs. The
findings of the two studies with an adequate reference standard
are presented in Appendix 8.
Summary of results
Summary of results. New Summary of results table
What is the diagnostic accuracy of Rapid Diagnostic Tests for detecting malaria? What are the best types of tests?
Patients/
populations
People presenting with symptoms suggestive of uncomplicated malaria
Prior testing None
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Summary of results. New Summary of results table (Continued)
Settings Ambulatory healthcare settings in P. falciparum malaria endemic areas in Asia, Africa and South America
Index tests Immunochromatography-based rapid diagnostic tests for P. falciparum malaria
Reference stan-
dard
Conventional microscopy or PCR
Importance Accurate and fast diagnosis allows appropriate and quick treatment for malaria to be provided
Studies Consecutive series of patients; 74 studies presented 111 test evaluations based on 60,396 patient test results
Quality
concerns
Poor reporting of patient characteristics, samplingmethod and reference standardmethods were common concerns
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in accuracy P =
0.009
Type 1 3.3% more sensitive than
Type 4 (P = 0.20)
Type 4 3.5%more specific thanType
1 (P < 0.001)




in accuracy P =
0.26
Type 1 2.5% more sensitive than
Type 4 (P = 0.51)
Type 4 2.9%more specific thanType
1 (P = 0.31)
HRP-2 vs
pLDH
All studies 75 HRP-2 vs 19
pLDH
HRP-2 1.8% more sensitive than
pLDH (P = 0.34)
pLDH 3.3% more specific than
HRP-2 (P = 0.01)
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Summary of results. New Summary of results table (Continued)
Overall signif-
icant difference
in accuracy P =
0.01




in accuracy P =
0.35
HRP-2 0.8% more sensitive than
pLDH (P = 0.60)
pLDH 2.3% more specific than
HRP-2 (P = 0.22)
D I S C U S S I O N
Malaria diagnosis and treatment policies have shifted rapidly over
the past few years. In 2006, in its guidelines on malaria treatment,
the WHO abandoned presumptive treatment with ineffective or
only partly effective treatments for the new ACTs. Now, in the sec-
ond (2010) edition of these guidelines, parasitological diagnosis is
expected (WHO 2010): “prompt parasitological confirmation by
microscopy or alternatively by RDTs is recommended in all pa-
tients suspected of malaria before treatment is started”. In primary
care in most developing countries, prompt, accurate results from
microscopy can’t be delivered efficiently, and so demonstrating the
sensitivity and specificity of these tests helps reassure policymakers
pushing investment in and purchase of this technology.
For P. falciparum malaria, targeting treatment will help to reduce
unnecessary drug use and thus help to avoid the development
of drug resistance. The test will also help health workers exclude
malaria as a cause of fever and thus improve the diagnosis and
treatment of other infections. In addition, as malaria control im-
proves as a result of all the new approaches including use of ACTs
(Sinclair 2009) and other preventivemeasures such as impregnated
mosquito nets (Lengeler 2004), transmission will drop, immunity
will drop and thus prompt detection and treatment becomes even
more important for reducing severe illness.
Thus, the current policy question is: howwell do RDTs perform in
diagnosing symptomatic patients compared to the previous stan-
dard ofmicroscopy? There are subsidiary questions about howwell
the various types and individual commercial tests perform against
microscopy and against each other. This information will help to
inform choice, although factors such as price, product consistency,
stability, and shelf life will also influence those decisions. In addi-
tion, areas vary in relation to malaria species not detected by these
tests (P. vivax and other non-falciparummalaria species). Thus the
choice of commercial product will also depend on whether it is
important for clinicians to detect these species. For example, as
malaria eradication proceeds and endemicity of malaria falls, be-
ing able to detect P. vivax is likely to become more important. In
these circumstances, the sensitivity and specificity of the commer-
cial product to P. vivax may be a factor in the choice of product.
This is the subject of a forthcoming Cochrane review.
Summary of main results
The main results are summarized in the Summary of Results table
(Summary of results).
• There is a large volume of research on the accuracy of RDTs
in malaria endemic countries that required meta-analysis.
• In diagnosing P. falciparum malaria, all tests performed
reasonably well. Most studies identified for the current review
were carried out on Type 1 (HRP-2) and Type 4 (pLDH) test,
with fewer reports available on the other HRP-2 tests (Types 2
and 3) and the other pLDH tests (Type 5).
• There is a trade-off between sensitivity and specificity for
Type 1 and Type 4 tests. Type 1 tests were falsely negative in
about 5% of P. falciparum cases and were falsely positive in about
5% of people without P. falciparum. Type 4 tests were falsely
negative in 8% to 9% of cases but were falsely positive only in
about 1% of non-malaria cases. The results are mirrored by the
available direct within-study comparisons between tests
(although results were not statistically significant). There were
only two brands of Type 1 and Type 4 tests that failed to follow
these patterns. These findings support the results of laboratory-
based testing undertaken by WHO (WHO 2010a), and
probably reflect the different antigens used by different test
types. The lower specificity of Type 1 tests may be due to the use
of HRP-2 antibodies, which can give a false positive result in
cases where a person has recently been successfully treated for P.
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falciparum malaria, due to persistent antigenaemia. Analysis of
all HRP-2 antibody-based tests and all pLDH antibody-based
tests was undertaken and gave similar results, but was dominated
by Type 1 and Type 4 tests.
• The sensitivities and specificities of Type 2, Type 3 and
Type 5 tests were similar to those of Type 1 and Type 4 tests, but
these three types have not been evaluated widely and robust
comparisons are not possible.
• Studies of Type 1 tests conducted in Africa reported slightly
lower estimates of sensitivity and specificity than those
conducted in Asia. The reasons for this are unclear, and may
relate to the relative quality of the studies conducted in different
locations, but are most likely due to higher rates of transmission
and persistent antigenaemia in Africa.
• Reporting of studies is variable: 40% reported an adequate
reference standard, 40% did not provide enough information to
assess the quality of the reference standard and 20% reported an
inadequate reference standard. Other published studies were
excluded from the review due to inadequate reporting. It would
be helpful in the future for diagnostic test accuracy studies to be
more carefully reported on, using the STARD (Bossuyt 2003)
criteria, to ensure their inclusion in meta-analyses.
Application of meta-analysis to hypothetical cohort
Table 1 (Summary of results) summarizes the findings of the re-
view and applies them to two hypothetical cohorts of 1000 symp-
tomatic patients. In one of the cohorts, the prevalence of P. falci-
parummalaria parasitaemia is 30%, while in the other cohort it is
50%.
Falciparum malaria prevalence at 30%: on average, a Type 1
test would miss 16 P. falciparum cases, while a Type 4 test would
miss 26 cases. In contrast, a Type 1 test would wrongly identify
34 non-cases as having falciparum malaria, whereas a Type 4 test
would only wrongly identify nine non-cases as falciparummalaria.
Falciparum malaria prevalence at 50%: on average, a Type 1
test would miss 26 cases of falciparummalaria, while a Type 4 test
would miss 43 cases. In contrast, a Type 1 test would wrongly
identify 24 non-cases as having falciparummalaria, whereas a Type
4 test would only wrongly identify seven non-cases as falciparum
malaria.
At very low and very high falciparum malaria prevalence: the
sensitivity advantage of Type 1 tests, in terms of cases not missed,
is less. For example, where prevalence is 10%, Type 1 tests would
result in five cases being missed and 43 non-cases incorrectly iden-
tified as falciparummalaria. At higher prevalence, the greater sen-
sitivity of Type 1 tests makes a greater difference; at 80% preva-
lence, Type 1 tests would result in 42 missed cases compared with
68 missed cases with Type 4 tests.
The numbers of false positives presented should be viewed with
caution, as some RDTs may be more sensitive than microscopy.
Strengths and weaknesses of the review
The results of this review are based on strict and careful searching,
study inclusion, and data extraction. The strength of this review is
that it allows an assessment to be made between types and brands
of test, and also provides an accurate assessment of the trade-offs.
Completeness of evidence
This is a reasonably complete data set. We excluded 18 potentially
eligible studies not published in English, 17 studies that did not
provide enough information to accurately assess whether they met
our inclusion criteria, and 12 studies that gave only calculated
values where imputation was not possible. However, it is known
that studies of diagnostic test accuracy tend to be poorly indexed
(Whiting 2009), and we may therefore have missed some studies
despite the comprehensive search; in fact, two of the included
studies were identified only in an earlier, scoping search.
Accuracy of the reference standards used:
Microscopy is regarded as the gold standard formalaria, and hence
is the primary comparison, although PCR may be more sensitive.
Comparisons of microscopy and PCR showed that microscopy
was highly accurate when the microscopy methods were classified
as ’adequate’, but less accurate when themicroscopy methods were
of poorer quality. However, the quality of the microscopy did not
explain any heterogeneity in the meta-analysis of Type 1 tests and
therefore is unlikely to be an important factor in the interpretation
of the study findings.
Quality and quality of reporting of the included studies:
Many of the included studies was not well reported. For example,
reference standards were often not well described, there was often
insufficient methodological detail, and numbers sometimes did
not add up.
Only 40% of the included studies reported an adequate reference
standard and 20% reported an inadequate reference standard. In
Type 1 test studies, which were generally older and of lower qual-
ity, only 25% reported an adequate reference standard. As the
quality of the reference standard did not explain heterogeneity in
this analysis, it seems unlikely that including studies with an un-
clear or inadequate reference standard caused any kind of bias.
In addition, only half of the included studies were explicit about
patient recruitment involving a consecutive or random series of
patients. Blinding of the index and reference tests was reported in
the majority of studies (65% and 70%, respectively). Only 60%
of studies explained withdrawals or stated that there were none.
Sampling did not seem to be a significant problem, as the tests
were taken at the same time, and few lost or uninterpretable test
results were reported.
Interpretability of subgroup analyses:
The subgroup analysis is interpreted in relation to the antigen
type, test type, and brand, and appears to make sense, although a
confounding effect of quality over time cannot be excluded with
the newer tests. The differences in specificity observed between
HRP-2 and pLDH antibody-based tests are significant and repli-
cate those found in systematic laboratory-based in vitro studies
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(WHO 2010a).
Completeness and relevance of the review:
This review covers P. falciparum malaria only, and stands alone
as relevant to areas where P. falciparum malaria predominates. A
further Cochrane diagnostic review in this series will cover P. vivax
and other non-falciparum malaria species.
Applicability of findings to clinical practice and
policy
We found no important differences in accuracy between differ-
ent RDT brands within the same type. Where significant differ-
ences between tests were found, these differences were small, and
were based onweaker between-study comparisons. For some types,
there were insufficient data to analyse differences between brands.
We found Type 1 RDTs to be more sensitive than Type 4, and
HRP-2 antibody-based tests to be more sensitive than pLDH an-
tibody-based tests, although the differences were not statistically
significant. The direction of this finding corresponds closely with
a similar analysis in a diagnostic test accuracy review of RDTs for
travellers with fever returning from malaria endemic areas to non-
endemic areas (Marx 2005). It also corresponds with laboratory-
based testing undertaken by WHO (WHO 2010a), where Type
1 tests had a lower threshold for detection of parasitaemia than
Type 4 tests. However, Type 4 tests and pLDH antibody-based
tests tended to bemore specific, and this difference was significant.
This research assesses sensitivity and specificity in applied research
settings. In the field, the quality of microscopy is likely to be lower
and the RDTs may not be read so accurately (Hawkes 2009).
Further research is required on effective implementation of RDTs,
as they can only influence clinical practice if the results are believed
and acted upon. There may be a reluctance on the part of both
health providers and patients to believe negative RDT results,
leading to unnecessary prescribing of antimalarials for negative
cases (Tavrow 2000). Trials in this area are in the process of being
summarized (Odaga 2011).
The consequences of a false positive are that someone may be
treated for malaria when they are not infected. The consequences
of a false negative in an endemic area, particularly when related
to low parasitaemia, means the patient is unlikely to die. The
infection may clear by itself, as people living in endemic areas have
partial immunity; if it does not, the illness will recur and they
would seek care again.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Thehigh sensitivity and specificity ofRDTsmeans they can replace
or augment microscopy for diagnosing P. falciparum malaria.
The performance of RDT types varied but the differences were
not large. HRP-2-based tests tended to be more sensitive and were
significantly less specific than pLDH-based tests. Choice will de-
pend on prevalence of malaria, and we provide data in this review
to assist these decisions, although policy makers will also take into
account other factors relating to cost and test stability.
Implications for research
Future studies should include comparisons between new RDTs
and commonly-used Type 1 and/or Type 4 RDTs in the same
patients.
Studies should be reported according to the STARD guidelines
(Bossuyt 2003), which will also facilitate incorporation into meta-
analysis.
Further research on effective implementation of RDTs within rou-
tine clinical practice is needed.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
A-Elgayoum 2009
Clinical features and settings Presenting signs and symptoms: Clinically suspected malaria
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but actual data not provided.
Clinical setting: Primary healthcare facilities
Country: Khartoum state, central Sudan
Malaria endemicity: Seasonal and low
Malaria endemic species: P. falciparum
Participants Sample size: 410
Age: All age groups eligible. Mean age 21 years.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Expert malaria microscopist
Microscopy setting: Quality Assurance Laboratory
Number of high power fields examined before declaring negative: 300
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not stated
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not stated
Person(s) performing RDT: Technicians
RDT setting: Primary healthcare facilities
Follow-up Not applicable
Notes Source of funding: PhD financial support from the Ministry of Higher Education and
Scientific Research
Table of Methodological Quality
Item Authors’ judgement Description
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Yes Participants were a consecutive sample of
people presenting at healthcare facilities
with clinically suspected malaria
Acceptable reference standard?
All tests
Unclear Unclear how many observer repeats were




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Reported that the tests were performed
blindly
Index test results blinded?
All tests




Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore no
withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore no
withdrawals
Abeku 2008a
Clinical features and settings Presenting signs and symptoms: Clinically diagnosed malaria based on fever or history
of fever and absence of any other obvious cause of fever
Previous treatment for malaria: No exclusions based on previous malaria treatment.
Information on previous treatment collected, but data not presented.
Clinical setting: Government health centres
Country: Uganda
Malaria endemicity: Incidence 359.8 per 1,000 per year
Malaria endemic species: P. falciparum
Participants Sample size: 1237
Age: All age groups eligible. Actual age profile of participant population not presented,
but it is clear that the sample contains both children and adults.
Sex: Both males and females eligible. Actual proportions of males and females in the
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Abeku 2008a (Continued)
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent microscopists
Resolution of discrepancies between observers: By a third microscopist, who had the
final say
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at room temperature within the temperature
range recommended by the manufacturer and used within 24 months
Person(s) performing RDT: Laboratory staff who had been trained in their use
RDT setting: Health centres
Follow-up Not applicable
Notes Source of funding: Gates malaria Partnership and UK DFID
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of




Yes Two independent experienced micro-
scopists examined at least 200 high power
fields before declaring samples negative.
Discordant results were resolved by a third
microscopist in a double-blind manner.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
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Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Study report states that microscopists were
blinded to the RDT results
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was not clear; there-
fore unclear whether there were any with-
drawals due to invalid results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not clear; there-
fore unclear whether there were any with-
drawals
Abeku 2008b
Clinical features and settings Presenting signs and symptoms: Clinically diagnosed malaria based on fever or history
of fever and absence of any other obvious cause of fever
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but data not presented.
Clinical setting: Government health centres
Country: Kenya
Malaria endemicity: Incidence 43.2 per 1,000 per year
Malaria endemic species: P. falciparum
Participants Sample size: 1000
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent microscopists
Resolution of discrepancies between observers: By a third microscopist, who had the
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Abeku 2008b (Continued)
final say
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at room temperature within the temperature
range recommended by the manufacturer and used within 24 months
Person(s) performing RDT: Laboratory staff who had been trained in their use
RDT setting: Health centres
Follow-up Not applicable
Notes Source of funding: Gates malaria Partnership and UK DFID
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of




Yes Two independent experienced micro-
scopists examined at least 200 high power
fields before declaring samples negative.
Discordant results were resolved by a third
microscopist in a double-blind manner.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Study report states that microscopist were
blinded to the RDT results
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore unclear whether there were any
withdrawals due to invalid results
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Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore unclear whether there were any
withdrawals
Banchongaksorn 1996a
Clinical features and settings Presenting signs and symptoms: All patients attending malaria clinics
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but actual data not provided.
Clinical setting: Two malaria clinics
Country: Thailand (Tak Province and Trat province, East Thailand)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 520
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy:Microscopist and consultant
Microscopy setting: Regional and national malaria centres
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two
Resolution of discrepancies between observers: Not clear, ’the data were compared
and confirmed’
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: The study team
RDT setting: Malaria clinics
Follow-up Not applicable
Notes Source of funding: WHO Regional Office for South East Asia, new Delhi, India. Also
Dr Joe Perrone of Becton Dickinson provided the ParaSight-F kits
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Banchongaksorn 1996a (Continued)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were attending malaria clin-
ics and therefore suspected themselves that




Yes Two independent microscopists based at a
central laboratory examined at least 100




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that different tests were un-
dertaken “independently”
Index test results blinded?
All tests




Unclear Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore no
withdrawals due to invalid results
Withdrawals explained?
All tests
Yes Number enrolled in the study was explic-
itly stated and corresponded to the num-
ber presented in the analysis; therefore no
withdrawals
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Banchongaksorn 1996b
Clinical features and settings Presenting signs and symptoms: All patients attending malaria clinics
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but actual data not provided.
Clinical setting: Two malaria clinics
Country: Thailand (Tak Province and Trat province, East Thailand)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 520
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: PCR
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: The study team
RDT setting: Malaria clinics
Follow-up Not applicable
Notes Source of funding: WHO Regional Office for South East Asia, new Delhi, India. Also
Dr Joe Perrone of Becton Dickinson provided the ParaSight-F kits
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were attending malaria
clinics and therefore suspected themselves




Yes Reference standard was PCR
Partial verification avoided?
All tests
No 913 participants received the index test,
520 received the reference tests
61Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)




Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that different tests were un-
dertaken “independently”
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore unclear whether there were any
withdrawals due to invalid results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore unclear whether there were any
withdrawals
Banchongaksorn 1997
Clinical features and settings Presenting signs and symptoms: Fever over 37.5 °C by oral thermometer
Previous treatment for malaria: Not mentioned, but no indication of any exclusion
criteria based on previous antimalarial use
Clinical setting: 34 health centres and 22 mobile health units
Country: Thailand (Chiang Mai and Mae Hong Son provinces)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 3361
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Expert microscopists
Microscopy setting: Malaria Regional Centre, Chiang Mai
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Banchongaksorn 1997 (Continued)
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Performed by health workers with 3 hours training, but
results confirmed by experts at the Malaria Regional Centre
RDT setting: Health centres and mobile health units
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending malaria




Unclear Microscopy was undertaken by experts at a
central laboratory, but there were no details
provided about the processes used
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was undertaken at a different
location than the RDTs
Index test results blinded?
All tests
Yes RDTs were undertaken at a different loca-
tion than the microscopy
Uninterpretable results reported?
All tests
Unclear Number of participants enrolled in the
study was explicitly stated and corre-
sponded to the number presented in the
analysis; therefore there were no with-
drawals due to invalid results
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Yes Number of participants enrolled in the
study was explicitly stated and corre-
sponded to the number presented in the
analysis; therefore there were no with-
drawals
Bechem 1999
Clinical features and settings Presenting signs and symptoms: Fever of >38 °C
Previous treatment for malaria: No exclusion criteria based on antimalarial use. Ap-
proximately 55% of the children had been given one or more antimalarial drugs between
onset of symptoms and presentation at the hospital.
Clinical setting: Paediatric Unit of Central Hospital
Country: Cameroon (Yaounde)
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 199
Age: Children 2.5 months to 16 years
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy: No criteria based on co-morbidities. No details of the
frequency of these conditions in the participant population were presented.
Parasite density of microscopy positive cases: Range 90 to 456,000 parasites per µl,
geometric mean 7620
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy of thick and thin blood smears
Person(s) performing microscopy:Microscopists
Microscopy setting: Research laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two; however their method of working together was
not described
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICTDiagnostics, Brookvale, NSW, Aus-
tralia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Physician
RDT setting: Paediatric unit
Follow-up Not applicable
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Bechem 1999 (Continued)
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Consecutive sample presenting to a paedi-
atric unit with fever
Acceptable reference standard?
All tests
Unclear Although it states that there were 2 micro-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Reference tests were carried out in the lab-
oratory, RDTs were carried out in the clinic
Index test results blinded?
All tests
Yes Reference tests were carried out in the lab-
oratory, RDTs were carried out in the clinic
Uninterpretable results reported?
All tests
Yes One participant was excluded from the




Yes One participant was excluded from the
analysis because their blood slide was un-
readable
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Bell 2001a
Clinical features and settings Presenting signs and symptoms: History of fever, headache, chills or rigors occurring
within the preceding three days; or more distant history of fever or non-specific signs
suggestive of malaria.
Previous treatment for malaria: Participants who had recently taken antimalarials were
not excluded; 5% of participants reported prior antimalarial use.
Clinical setting: Village health workers in five barangaya (districts)
Country: Philippines (Agusan del Sur Province in the northeast of the island of Main-
dano)
Malaria endemicity: Generally low perennial transmission, with pockets of high trans-
mission
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 350
Age: Eligible age range not stated. Mean age of the participants was 19.5 years.
Sex: Both males and females eligible. There were 171 male and 179 female participants.
Co-morbidities and pregnancy: Not mentioned, either an exclusion criteria or charac-
teristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy of thick and thin blood smears
Person(s) performing microscopy: An experienced local microscopist for all slides;
selected slides were also read by an experienced parasitologist
Microscopy setting: Local laboratory and hospital laboratory in Australia
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: One, except in discordant cases where RDT and
microscopy results differed, all cases RDT-positive for P. vivax and 20% of cases negative
by slide and RDT, in which case a second reader was used
Resolution of discrepancies between observers:The second, off-site reading was taken
as the correct one
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Amrad-ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Refrigerated until two weeks before use
Person(s) performing RDT: Researchers
RDT setting: Study villages
Follow-up Not applicable
Notes Source of funding: The Australian National Health and Medical Research Council
Table of Methodological Quality
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Bell 2001a (Continued)
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants had approached village
health workers with symptoms suggestive




Yes An experiencedmicroscopist viewed at least




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “Slides were read by a local microscopist
who was not aware of the results of the ICT
tests”
Index test results blinded?
All tests








Unclear The number of participants originally en-
rolled in the study was not stated; therefore
it is unclear whether there were any with-
drawals
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Bell 2001b
Clinical features and settings Presenting signs and symptoms: History of fever, headache, child or rigors occurring
within the preceding 3 days; or more distant history of fever or non-specific signs sug-
gestive of malaria
Previous treatment for malaria: Patients treated with antimalarials during the four
weeks preceding the test were excluded from the analysis
Clinical setting: Health centre in Visaya
Country: Philippines (Agusan del Sur Province in the northeast of the island of Main-
dano)
Malaria endemicity: Generally low perennial transmission, with pockets of high trans-
mission
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 113
Age: Eligible age range not stated. Mean age of the participants was 19.8 years.
Sex: Both males and females eligible. There were 73 male and 40 female participants.
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy of thick and thin blood smears
Person(s) performing microscopy: Not stated
Microscopy setting: Regional Health Units
Number of high power fields examined before declaring negative: Not stated, but
probably 100 as in the other trial reported together in the same paper
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Amrad-ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Stored by barangya health workers at room temper-
ature, averaging about 25 °C for up to six months
Person(s) performing RDT: Barangay health workers
RDT setting: Health centre
Follow-up Not applicable
Notes Source of funding: The Australian National Health and Medical Research Council
Table of Methodological Quality
Item Authors’ judgement Description
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Unclear All participants were attending a health
centre with history of fever, headache, child
or rigours within the preceding 3 days;
more distant history of fever or non-specific
signs suggestive of malaria; but the sam-
pling method was not described
Acceptable reference standard?
All tests
Unclear No details given of the microscopy process
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Clear that blinding had taken place, as it
was not possible to match up all the RDT
and microscopy results by name and date
Index test results blinded?
All tests
Yes Clear that blinding had taken place, as it
was not possible to match up all the RDT
and microscopy results by name and date
Uninterpretable results reported?
All tests
Yes 25 of 393 tests done were considered in-
valid because of an indistinct control band.




Yes Only 113 microscopy results could be
matched with RDT results by name and
date; the others were lost from the analysis
Bharti 2008
Clinical features and settings Presenting signs and symptoms: Fever or history of fever, and suspicion of malaria
Previous treatment for malaria: No exclusions based on previous treatment; it was
undertaken in a remote area with no medical facilities
Clinical setting: Mobile field clinics in 10 villages
Country: India (Remote forested region of Jabalpur during the peak monsoon season)
Malaria endemicity: Low endemic areas with higher transmission during the monsoon
Malaria endemic species: P. falciparum and P. vivax
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Bharti 2008 (Continued)
Participants Sample size: 291
Age: All age groups eligible. Actual age range of participants 1 to 60 years.
Sex: Both males and females eligible. Male: female ratio 1:1.15.
Co-morbidities and pregnancy: No criteria based on co-morbidities or pregnancy. No
details of the frequency of these conditions in the participant population presented.
Parasite density of microscopy positive cases: Range 80 to 111,920 parasites per cul,
mean 8011, Standard Deviation 21,595
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Experienced microscopist
Microscopy setting: Laboratory of NIMR
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: One for all samples, two independent readers for
samples discordant between microscopy and RDT
Resolution of discrepancies between observers: Where the second reading gave a
different result from the first, the results of the second reading were confirmed by a third
examination by another technician
Index and comparator tests Commerical name of RDT: First Response ComboMalaria Ag card test (Premier Med-
ical Corporation Ltd, Mumbai, India)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 3
Batch numbers: 61F0107
Transport and storage conditions: RDTs were stored properly, at temperature of 4 °C
to 30 °C, and used within their shelf life
Person(s) performing RDT: Field laboratory assistants. Independent staff re-read the
saved tests after two months and matched them with the originally recorded results
RDT setting: Field laboratory
Follow-up Not applicable
Notes Source of funding: Indian Council of Medical Research, Delhi. Test kits provided by
Premier Medical Corporation Ltd.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending mobile field clinics with
fever or history of fever, and suspicion of
malaria
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Yes An experiencedmicroscopist viewed at least
100 high power fields before declaring a
slide negative, and results discordant with
RDT were independently re-examined by




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was undertaken “without ref-
erence to the RDT”
Index test results blinded?
All tests
Yes RDTs were undertaken on site, and the re-








Yes The number of participants enrolled in the
study was clearly stated, and corresponded
to the number presented in the analysis;
therefore there were no withdrawals
Bojang 1999
Clinical features and settings Presenting signs and symptoms: Temperature of 37.5 °C or higher, or a recent history
of fever
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment, except for those with false positive results
on RDT
Clinical setting: Malaria outpatient clinic
Country: The Gambia (Basse, Upper River Division)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum
Participants Sample size: 139
Age: Inclusion criteria stipulated all were children; actual age range not stated
Sex: Not mentioned either as an inclusion criteria or a characteristic of included partic-
ipants
Co-morbidities and pregnancy: Not mentioned either as an inclusion criteria or a
characteristic of included participants
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Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood smear
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type I
Batch numbers: Not stated
Transport and storage conditions: Not stated
Person(s) performing RDT: Field staff who had attended three training session
RDT setting: Malaria clinic
Follow-up Not applicable
Notes Source of funding: Medical Research Council Laboratories, The Gambia
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending a malaria
clinic with fever or history of fever, but the
sampling method was not described
Acceptable reference standard?
All tests
Unclear Not details given of the microscopy process
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
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Index test results blinded?
All tests
Yes “Test performed without reference to the




Unclear The number of participants enrolled was
explicitly stated and corresponded to the
number presented in the analysis; therefore




Yes The number of participants enrolled was
explicitly stated and corresponded to the
number presented in the analysis; therefore
there were no withdrawals
Caraballo 1996
Clinical features and settings Presenting signs and symptoms: Fever and suspicion of malaria
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment, except for those with false positive results
on RDT
Clinical setting: Malaria diagnostic post
Country: Venezuela - Bolivar state. Gold-mining area.
Malaria endemicity: Annual parasite index 352/1000
Malaria endemic species: P. falciparum
Participants Sample size: 1398
Age: All ages eligible; actual age range 3 months to 84 years
Sex: Both males and females eligible: actual sample 81.2% male, 18.8% female
Co-morbidities and pregnancy:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood smear
Person(s) performing microscopy: Trained malaria microscopists
Microscopy setting: Central Headquarters of the Venezuelan Malaria Programme
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two
Resolution of discrepancies between observers: Not stated
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type I
Batch numbers: Not stated
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Transport and storage conditions: Not stated
Person(s) performing RDT: Rural visitor from the Malaria Programme
RDT setting: Malaria diagnostic post
Follow-up Not applicable
Notes Source of funding:UNDP/World Bank/WHO-TDR (Project number 930439), Beck-
ton Dickinson Advanced Diagostics provided the supplies to carry out this work
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending diagnos-
tics facilities with fever and suspicion of




Unclear Two trained microscopists at a central lab-
oratory viewed 100 high power fields be-
fore declaring negative; however it is not
clear whether the microscopists worked in-
dependently of each other
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Blinding described in detail
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was unclear; therefore it
is not possible to judge whether any were




Unclear The number of participants originally en-
rolled in the study was unclear; therefore it
is not possible to judge whether there were
any withdrawals
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Chayani 2004
Clinical features and settings Presenting signs and symptoms: Specific symptoms: rigor, chills, rise of high temper-
ature and profuse sweating; or irregular fever, joint pain and jaundice
Previous treatment for malaria: No explicit exclusions based on previous treatment
and no information presented on previous treatment.
Clinical setting: Diagnostic and research centre (takes referrals from physicians for the
diagnosis of malaria)
Country: Orissa, India
Malaria endemicity: Not stated
Malaria endemic species: In sample, 78.6% P. falciparum, 21.4% P. vivax
Participants Sample size: 232
Age: Not mentioned, either as inclusion criteria or characteristic of participants
Sex: Not mentioned, either as inclusion criteria or characteristic of participants
Co-morbidities and pregnancy: Not mentioned, either as inclusion criteria or charac-
teristic of participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollmentwas prospective. The samplingmethodwas unclear.OneRDTwas evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smear
Person(s) performing microscopy:Microscopists
Microscopy setting: Diagnostic and research centre
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent observers
Resolution of discrepancies between observers: A third microscopist’s opinion was
taken into account
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending an ambu-
latory clinic with rigor, chills, rise of high
temperature and profuse sweating; or irreg-
ular fever, joint pain and jaundice.However
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Chayani 2004 (Continued)
the sampling method was not described.
Acceptable reference standard?
All tests
Yes Two independent microscopists viewed




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is not possible to judge whether




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is not possible to judge whether
there were any withdrawals
Chitkara 2004
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment, although this data was collected as part of
the study
Clinical setting: Temporary fever treatment camp
Country: India (Assam and Arunachal Pradesh)
Malaria endemicity: Varied
Malaria endemic species: mainly P. falciparum, some P. vivax
Participants Sample size: 673
Age: All age groups eligible; actual age range not reported
Sex: Both males and females eligible; actual proportions in the sample not reported
Co-morbidities and pregnancy: No exclusions based on co-morbidities or pregnancy;
actual frequency of these conditions in the same not reported
Parasite density of microscopy positive cases: Not presented
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Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smear
Person(s) performing microscopy: Chief microscopist of the District Malaria Office
and two pathologists of Assam Medical College
Microscopy setting: District Malaria Office and Assam Medical College
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: All positive slides and 20% of negative slides were
independently read by the pathologists from Assam Medical College
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: ParaHIT-F (Span diagnostics Ltd, Surat, India)
Parasite(s) designed to detect: P .falciparum
Designated Type: Type I
Batch numbers: Not stated
Transport and storage conditions: Not stated
Person(s) performing RDT: Laboratory technicians
RDT setting: Temporary fever treatment camp
Follow-up Not applicable
Notes Source of funding: Span Diagnostics provided the RDT test kits free of charge
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample at-




Unclear Unclear, as the numbers of high power
fields viewed before declaring negative was
not stated. However, the microscopy was




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
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Chitkara 2004 (Continued)
Reference standard results blinded?
All tests
Yes Two different technicians did the micro-
scopic examination and the ParaHIT-f test
and the results of their observations were
compared later.
Index test results blinded?
All tests
Yes Two different technicians did the micro-
scopic examination and the ParaHIT-f test




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is not possible to judge whether




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is not possible to judge whether
there were any withdrawals
Cooke 1999
Clinical features and settings Presenting signs and symptoms: Fever or history of fever and a suspected diagnosis of
malaria
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment
Clinical setting: Outpatient clinic
Country: The Gambia (Fajara)
Malaria endemicity:Not stated: study undertaken during period of seasonal high trans-
mission
Malaria endemic species: mainly P. falciparum
Participants Sample size: 409
Age: Over the age of one year
Sex: No exclusions based on sex; actual proportions of males and females in the sample
not stated
Co-morbidities and pregnancy: No exclusions based on co-morbidities or pregnancy;
actual proportions with these conditions in the sample not stated
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood smear. Thin blood smear in the case of
discordant results between RDT and blood smear.
Person(s) performing microscopy: Experienced microscopist at the clinic laboratory.
In the case of discordant results between the RDT and microscopy, a second expert
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technician at the main laboratory re-examined the slides.
Microscopy setting: Clinic laboratory and central laboratory.
Number of high power fields examined before declaring negative: 100 at the clinic,
500 at the main laboratory
Number of observer or repeats: One, except in the case of discordant results, where a
second observer was used
Resolution of discrepancies between observers:Where index and reference test results
were discordant the blood film at the main laboratory was read and this result used
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: A member of the study team
RDT setting: Outpatient clinic
Follow-up Not applicable
Notes Source of funding: The OptiMAL assays were provided by FLOW Inc.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending an outpatient clinic with




Yes All slides were examined by an experienced
microscopist viewing 100 high power fields
before declaring negative.Where RDT and
microscopy gave discordant results, slides
were re-examined by another microscopist
viewing at least 500 high power fields
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
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Reference standard results blinded?
All tests
Yes The study number and laboratory num-
ber were only matched after the blood film
examination and OptiMAL test had been
completed
Index test results blinded?
All tests
Yes The study number and laboratory num-
ber were only matched after the blood film




Yes Of 409 participants recruited, one was ex-
cluded from the analysis because the test
strip failed to give a results
Withdrawals explained?
All tests
Yes Of 409 participants, seven were excluded
because the results were not recorded in the
clinic book, and one because the index test
failed to give a results
De Oliveira 2009
Clinical features and settings Presenting signs and symptoms: Suspected malaria
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment
Clinical setting: Various health facilities including 7 hospitals, 23 health centres and 30
dispensaries
Country: Kenya (Karicho, Bondo and Siaya Districts)
Malaria endemicity: 30 health facilities in seasonal areas, 30 in perennial areas
Malaria endemic species: P. falciparum
Participants Sample size: 1827
Age: Five years or over
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusions criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Expert microscopists, who receive regular training
at the Malaria Diagnostics and Control Centre of Excellence of the US Army Medical
Research Unit in Kenya and consistently attain acceptable competency scores during
such training sessions
Microscopy setting: Malaria laboratories of the Kenya Medical Research Institute
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(KEMRI) and US Centres for Disease Control and Prevention (CDC) in Kisumu
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two independent observers
Resolution of discrepancies between observers: A third microscopist, blinded to all
previous blood tests, reviewed the smear
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type I
Batch numbers: 31422
Transport and storage conditions: Kept at health facilities during the study. Study staff
recommended that they be stored in a cool and dry place and provided thermometers
to monitor daily storage temperatures.
Person(s) performing RDT: Laboratory technicians who were trained to perform the
tests according to the manufacturer’s instructions
RDT setting: Health facilities
Follow-up Not applicable
Notes Source of funding: US Centres for Disease Control and Prevention
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of




Yes Two independent expert microscopists
each viewed 100 high power fields before
declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopists reported to be blinded to the
results of the RDTs
Index test results blinded?
All tests
Yes RDTs undertaken and results recorded at
the health facilities before microscopy
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Uninterpretable results reported?
All tests




Yes Participants were excluded from the analy-
sis if they refused to give blood samples or
complete clinical information
Dev 2004
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No information presented on previous treatment; no
suggestion of any exclusions based on previous treatment
Clinical setting: Malaria clinics
Country: India (Assam)
Malaria endemicity: Mesendemic
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 336; but varied by RDT evaluated (10 to 139)
Age: Infants under 12 months excluded; actual age range 1 to 60 years
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy were stated, and no details of the frequency of these conditions in the participant
population is presented
Parasite density of microscopy positive cases: Range 300 to 350,000 parasites per µl,
mean 59,842, Standard Deviation 78,780
Study design Enrollment was prospective. The sampling method was not described. Seven RDTs were
evaluated; it is unclear how each RDT was allocated, as no participant received all the
tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Technician; all positive slides and 20% of negative
slides were also examined by the senior technician for confirmation of result.
Microscopy setting: Laboratory at the malaria clinics
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: One in the case of most smears judged negative by
the technician. Two in the case of 20% of those initially judged negative, and all those
judged positive.
Resolution of discrepancies between observers: The judgement of the senior techni-
cian was used
Index and comparator tests Commerical name of RDT:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
ParaHIT-F (Span diagnostics Ltd, Surat, India)
ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
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New Pf-1 mini (Monozyme India Ltd, Secundrabad, India)
SD Malaria Pf/Pv (SD Diagnostics Inc, Korea)
Diamed OptiMAL (Flow Inc., Portland, OR, US)
Parasite(s) designed to detect:
Paracheck Pf - P. falciparum
ParaSight-F - P. falciparum
ParaHIT-F - P. falciparum
ICT Malaria Pf - P. falciparum
New Pf-1 mini - P. falciparum
SDMalaria Pf/Pv - P. falciparum or mixed infection, non-falciparummalaria species only
Diamed OptiMAL - P. falciparum or mixed infection, non-falciparum malaria species
only
Designated Type:
Paracheck Pf - Type I
ParaSight-F - Type I
ParaHIT-F - Type I
ICT Malaria Pf - Type I
New Pf-1 mini - Type I
SD Malaria Pf/Pv - Type 3
Diamed OptiMAL - Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: The laboratory attendant performed the test and recorded
his or her interpretation. The test kit result was then re-read for verification by the senior
technician.
RDT setting: Malaria clinic laboratory
Follow-up Not applicable
Notes Source of funding: Main source of funding not stated. Test kits supplied by the Gov-
ernment of Assam.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending malaria
clinics with fever. However, during the
study period, 6663 blood smears were ex-
amined, but only 336 were evaluated with
RDT kits, and the sampling method for
RDT evaluation was unclear.
Acceptable reference standard?
All tests
Unclear Two observers were used in the vast major-
ity of cases; however, it is unclear whether
the observers worked independently
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
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Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy and RDT results were com-
pared by an independent observer
Index test results blinded?
All tests
Yes Microscopy and RDT results were com-
pared by an independent observer
Uninterpretable results reported?
All tests
Unclear No information presented on numbers ini-




Unclear No information presented on numbers ini-
tially allocated each RDT, so not possible
to judge this
Devi 2002
Clinical features and settings Presenting signs and symptoms: Fever and referred for malaria diagnosis by physicians
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment
Clinical setting: Exact setting unclear, but based at M.S. Ramaiah Medical Teaching
Hospital, Bangalore
Country: India, Bangalore
Malaria endemicity: Not stated
Malaria endemic species: mainly P. falciparum some P. vivax
Participants Sample size: 100
Age: All age groups eligible. Actual age structure of the study sample not described.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusions criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was random and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Not stated
Microscopy setting: Large teaching hospital, in a malaria endemic area
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
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Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ParaHIT-f (Span Diagnostics, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type I
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Large teaching hospital, in a malaria endemic area
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants had a fever and were re-
ferred to the study site for diagnosis of
malaria; however it is unclear how partici-
pants were selected for referral
Acceptable reference standard?
All tests
Unclear No details given of the microscopy process
Partial verification avoided?
All tests




Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is not possible to judge whether




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
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therefore it is not possible to judge whether
there were any withdrawals
Durrheim 1998
Clinical features and settings Presenting signs and symptoms:Clinical signs and symptoms compatible with malaria
Previous treatment for malaria: No exclusions based on previous treatment and no
information presented on previous treatment
Clinical setting: Outpatient clinic
Country: South Africa (Lowveld region)
Malaria endemicity: Seasonal
Malaria endemic species: P. falciparum
Participants Sample size: 264
Age: All age groups eligible. Actual age structure of the study sample not described.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Person(s) performing microscopy: Experienced laboratory technologist
Microscopy setting: Reference malaria laboratory
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Clinic nurse checked by skilled reader
RDT setting: Outpatient clinic
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
86Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)




Yes Participants were a consecutive series of pa-
tients attending clinics with clinical signs
and symptoms of malaria
Acceptable reference standard?
All tests
No Only one observer was used
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was reported to be done with
no prior knowledge of the results of the
RDT
Index test results blinded?
All tests
Yes The RDT was reported to be performed
before themicroscopy results were available
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled in the
study is explicitly stated and corresponds
to the number presented in the analysis;
therefore there were no exclusions from the
analysis due to invalid test results
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study is explicitly stated and corresponds
to the number presented in the analysis;
therefore there were no withdrawals
Fernando 2004
Clinical features and settings Presenting signs and symptoms: Fever or history of fever
Previous treatment for malaria: No exclusions because of prior antimalarial use, and
no data presented on the frequency of recent antimalarial use in the participants
Clinical setting: A malaria research station and a malaria clinic
Country: Sri Lanka
Malaria endemicity: Not stated
Malaria endemic species: P. vivax (70%) and P. falciparum
Participants Sample size: 328
Age: All ages above five years eligible; mean age 28.3 years (range 5 to 72 years)
Sex: Both males and females eligible; 64% of the participants were males
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
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nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and think blood films
Person(s) performing microscopy: Trained microscopists
Microscopy setting: At the clinics and in a laboratory
Number of high power fields examined before declaring negative: 400
Number of observer or repeats:Two independent readers; one at the clinics and another
in a laboratory
Resolution of discrepancies between observers: There were no discrepancies between
the two microscopists
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Amrad-ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 2
Batch numbers: Not stated
Transport and storage conditions: Stored and used at room temperature, which often
exceeds 30 °C
Person(s) performing RDT: The researchers
RDT setting: At the clinics
Follow-up Not applicable
Notes Source of funding: National Science Foundation, Sri Lanka
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of




Yes Twp independent trained microscopists
viewed 400 high power fields before declar-
ing a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
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Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled was
clearly stated, and the number included in




Yes The number of participants enrolled was
clearly stated, and the number included in
the analysis corresponds to this number, in-
dicating no withdrawals
Forney 2001
Clinical features and settings Presenting signs and symptoms: Fever over 38 °C or headache or history of fever in
the previous 72 hrs
Previous treatment formalaria:Patients whowere currently taking antimalarial therapy
or who had been treated with antimalarial drugs within the previous two weeks were
excluded
Clinical setting: Outpatient malaria clinics
Country: Iquitos, Peru (28% of participants); Mae Sod, Thailand (72% of participants)
Malaria endemicity: Seasonal
Malaria endemic species: P. falciparum and P.vivax
Participants Sample size: 3006 enrolled, 2993 had blood collected, 2988 included (2162 Thailand,
838 Peru)
Age: 15 years or over (Thailand, 72% of participants); one year or over (Peru, 28% of
participants)
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood film
Person(s) performing microscopy: Trained, certified microscopist
Microscopy setting: Malaria testing station
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Forney 2001 (Continued)
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent observers
Resolution of discrepancies between observers: A third senior microscopist examined
both microscopist A’s and microscopist B’s slides, and gave the final judgement
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Trained investigator and technician, with quality control
checks by the principal investigator
RDT setting: Malaria testing station
Follow-up Not applicable
Notes Source of funding: Main funding source not stated. RDT kits provided by the manu-
facturer.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of
people attending malaria clinics with fever
over 38 °C or headache or history of fever
in the previous 72 hrs
Acceptable reference standard?
All tests
Yes Two independent trained microscopists




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes In all cases, the results of the ParaSight-
F test were determined prior to diagnostic
microscopy, with strict blinding between
the rapid test results and technicians per-
forming the microscopy
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Index test results blinded?
All tests
Yes In all cases, the results of the ParaSight-
F test were determined prior to diagnostic
microscopy, with strict blinding between




Yes Tests whose results were reported as unin-
terpretable after the initial procedure were
repeated in an attempt to resolve the dis-
crepant event. Repeatedly uninterpretable
results were reported as such and were in-
corporated into calculation of sensitivity
and specificity as ’false’ results. There were
a total of seven uninterpretable results; all




Yes There were five withdrawals after collec-
tion of blood samples; reasons were docu-
mented in all cases.
Forney 2003
Clinical features and settings Presenting signs and symptoms: Fever over 38 °C or history of fever over the previous
72 h, or headaches
Previous treatment for malaria: Patients who had taken antimalarials recently were
included. No data is presented on the actual number who reported recent antimalarial
use.
Clinical setting: Outpatient malaria clinics
Country: Thailand (Mae Sod) and Peru (Iquitos)
Malaria endemicity: Not stated; study conducted in endemic areas during peak trans-
mission seasons
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 477 in Thailand, 393 in Peru
Age: Eligibility criteria for age not stated; in practice, although younger patients were
eligible, all participants were over the age of 18
Sex: Not mentioned, either as inclusion criteria or characteristics of participants
Co-morbidities and pregnancy: Not mentioned, either as inclusion criteria or charac-
teristics of participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. Three prototype
RDTs were evaluated; only the most recent is presented.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smear
Person(s) performing microscopy: Skilled, certified technicians
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Microscopy setting: Malaria testing station
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent observers; three for discordant slides
and 5% of concordant slides
Resolution of discrepancies between observers: A third senior microscopist examined
both microscopist A’s and microscopist B’s slides, and gave the final judgement
Index and comparator tests Commerical name of RDT: ParaSight Pf/Pv Final Prototype FV99-2 (Becton Dickin-
son, Franklin Lakes, NJ, USA)
Parasite(s) designed to detect: P. falciparum and P. vivax
Designated Type: Unknown
Batch numbers: Not applicable (prototype)
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were all attending clinics
with fever or headaches, but the sampling
method was not described
Acceptable reference standard?
All tests
Yes Two independent, trained microscopists
viewed at least 200 high power fields before
declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “In all cases the results of the ParaSight Pf/
Pv tests were determined prior to the com-
pletion of diagnostic microscopy”
Index test results blinded?
All tests
Yes “The technicians examining the stained
smearswere strictly blinded to the rapid test
results”
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Yes Uninterpretable test results were excluded
from the analysis (1 participant)
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study was clearly stated, and corresponded
to the number included in the analysis,
with the exception of one participant not
included because of uninterpretable test re-
sults
Gaye 1998
Clinical features and settings Presenting signs and symptoms: Malaria symptoms
Previous treatment for malaria:No exclusion criteria relating to prior antimalarial drug
use. Data collected but only presented in the case of false positives.
Clinical setting: Outpatient clinic
Country: Senegal (Dakar)
Malaria endemicity: Hypoendemic and seasonal
Malaria endemic species: Predominantly P. falciparum
Participants Sample size: 66
Age: All ages eligible. Actual age range 1 to 65 years
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population 35 female, 31 male.
Co-morbidities and pregnancy: Not mentioned
Parasite density of microscopy positive cases: Range 500 to 86,286 parasites per µl
Study design Enrollment was prospective. The sampling method was not described. Three RDTs were
evaluated and all participants received all three tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:
ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Malaria IgG CELISA (CelLabs Sydney, Australia) (excluded as not eligible for inclusion
in this review)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
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Gaye 1998 (Continued)
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were presenting to an out-
patient clinic with malaria symptoms, but
the sampling method was not described
Acceptable reference standard?
All tests
Unclear No details given of the microscopy process
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was clearly stated, and
corresponds to the number presented in the
analysis; therefore there were no exclusions
due to invalid test results
Withdrawals explained?
All tests
Yes The numbers of participants originally en-
rolled in the study was clearly stated, and
corresponds to the number presented in
the analysis; therefore there were no with-
drawals
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Gaye 1999
Clinical features and settings Presenting signs and symptoms: Malaria symptoms
Previous treatment for malaria:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Clinical setting: Outpatient clinic
Country: Senegal (North Senegal, Richard-Toll)
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 182
Age: All ages eligible. Actual age range 1 to 55 years
Sex: Not mentioned, either as an inclusion criteria or characteristic of included partici-
pants
Co-morbidities and pregnancy:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One test was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: PATH Falciparum Malaria
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were presenting to an out-
patient clinic with malaria symptoms, but
the sampling method was not described
Acceptable reference standard?
All tests
Unclear Not details given of the microscopy process
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Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was clearly stated, and
corresponds to the number presented in the
analysis; therefore there were no exclusions
due to invalid test results
Withdrawals explained?
All tests
Yes The numbers of participants originally en-
rolled in the study was clearly stated, and
corresponds to the number presented in
the analysis; therefore there were no with-
drawals
Gerstl 2009
Clinical features and settings Presenting signs and symptoms: Fever (axillary temperature >37.5 °C) or history of
fever in the previous 72 h and no signs of severe disease
Previous treatment for malaria:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Clinical setting: MSF community health centre
Country: Sierra Leone (Bo District, Eastern Sierra Leone)
Malaria endemicity: Hyperendemic
Malaria endemic species: P. falciparum
Participants Sample size: 345
Age: Inclusion criteria 2 to 59 months
Sex: Both males and females eligible
Co-morbidities:Noexclusions based on co-morbidities; no informationpresented about
the frequency of co-morbid conditions in the study sample
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One test was evaluated.
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Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:
ParaCheck-Pf (Orchid Biomedical Systems, Goa, India)
Carestart Pf/Pan
Parasite(s) designed to detect:
ParaCheck-Pf - P. falciparum
Carestart Pf/Pan - P. falciparum or mixed infection, non-falciparum malaria species only
Designated Type:
ParaCheck-Pf - Type 1
Carestart 3 line - Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of












Unclear The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
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Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear Not enough information presented to en-
able assessment of this
Withdrawals explained?
All tests
Unclear Not enough information presented to en-
able assessment of this
Ghosh 2000
Clinical features and settings Presenting signs and symptoms: Febrile illness
Previous treatment for malaria:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Clinical setting: Unclear (PHC Banavara district Hassan, Karnataka)
Country: India (Karnataka)
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 100
Age: Malaria cases were aged 5 years to 80 years
Sex: Both males and females were included
Co-morbidities and pregnancy:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One test was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin smears
Person(s) performing microscopy: One set was immediately examined in the field
while the second one was stained in the laboratory and examined carefully
Microscopy setting: Field and laboratory (unclear which is the reference standard)
Number of high power fields examined before declaring negative: About 200
Number of observer or repeats: Unclear
Resolution of discrepancies between observers: Unclear/Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria (ICT Diagnostics, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
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Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending health facil-
ities with febrile illnesses; however the ex-
act setting was unclear, and the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Microscopy was undertaken under field
conditions and also examined carefully in




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study is not clearly stated,
therefore it is unclearwhether anymay have




Unclear The number of participants originally en-
rolled in the study is not clearly stated,
therefore it is unclearwhether anymay have
been withdrawn or excluded from the anal-
ysis, and the reasons for this
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Guthmann 2002
Clinical features and settings Presenting signs and symptoms:Clinical suspicion of malaria, diagnosed by the clinical
officer
Previous treatment for malaria:No exclusion criteria based on antimalarial use and no
data collected on this
Clinical setting: Outpatient department of a reference hospital
Country:Mbarara, Uganda
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum
Participants Sample size: 742
Age: All age groups eligible; 315 were aged less than 5 years
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated
Co-morbidities and pregnancy: No exclusions were made, and there was no informa-
tion presented on pregnancy or co-morbidities
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Five RDTs were tested, and most partici-
pants received all the tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Trained malaria technician
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One, except in the case of discordant results between
microscopy and RDTs
Resolution of discrepancies between observers: All discordant results, all slides where
only gametocytes were detected and a random sample of 20% of the remaining slides
were checked blind by an independent trained laboratory technician
Index and comparator tests Commerical name of RDTs:
Paracheck Pf dipstick (Orchid Biomedical Systems, Goa, India)
Paracheck Pf device (Orchid Biomedical Systems, Goa, India) (data not included in
review as duplicates Paracheck Pf dipstick)
ParaHIT-f (Span diagnostics Ltd, Surat, India) (excluded as required data could not be
extracted)
BIO P.F (excluded as required data could not be extracted)
Malaria Rapid (excluded as required data could not be extracted)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Two independent readers (persons unspecified)
RDT setting: The research clinic
Follow-up Not applicable
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Guthmann 2002 (Continued)
Notes Source of funding:Medicins sans Frontieres, French section. Laboratories provided the
tests kits free of charge.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of
people suspected to have malaria and at-
tending an outpatient clinic
Acceptable reference standard?
All tests
No Microscopy was undertaken by trained
microscopists viewing 200 high powered
fields before declaring negative, but their




Yes All participantswho received the index tests
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that the results were blind
Index test results blinded?
All tests




Yes A small number of test results (one each
for Paracheck dipstick and cassette, four
for paraHIT, three for BIO PF and 21 for
Malaria Rapid) were invalid, and these are




Yes Of the 742 participants who received mi-
croscopy, 741 received Paracheck Pf, 738
received ParaHIT Pf, 739 received BIO PF
and 721 received Malaria Rapid. All with-
drawals after tests were given represent in-
valid RDTresults
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Harani 2006
Clinical features and settings Presenting signs and symptoms: Clinical symptoms of malaria and history of fever
over 37.5 °C. People with known causes of fever other than malaria were excluded.
Previous treatment for malaria: Patients who had been treated for malaria in the pre-
vious 4 weeks were excluded from the study
Clinical setting: Outpatient department of a reference hospital
Country: Pakistan
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 560
Age: All age groups eligible; actual age range of included participants 2 to 73 years
Sex: Both males and females eligible. Participants included 339 males and 221 females.
Co-morbidities and pregnancy:Not mentioned, either as an inclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Senior technologist and principle author
Microscopy setting:Department of Pathology and Microbiology, Aga Khan University
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Unclear, two microscopists were used but how they
divided the work between them was not described
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (Binax Inc., Portland, Maine, US)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 2
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: The second author
RDT setting: Microbiology section of Aga Khan University
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were presenting at an out-
patients department with symptoms of
malaria and history of fever, but the sam-
pling method was not described
102Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)




Unclear Two microscopists at a University labora-
tory viewed 200 high power fields before
declaring a slide negative; however, it is un-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The microscopists were unaware of the
microscopy results”
Index test results blinded?
All tests
Yes “These results were read by the second au-




Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no exclu-
sions due to invalid results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no with-
drawals due to invalid results
Hopkins 2007
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria:No exclusion criteria based on antimalarial use and no
data collected on this
Clinical setting: Clinic specially set up as part of a longitudinal study, based within a
main public hospital
Country: Uganda (Kampala)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum
Participants Sample size: 918
Age: Children aged 1.5 to 11.5 years
Sex: Both males and females eligible. Actual proportions of males and females in the
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participant population not stated.
Co-morbidities: No exclusions were made, and there was no information presented on
co-morbidities
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Two RDTs were tested, and all participants
received both tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced laboratory technologists
Microscopy setting: Hospital laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two; all smears were read a second time by study
laboratory staff to confirm results
Resolution of discrepancies between observers: Discrepant readings were resolved by
a third reader
Index and comparator tests Commerical name of RDTs:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parabank (Zephyr Biomedicals, Goa, India)
Parasite(s) designed to detect:
Paracheck Pf (Orchid Biomedical Systems, Goa, India) - P. falciparum
Parabank (Zephyr Biomedicals, Goa, India) - P. falciparum or mixed infection, non-




Batch numbers: Not stated
Transport and storage conditions:Obtained directly from themanufacturer and stored
in their original packaging at room temperature in the clinic. The temperature ranged
from 19 °C to 29 °C over the course of the study.
Person(s) performing RDT: Laboratory technicians.
RDT setting: The research clinic
Follow-up Not applicable
Notes Source of funding: US National Institute of Health, with additional support from the
Doris Duke Charitable Foundation
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of
children attending a clinic with fever in a
malaria endemic area
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Yes Two independent experienced micro-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was undertaken at a different
location to the RDTs
Index test results blinded?
All tests
Yes Readers were unaware of the microscopy
results at the time they undertook the study
Uninterpretable results reported?
All tests
Unclear The number of participants who received
the tests was explicitly stated and corre-
sponded to the number included in the
analysis; therefore there were no exclusions
due to invalid results
Withdrawals explained?
All tests
Yes RDTs were not performed in 15 episodes:
nine at the discretion of the physician dur-
ing follow-up for non-febrile illness, and
six because of protocol errors
Hopkins 2008a
Clinical features and settings Presenting signs and symptoms: Outpatients who had been referred to the laboratory
for malaria blood smears in accordance with the usual standard of are.
Previous treatment for malaria:No exclusion criteria based on antimalarial use and no
data collected on this
Clinical setting: Health centres
Country: Uganda
Malaria endemicity: 7 different sites of varying endemicity. Results not presented sep-
arately.
Malaria endemic species: P. falciparum
Participants Sample size: 7000
Age: All ages included. 3161 participants were under the age of 5 years. No separate
analysis available by age.
Sex: Both males and females eligibles. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy: No exclusions were made, and there was no informa-
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Hopkins 2008a (Continued)
tion presented on co-morbidities or pregnancy
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Two RDTs were tested, and all participants
received both tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Health centre laboratory staff and expert micro-
scopists at a central laboratory
Microscopy setting: Health centre staff and central hospital laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two; all smears were read by both the health centre
laboratory staff and expert microscopists at the central laboratory
Resolution of discrepancies between observers: Discrepant readings between the
health centre and expert central laboratory microscopists were resolved by a second ex-
pert microscopist
Index and comparator tests Commerical name of RDTs:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parabank (Zephyr Biomedicals, Goa, India)
Parasite(s) designed to detect:
Paracheck Pf - P. falciparum




Batch numbers: Not stated
Transport and storage conditions:Obtained directly from themanufacturer and stored
in their original packaging at room temperature in the clinic. The temperature ranged
from 19 °C to 31 °C over the course of the study, and relative humidity from 39% to
87%.
Person(s) performing RDT: Study staff
RDT setting: Health centres
Follow-up Not applicable
Notes Source of funding: US National Institute of Health, with additional support from the
Doris Duke Charitable Foundation
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were referred for mi-
croscopy for suspected malaria under usual
care protocols
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Yes Two microscopists, including one expert
microscopist at a central laboratory, read
each smear. They examined 100 high pow-
ered fields before declaring negative.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no exclu-
sions due to invalid results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no with-
drawals due to invalid results
Hopkins 2008b
Clinical features and settings Presenting signs and symptoms: Outpatients who had been referred to the laboratory
for malaria blood smears in accordance with the usual standard of care
Previous treatment for malaria:No exclusion criteria based on antimalarial use and no
data collected on this
Clinical setting: Health centres
Country: Uganda
Malaria endemicity: 7 different sites of varying endemicity. Results not presented sep-
arately.
Malaria endemic species: P. falciparum
Participants Sample size: 7000
Age: All ages included. 3161 participants were under the age of 5 years.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy: No exclusions were made, and there was no informa-
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Hopkins 2008b (Continued)
tion presented on co-morbidities or pregnancy
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Two RDTs were tested, and all participants
received both tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy corrected by PCR (discordant results between mi-
croscopy and RDTs were re-analysed using PCR)
Person(s) performing microscopy: Health centre laboratory staff and expert micro-
scopists at a central laboratory
Microscopy setting: Health centre staff and central hospital laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two. All smears were read by both the health centre
laboratory staff and expert microscopists at the central laboratory
Resolution of discrepancies between observers: Discrepant readings between the
health centre and expert central laboratory microscopists were resolved by a second ex-
pert microscopist
Index and comparator tests Commerical name of RDTs:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parabank (Zephyr Biomedicals, Goa, India)
Parasite(s) designed to detect:
Paracheck Pf - P. falciparum




Batch numbers: Not stated
Transport and storage conditions:Obtained directly from themanufacturer and stored
in their original packaging at room temperature in the clinic. The temperature ranged
from 19 °C to 31 °C over the course of the study, and relative humidity from 39% to
87%.
Person(s) performing RDT: Study staff
RDT setting: Health centres
Follow-up Not applicable
Notes Source of funding: US National Institute of Health, with additional support from the
Doris Duke Charitable Foundation
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were referred for mi-
croscopy for suspected malaria under usual
care protocols
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Yes Two microscopists, including one expert
microscopist at a central laboratory, read
each smear. They examined 100 high pow-
ered fields before declaring negative.
Discordant results between expert mi-
croscopy and RDTs were then re-examined




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
No Discordant results between expert mi-
croscopy and RDTs were re-examined us-




Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no exclu-
sions due to invalid results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponds with the number presented in
the analysis; therefore there were no with-
drawals due to invalid results
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Iqbal 2003
Clinical features and settings Presenting signs and symptoms: History of fever for 2 to 3 days and possible malaria
infection
Previous treatment for malaria: Patients with a history of antimalarial use in the pre-
vious 4 weeks were excluded
Clinical setting: Basic health units
Country: Pakistan (central areas of Punjab)
Malaria endemicity: Seasonal
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 930
Age:Range 2 to 55 years (not clear whether this was an inclusion criteria or characteristic
of included participants)
Sex:Not mentioned, either as an inclusion criteria or a characteristic of the participants
Co-morbidities and pregnancy: Not mentioned, either as an inclusion criteria or a
characteristic of the participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Experienced microscopist
Microscopy setting: District Health Centre
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One; however for quality assessment, 100 random
slides were sent to the Microbiology Unit, University of Kuwait, for a second reading;
these results were comparable to the District Health Centre results
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: OptiMAL (Flow Inc., Portland, Oregon, USA)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Laboratory staff
RDT setting: District Health Centre
Follow-up Not applicable
Notes Source of funding: Kuwait University
Table of Methodological Quality
Item Authors’ judgement Description
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Unclear All participants were attending basic health
units with symptoms ofmalaria and history




No An microscopist working at a district labo-
ratory viewed at least 200 high power fields
before declaring a slide negative; however




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “tests were performed in a double-blind
manner”
Index test results blinded?
All tests




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Kar 1998
Clinical features and settings Presenting signs and symptoms: People attending a malaria clinic
Previous treatment for malaria: No exclusion criteria based on prior antimalarial drug
use; this information was recorded for each participants, but no data is presented
Clinical setting: Malaria Clinic at a Malaria Research Centre
Country: India (Chennai, Tamil Nadu)
Malaria endemicity: Perennial
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 93
Age: Not mentioned either as an inclusion criteria or characteristic of participants
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Kar 1998 (Continued)
Sex: Not mentioned either as an inclusion criteria or characteristic of participants
Co-morbidities and pregnancy: No information presented on co-morbidities or preg-
nancy
Parasite density of microscopy positive cases: Less than 100 parasites perµl in 3 cases;
between 100 and 1000 in 8 cases, over 1000 in 34 cases
Study design Enrolment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Malaria clinic at malaria research centre
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDTs: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ,
USA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Malaria clinic at malaria research centre
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending a malaria
clinic, but their symptoms were not de-




Unclear Study report did not state who performed
the microscopy, how many observers or re-
peats were used, or how many high power




Yes All participants who received the index test
also received the reference test
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Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Kilian 1999
Clinical features and settings Presenting signs and symptoms: Suspected uncomplicated malaria
Previous treatment for malaria: There were no explicit exclusion criteria based on
previous use of antimalarials, and no data on previous antimalarial use of the participants
was presented
Clinical setting: District malaria control programme health facilities and hospital out-
patient clinic
Country: Uganda (Kaborole District)
Malaria endemicity: Various locations with varying endemicities
Malaria endemic species: Mainly P. falciparum
Participants Sample size: 1326
Age: Included 336 infants and 710 adults; plus 180 with ages not stated
Sex: Included 124 pregnant women; number of other female participants was not stated
Co-morbidities and pregnancy: Included 124 pregnant women and 586 people with
previous malaria treatment failure
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. Sampling was purposive to include mainly people of high
risk groups. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Central malaria laboratory
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Kilian 1999 (Continued)
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: At the hospital, all slides were read independently by
two microscopists; at two health centres a second reading was only performed where
RDT and microscopy results disagreed
Resolution of discrepancies between observers: In the case of the second slide reading
differing from the first, a third independent reading was carried out by a senior micro-
scopist and this was considered true
Index and comparator tests Commerical name of RDT: ParaSight-F (Becton Dickinson Tropical Disease Diagnos-
tics, Sparks, MD, USA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: At the hospital, tests were carried out and read by an
experienced laboratory assistant. At the health centres, the tests were carried out by health
workers after training, and within one week were re-read by an experienced laboratory
assistant blind to the evaluation of the health care staff.
RDT setting: Two health units and a hospital.
Follow-up Not applicable
Notes Source of funding: The ParaSight-F tests were provided by both Becton-Dickinson and
the Malaria Unit, Ministry of Health, Uganda. The study was financially supported by
the Federal Ministry of Economic Cooperation and Development, Germany, through
Project PN 94.2195.9.
Additional Information: This study was part of a larger study which included a group
of people who had been treated for malaria but where treatment had failed.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
No The majority of participants were pur-
posively selected as members of high-risk
groups (infants, pregnant women and peo-
ple with treatment failure)
Acceptable reference standard?
All tests
Yes Two independent microscopists viewed at




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
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Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes RDT andmicroscopy undertaken at differ-
ent locations
Index test results blinded?
All tests




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results.
The text “complete data were available for
1326 patients” suggests some missing data
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals. The text “complete data
were available for 1326 patients” suggests
some missing data.
Kolaczinski 2004
Clinical features and settings Presenting signs and symptoms: Suspected malaria/febrile illness
Previous treatment for malaria: No exclusion criteria based on previous use of anti-
malarials, and no data on previous antimalarial use of the participants was presented
Clinical setting: Basic health units within an Afghan refugee camp
Country: Pakistan (North West Frontier Province)
Malaria endemicity: Not stated
Malaria endemic species: 80% P. vivax, 20% P. falciparum
Participants Sample size: 499
Age: All age groups eligible for inclusion; actual age range of the participants not stated
Sex: Both males and females eligible for inclusion; actual age range of the participants
not stated
Co-morbidities and pregnancy: No exclusions based on co-morbidities or pregnancy,
and no data presented on the frequency of these conditions in the study population
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy:Microscopists
Microscopy setting: Basic health units within an Afghan refugee camp and HNI’s
reference laboratory in Peshawar
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Kolaczinski 2004 (Continued)
Number of high power fields examined before declaring negative: 100
Number of observer or repeats:Two, one at theBHUandone at the reference laboratory
Resolution of discrepancies between observers: Not clear, “all of the smears checked
by the microscopist at each BHU were cross checked at HNI’s reference laboratory at
Pashawar”
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparummalaria
species only
Designated Type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Microscopists
RDT setting: Basic health units
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-




Yes Two microscopists, one working in a cen-
tral laboratory, viewed at least 100 high




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
No The index test and reference test were un-
dertaken by the same person
Index test results blinded?
All tests
No The index test and reference test were un-
dertaken by the same person
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Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no exclu-
sions due to invalid test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no with-
drawals
Kumar 1996
Clinical features and settings Presenting signs and symptoms: Febrile patients
Previous treatment formalaria:Noexclusion criteria based on prior use of antimalarials;
relevant data collected but presented only for false positives
Clinical setting: Clinic of the Malaria Research Centre
Country: India (Goa)
Malaria endemicity: Not stated
Malaria endemic species: P. vivax and P. falciparum
Participants Sample size: 98
Age: Not mentioned, either as an inclusion criteria or characteristic of included partici-
pants
Sex: Not mentioned, either as an inclusion criteria or characteristic of included partici-
pants
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Not stated
Microscopy setting: Clinic of the Malaria Research Centre
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDTs: ICTMalaria-Pf (ICT Diagnostics, Brookvale, NSW, Aus-
tralia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at 4 °C prior to use
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Kumar 1996 (Continued)
Person(s) performing RDT: Not stated
RDT setting: Clinic of the Malaria Research Centre
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending a Malaria
Research Clinic with fever; however the
sampling method was not described
Acceptable reference standard?
All tests
Unclear The microscopy process was not described
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated;
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated;
therefore it is unclear whether there were
any withdrawals
118Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kumar 2004
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No mention of previous treatment for malaria, either
as an exclusion criteria or a characteristic of included participants
Clinical setting: Primary health centres
Country: India (Karnataka state)
Malaria endemicity: Not stated
Malaria endemic species: Mainly P. falciparum, some P. vivax
Participants Sample size: 2891
Age:Not mentioned either as an exclusion criteria or a characteristic of included partic-
ipants
Sex: Not mentioned either as an exclusion criteria or a characteristic of included partic-
ipants
Co-morbidities and pregnancy: Not mentioned either as an exclusion criteria or a
characteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDTs was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood film
Person(s) performing microscopy: Laboratory technicians
Microscopy setting: Initially undertaken at the primary health centres and later cross-
checked at the Central Malaria Laboratory
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Two
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: Paracheck-Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at 4 °C and brought to room temperature
before performing the test
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending health cen-
tres with fever, but the sampling methods
were not described
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Unclear Two independent microscopists read the
slides; however the number of high power
fields viewed before declaring a slide nega-
tive was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated;
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated;
therefore it is unclear whether there were
any withdrawals
Kyabayinze 2008
Clinical features and settings Presenting signs and symptoms: History of fever in the previous 24 h or axillary
temperature 37.5 °C or over; no evidence of concomitant febrile illness; no danger signs
or evidence of severe malaria
Previous treatment for malaria: No exclusion criteria based on antimalarial use; data
collected on prior antimalarial use but not presented for the study sample
Clinical setting: Regional referral hospital outpatient department
Country: Uganda
Malaria endemicity: Hyperendemic
Malaria endemic species: Mainly P. falciparum
Participants Sample size: 357
Age: Inclusion criteria over the age of six months; 46%were under the age of five;median
age 11 years (range 1 to 28 years)
Sex: Both males and females eligible; 60% were female and 40% male
Co-morbidities and pregnancy: People with evidence of concomitant febrile illness
were excluded from the study
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Kyabayinze 2008 (Continued)
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Hospital microscopists
Microscopy setting: Hospital laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two in most cases. A third microscopist read a random
10% of slides for quality control.
Resolution of discrepancies between observers:A third externalmicroscopist, unaware
of the first two results, resolved any discordant results
Index and comparator tests Commerical name of RDTs: ICTMalaria-Pf (ICT Diagnostics, Brookvale, NSW, Aus-
tralia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Storage temperature ranged from 22 °C to 29 °C,
and a single spike temperature of 38 °C was recorded during transportation
Person(s) performing RDT: Two independent readings by trained staff
RDT setting: Hospital laboratory
Follow-up Not applicable
Notes Source of funding: UKDFID through the COMDIS research programme consortium
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of




Yes Twomicroscopists working in a central lab-
oratory viewed at least 100 high power
fields before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
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Kyabayinze 2008 (Continued)
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Yes 7 enrolled participants were excluded due
to uninterpretable blood smears
Withdrawals explained?
All tests
Yes 7 enrolled participants were excluded due
to uninterpretable blood smears; otherwise
there were no withdrawals
Labbe 2001
Clinical features and settings Presenting signs and symptoms: Fever or history of fever in the previous 24 h
Previous treatment for malaria: Excluded if gave a history of ingestion of antimalarials
in the preceding month or a history of chloroquine intolerance
Clinical setting: Local malaria clinics run by the Laos InstituteMalariology, Parasitology
and Entomology
Country: Lao PDR, Vang Vieng district of Vientiane province
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 196
Age: Excluded children less than one year old. No more details are given about the age
presentation of the participants.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy: Participants were excluded if known to be pregnant
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Expert microscopist
Microscopy setting: National malaria reference centre (IMPE in Vientiane)
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Unclear text states “were read by expert microscopists”
Resolution of discrepancies between observers: Not applicable or unclear
Index and comparator tests Commerical name of RDT: PATH-developed dipstick
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not stated
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Labbe 2001 (Continued)
Person(s) performing RDT: Trained local healthcare providers
RDT setting: Local malaria clinics
Follow-up Not applicable
Notes Source of funding: Supported in part by the Banjamin H Kean Fellowship awarded by
the American Society of Tropical Medicine and Hygiene, the Bayers Healthcare/Univer-
sity of Toronto fellowship in Medical Microbiology, and a Career Scientist Award from
the Ontorio Ministry of Health. Development of the PATH PfHRP-2 assay was funded
by the United States Agency for International Development under the Technologies for
Health Programme (Cooperative Agreement No. HRN-A-0096-90007).
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending malaria
clinic with fever symptoms, however the
sampling method was unclear
Acceptable reference standard?
All tests
Unclear An expert microscopist viewed at least 100
high power fields before declaring a slide
negative, however it is unclear whether




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “All testing was performed blinded to the
results of the other assay”
Index test results blinded?
All tests
Yes “All testing was performed blinded to the
results of the other assay”
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no exclu-
sions due to invalid test results
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Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no with-
drawals
Mboera 2006a
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Hospitals, health centres and dispensaries
Country: Tanzania, Babati
Malaria endemicity: Prevalence of infection varying from 1.3% in highlands to 62%
in the lowlands
Malaria endemic species: P. falciparum
Participants Sample size: 308
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at 4 °C and used within one month of
purchase
Person(s) performing RDT: Local study team trained in the use of the RDT
RDT setting: Not stated
Follow-up Not applicable
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Mboera 2006a (Continued)
Notes Source of funding: Italian cooperation and international water management institute
through the system-wide initiative in malaria and agriculture. Also the Sir Halley Stewart
Trust for one author.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series who




No An experienced microscopist viewed at
least 200 high power fields before declar-
ing a slide negative; however their results




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The blood smears were examined by ex-
periencedmicroscopists who were unaware
which samples had been found positive in
the RDT and which negative”
Index test results blinded?
All tests
Yes “Local team member read the results inde-




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
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Mboera 2006b
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Hospitals, health centres and dispensaries
Country: Tanzania, Dodoma
Malaria endemicity: Prevalence of infection approximately 25%
Malaria endemic species: P. falciparum
Participants Sample size: 88
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at 4 °C and used within one month of
purchase
Person(s) performing RDT: Local study team trained in the use of the RDT.
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Italian cooperation and international water management institute
through the system-wide initiative in malaria and agriculture. Also the Sir Halley Stewart
Trust for one author.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series who
had a fever and were seeking treatment for
suspected malaria
126Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)




No An experienced microscopist viewed at
least 200 high power fields before declar-
ing a slide negative; however their results




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The blood smears were examined by ex-
periencedmicroscopists who were unaware
which samples had been found positive in
the RDT and which negative”
Index test results blinded?
All tests
Yes Local team member read the results inde-




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Mboera 2006c
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Hospitals, health centres and dispensaries
Country: Tanzania, Iringa
Malaria endemicity: Prevalence of infection over 73% in the lowlands, no malaria in
the highlands
Malaria endemic species: P. falciparum
Participants Sample size: 228
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
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Mboera 2006c (Continued)
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at 4 °C and used within one month of
purchase
Person(s) performing RDT: Local study team trained in the use of the RDT
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Italian cooperation and international water management institute
through the system-wide initiative in malaria and agriculture. Also the Sir Halley Stewart
Trust for one author.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series who




No An experienced microscopist viewed at
least 200 high power fields before declar-
ing a slide negative; however their results




Yes All participants who received the index test
also received the reference test
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Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The blood smears were examined by ex-
periencedmicroscopists who were unaware
which samples had been found positive in
the RDT and which negative”
Index test results blinded?
All tests
Yes Local team member read the results inde-




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Mboera 2006d
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Hospitals, health centres and dispensaries
Country: Tanzania, Muleba
Malaria endemicity: Prevalence of infection 40% to 44%
Malaria endemic species: P. falciparum
Participants Sample size: 306
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
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Mboera 2006d (Continued)
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at 4 °C and used within one month of
purchase
Person(s) performing RDT: Local study team trained in the use of the RDT
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Italian cooperation and international water management institute
through the system-wide initiative in malaria and agriculture. Also the Sir Halley Stewart
Trust for one author.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series who




No An experienced microscopist viewed at
least 200 high power fields before declar-
ing a slide negative; however their results




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The blood smears were examined by ex-
periencedmicroscopists who were unaware
which samples had been found positive in
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Mboera 2006d (Continued)
the RDT and which negative”
Index test results blinded?
All tests
Yes Local team member read the results inde-




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Yes The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Mboera 2006e
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Hospitals, health centres and dispensaries
Country: Tanzania, Mvovera
Malaria endemicity: Prevalence of infection about 43%
Malaria endemic species: P. falciparum
Participants Sample size: 64
Age: All age groups eligible. Actual age profile of participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
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Mboera 2006e (Continued)
Batch numbers: Not stated
Transport and storage conditions: Stored at room temperature for 12 months
Person(s) performing RDT: Local study team trained in the use of the RDT
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Italian cooperation and international water management institute
through the system-wide initiative in malaria and agriculture. Also the Sir Halley Stewart
Trust for one author.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series who




No An experienced microscopist viewed at
least 200 high power fields before declar-
ing a slide negative; however their results




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The blood smears were examined by ex-
periencedmicroscopists who were unaware
which samples had been found positive in
the RDT and which negative”
Index test results blinded?
All tests
Yes Local team member read the results inde-




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
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Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Mekonnen 2010
Clinical features and settings Presenting signs and symptoms: Febrile, clinically suspected for malaria
Previous treatment for malaria: No exclusions based on previous treatment, and no
relevant data presented
Clinical setting: Outpatient department of a health centre
Country: Ethiopia (Jimma, South-West), 300 km south-west of Addis Ababa, 1760 m
above sea level
Malaria endemicity: Not stated: transmission takes place throughout the year
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 240
Age: Eligible age range not stated. Actual age range of participants was 1 to 60 years,
with a mean age of 25 years
Sex: Both males and females eligible: 57.5% of the study participants were male, 42.5%
female
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of the included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced malaria technicians
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 300
Number of observer or repeats: Discordant results between RDTs and slides were
repeated
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: CareStart Malaria Pf/Pv Combo (Access Bio Inc, Mon-
mouth Junction, New Jersey, USA)
Parasite(s) designed to detect: P. falciparum and P. vivax
Designated Type: Type 5
Batch numbers: Not stated
Transport and storage conditions: Stored according to the guidelines of the manufac-
turer and quality of package desiccant was checked before use
Person(s) performing RDT: Experienced malaria technicians
RDT setting: Not stated
Follow-up Not applicable
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Mekonnen 2010 (Continued)
Notes Source of funding: Recieved financial support from the School of Laboratory Studies
of the Jimma Univeristy and the VLIR-IUC program between Flanders and Jimma
Univeristy. Access Bio Ltd donated the CareStart Malaria Pf/Pv Combo test kit.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending a clinic with
fever and suspected malaria, but the sam-
pling method was not described
Acceptable reference standard?
All tests
Yes Experienced technicians independently
viewed 300 high power fields before declar-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Blinding not described
Index test results blinded?
All tests
Yes “Results of the CareStart tests were deter-
mined prior to microscopic results with
strict blinding to themicroscopic examina-
tion of the blood film”
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no exclu-
sions due to invalid test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no with-
drawals
134Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mendiratta 2006
Clinical features and settings Presenting signs and symptoms: Clinically suspected to be suffering from malaria
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials, except for retrospective analysis in the
case of false positive results
Clinical setting: Not clear
Country: Sevagram, India
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum
Participants Sample size: 443
Age: Age profile of participant population not presented. Does not mention age as
inclusion criteria.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Department of Microbiology, Mahatma Ghandi Institute of Med-
ical Sciences, Sevagram
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Two independent observers
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Department of Microbiology, Mahatma Ghandi Institute of Medical
Sciences, Sevagram
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
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Unclear Participants were a consecutive sample of
people with fever and clinically suspected
malaria; however the setting is unclear
Acceptable reference standard?
All tests
Unclear Microscopy undertaken by two trained mi-
croscopists, but it is was not stated how
many high power fields they viewed before
declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no exclu-
sions due to invalid test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated, and
corresponded to the number presented in
the analysis; therefore there were no with-
drawals
Mens 2007a
Clinical features and settings Presenting signs and symptoms: Suspected uncomplicated malaria, fever or history of
fever in the previous 24 h
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Health centre
Country: Tanzania
Malaria endemicity: Hypoendemic
Malaria endemic species: P. falciparum
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Mens 2007a (Continued)
Participants Sample size: 154
Age: 6 months to 12 years
Sex: Both males and females eligible; Male:female ratio 1.8:1
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: 3 cases: 160, 120 and 1000 parasites
per µl
Study design Enrollment was consecutive and prospective. Three RDTs were tested. All individuals
received all three tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative:Not stated. Parasite
density was counted against 200 leukocytes.
Number of observer or repeats: Two
Resolution of discrepancies between observers: Report stated that there were no dis-
cordant results between the two microscopists
Index and comparator tests Commerical name of RDT:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
OptiMAL (Diamed AG, Switzerland) - P. falciparum or mixed infection, non-falciparum
malaria species only
Parasite(s) designed to detect:
Paracheck Pf - P. falciparum
OptiMAL - P. falciparum or mixed infection, non-falciparum malaria species only
Designated Type:
Paracheck Pf - Type 1
OptiMAL - Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Two independent readers
RDT setting: Not mentioned
Follow-up Not applicable
Notes Source of funding: The Hubrecht-Janssen Fund, KIT, Amsterdam, Netherlands
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
children with fever or history of fever in the
past 24 h
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Unclear Two independent microscopists examined
the slides. Unclear how many high power




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that microscopists were
blinded to the results of the others tests per-
formed
Index test results blinded?
All tests
Yes Report states that readers were blinded to
the results of the other tests performed
Uninterpretable results reported?
All tests
Yes Paracheck: 4 failures; OptiMAL: 4 failures
Withdrawals explained?
All tests
No Unclear whether test failures were repeated,
or whether they were included or excluded
in the analysis
Mens 2007b
Clinical features and settings Presenting signs and symptoms: Suspected uncomplicated malaria, fever or history of
fever in the previous 24 h
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials
Clinical setting: Hospital outpatients
Country: Kenya
Malaria endemicity: Mesoendemic
Malaria endemic species: P. falciparum
Participants Sample size: 184
Age: 6 months to 12 years
Sex: Both males and females eligible; male: female ratio 1:1
Co-morbidities and pregnancy: No exclusions based on co-morbidities. No details of
the frequency of these conditions in the participant population presented.
Parasite density of microscopy positive cases: Range 400 to 828,800 parasites per µl,
mean 18,680
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Mens 2007b (Continued)
Study design Enrollment was consecutive and prospective. Three RDTs were tested. All individuals
received all three tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative:Not stated. Parasite
density was counted against 200 leukocytes.
Number of observer or repeats: Two
Resolution of discrepancies between observers: Report stated that there were no dis-
cordant results between the two microscopists
Index and comparator tests Commerical name of RDT:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
OptiMAL (Diamed AG, Switzerland)
Parascreen (Zephyr Biomedical, Verna, Goa, India)
Parasite(s) designed to detect:
Paracheck Pf - P. falciparum
OptiMAL - P. falciparum or mixed infection, non-falciparum species only
Parascreen - P. falciparum or mixed infection, non-falciparum species only
Designated Type:
Paracheck Pf - Type 1
OptiMAL - Type 4
Parascreen - Type 3
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Two independent readers
RDT setting: Not mentioned
Follow-up Not applicable
Notes Source of funding: The Hubrecht-Janssen Fund, KIT, Amsterdam, Netherlands
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of




Unclear Two independent microscopists examined
the slides. Unclear how many high power
fields were examined before declaring a
slide negative.
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Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that microscopists were
blinded to the results of the other tests per-
formed
Index test results blinded?
All tests
Yes Report states that readers were blinded to
the results of the other tests performed
Uninterpretable results reported?
All tests




No Unclear whether test failures were repeated,
or whether they were included or excluded
in the analysis
Mharakurwa 1997a
Clinical features and settings Presenting signs and symptoms: Clinical symptoms of malaria
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials, although this data was collected as part
of the study
Clinical setting: Primary health care centres
Country: Hurungwe, Zimbabwe
Malaria endemicity: Hyperendemic
Malaria endemic species: P. falciparum
Participants Sample size: 136
Age: All age groups eligible. Actual age structure of the study sample not stated.
Sex: Both males and females eligible. Actual ratio of males and females not stated.
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Geometric mean 52 parasites per µl
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 100
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Mharakurwa 1997a (Continued)
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical nameofRDT:ParaSight-F (BecktonDickinson, Franklin Lakes,NJ,USA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Nurses who had been trained to use the test
RDT setting: Primary health care centre
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending health centres with clini-
cal symptoms of malaria
Acceptable reference standard?
All tests
Unclear It is unclear how many observer repeats
were done, who did the microscopy and
where the microscopy was done. However,
it is clear that 100 high power fields were
viewed before declaring a slide negative.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was undertaken at a different
site to the RDTs
Index test results blinded?
All tests
Yes RDTs were undertaken and the results




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
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Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Mharakurwa 1997b
Clinical features and settings Presenting signs and symptoms: Clinical symptoms of malaria
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials, although this data was collected as part
of the study
Clinical setting: Primary health care centres
Country:Mutasa, Zimbabwe
Malaria endemicity: Mesoendemic
Malaria endemic species: P. falciparum
Participants Sample size: 96
Age: All age groups eligible. Actual age structure of the study sample not described.
Sex: Both males and females eligible. Actual ratio of males and females not described.
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Geometric mean 188 parasites per µl
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical nameofRDT:ParaSight-F (BecktonDickinson, Franklin Lakes,NJ,USA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Nurses who had been trained to use the test
RDT setting: Primary health care centre
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
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Mharakurwa 1997b (Continued)
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending health centres with clini-
cal symptoms of malaria
Acceptable reference standard?
All tests
Unclear It is unclear how many observer repeats
were done, who did the microscopy and
where the microscopy was done. However,
it is clear that 100 high power fields were
viewed before declaring a slide negative.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was undertaken at a different
site to the RDTs
Index test results blinded?
All tests
Yes RDTs were undertaken and the results




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
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Mharakurwa 1997c
Clinical features and settings Presenting signs and symptoms: Specimens sent to the Public Health Laboratory for
malaria diagnosis
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials, although this data was collected as part
of the study
Clinical setting: Primary health care centres
Country: Harare, Zimbabwe
Malaria endemicity: Hypoendemic
Malaria endemic species: P. falciparum
Participants Sample size: 213
Age: All age groups eligible. Actual age structure of the study sample not described.
Sex: Both males and females eligibles. Actual ratio of males and females not described.
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Geometric mean 2 parasites per µl
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Nurses who had been trained to use the test
RDT setting: Primary health care centre
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants included all people who had
a blood sample sent to the Public Health
Laboratory for diagnosis of malaria - the
criteria for referral is unclear
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Unclear It is unclear how many observer repeats
were done, who did the microscopy and
where the microscopy was done. However,
it is clear that 100 high power fields were
viewed before declaring a slide negative.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy was undertaken at a different
site to the RDTs
Index test results blinded?
All tests
Yes RDTs were undertaken and the results




Unclear The numbers of participants originally en-
rolled in the study was not clearly stated;
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The numbers of participants originally en-
rolled in the study was not clearly stated;
therefore it is unclear whether there were
any withdrawals
Mohapatra 1996
Clinical features and settings Presenting signs and symptoms: Clinical symptoms of malaria
Previous treatment for malaria: No exclusions based on previous treatment, and no
data presented on previous use of antimalarials, although this data was collected as part
of the study
Clinical setting: Malaria clinics set up in the field
Country: India, Assam
Malaria endemicity: Highly endemic
Malaria endemic species: Mainly P. falciparum
Participants Sample size: 100
Age: All age groups eligible; actual age range of the participants not reported
Sex: Both males and females eligible; numbers of male and female participants not
reported
Co-morbidities and pregnancy: No exclusion criteria based on pregnancy or comor-
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Mohapatra 1996 (Continued)
bidity, and no relevant data presented for the included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was random and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Malaria clinic set up in the field
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Malaria clinic set up in the field
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were a random sample of
people attending malaria clinics with clin-
ical symptoms of malaria.
Acceptable reference standard?
All tests
Unclear There is no information presented on who
performed the test, the number of ob-
servers, or the number of high power fields
viewed before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
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Mohapatra 1996 (Continued)
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled in the
study was clearly stated, and corresponded
to the number presented in the analysis,




Yes The number of participants enrolled in the
study was clearly stated, and corresponded
to the number presented in the analysis,
therefore there were no withdrawals
Moonasar 2009
Clinical features and settings Presenting signs and symptoms: Fever or headache or chills
Previous treatment for malaria: Patients who had recent malaria or had recently been
on malaria treatment were excluded
Clinical setting: Clinics
Country: South Africa (Vhembe district, Limpopo province)
Malaria endemicity:Not stated. The study was conducted during the high-transmission
season in an area chosen because it had the highest incidence of malaria in the province
for the previous nine years.
Malaria endemic species: Mainly P. falciparum
Participants Sample size: 405
Age: All ages eligible for inclusion; actual age range was 1 to 81 years, median 24.5 years
Sex: Both males and females eligible for inclusion; 56% of included participants were
male
Co-morbidities and pregnancy: Severely ill patients needing referral; patients with an
obvious non-malarial fever and pregnant women were excluded
Parasite density of microscopy positive cases: Range 440 to >20,000 parasites per µl.
Median 25,680.
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Specialised malaria microscopists
Microscopy setting: Health Centre
Number of high power fields examined before declaring negative: 100 (stated that
“standard techniques” were used and gave an appropriate reference)
Number of observer or repeats: Two independent readers
Resolution of discrepancies between observers: In the case of discordant results be-
tween microscopy and RDT, a medical technologist at the Limpopo Department of
Health reference centre who was highly skilled in malaria microscopy and blinded to
previous results re-read the slides. This result was taken to be correct.
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Moonasar 2009 (Continued)
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Nurses trained in RDT testing
RDT setting: Outpatient clinic
Follow-up Not applicable
Notes Source of funding: Ernest Oppenheimer Trust provided financial assistance in conduct-
ing the study
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of




Yes Two experienced microscopists (3 in the
case of discordant results between mi-
croscopy and RDT) independently viewed
at least 100 high power fields before declar-
ing a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes The microscopists were blinded to the
RDT results and read the thin and thick
films independently
Index test results blinded?
All tests
Yes RDTs were carried out first and result
recorded by the nurse at the clinic
Uninterpretable results reported?
All tests
Unclear The number enrolled is clearly stated and
corresponds to the number included in the
analysis; therefore we can assume that there
were no exclusions due to invalid results
148Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)




Yes The number enrolled is clearly stated and
corresponds to the number included in the
analysis; therefore we can assume that there
were no withdrawals
Msellem 2009
Clinical features and settings Presenting signs and symptoms: Fever in the previous 24 h and symptoms compatible
with uncomplicated malaria
Previous treatment for malaria:No exclusions based on previous antimalarial use, and
no data presented for the study sample
Clinical setting: Four primary health care units
Country: Zanzibar (Muyuno and Uzini on Unguja Island and Kinyasini and Mzamba-
rauni on Pemba Island)
Malaria endemicity: Recorded parasite rates between 10% and 50% in different age
groups. The four study sites aimed to provide a representative picture of Zanzibar with
regard to malaria epidemiology. The study was conducted during both the low trans-
mission and high transmission seasons.
Malaria endemic species: P. falciparum
Participants Sample size: 1005 were allocated to receive RDTs
Age: All ages eligible for inclusion; 55% of participants were under the age of five years
Sex: Both males and females eligible for inclusion; actual proportions of males and
females in the study sample not stated
Co-morbidities and pregnancy: There were no exclusions based on co-morbidities or
pregnancy; and no data presented on the frequency of these conditions in the study
participants
Parasite density of microscopy positive cases: Geometric mean 3840 parasites per µl,
range 10 to 457,236, 95% CI 3150 to 4681
Study design Enrollment into the study was consecutive and participants were allocated to receive
RDTs according to the week of the study (quasi-randomly). Enrollment was prospective.
One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Qualified microscopists
Microscopy setting: Central laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two independent readers
Resolution of discrepancies between observers:Examined by the third reader (decision
rule not stated)
Index and comparator tests Commerical name of RDT: ParaCheck-Pf (Orchid Biomedical Systems, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
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Msellem 2009 (Continued)
Person(s) performing RDT: Nurses trained in RDT testing
RDT setting: Outpatient clinic
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were consecutively sampled
from people attending clinic with fever in
the previous 24 h and with symptoms com-
patible with uncomplicated malaria
Acceptable reference standard?
All tests
Yes Two independentmicroscopists working in
a central laboratory viewed 100 high power
field before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes The microscopy was undertaken at a dif-
ferent location to the RDTs
Index test results blinded?
All tests
Yes RDTs were
undertaken and results recorded before the
microscopy results became available
Uninterpretable results reported?
All tests
Unclear There were no reports of any uninter-
pretable results, and the number enrolled
was clearly stated and corresponds with the
number presented in the analysis
Withdrawals explained?
All tests
Yes Therewere nowithdrawals; the number en-
rolled in the study was clearly stated and
corresponds with the number presented in
the analysis
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Murahwa 1999
Clinical features and settings Presenting signs and symptoms: Clinical signs and symptoms associated with malaria
Previous treatment for malaria:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Clinical setting: Local clinic
Country: Zimbabwe (Burma Valley, Mutarre District, Manicaland)
Malaria endemicity: Mesoendemic
Malaria endemic species: P. falciparum
Participants Sample size: 123 for ICT Malaria Pf, 100 for ParaSight-F
Age: Not mentioned, either as an exclusion criteria or characteristic of included partici-
pants
Sex: Not mentioned, either as an exclusion criteria or characteristic of included partici-
pants
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy:Microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated. How-
ever, the alternative quality measure of viewing 300 white blood cells (WBCs) before
declaring a slide negative was used.
Number of observer or repeats: Two independent readers
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT:
ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, USA)
ICT Malaria Pf (ICT Diagnostics, Brookvale, NSW, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
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Unclear Participants were all people presenting at
an outpatient clinic with clinical signs and
symptoms of malaria, but the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Two independent microscopists viewed at
least 300 WBCs. Unclear if this is equiva-
lent to 100 high power fields.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes RDT tests results were coded and recorded
separately for each test; two microscopists
examined the slides blindly
Index test results blinded?
All tests
Yes RDT tests were performed and results




Yes Six ICTMalaria tests and three ParaSight-F




No Unclear why only 100 of 123 participants
received ParaSight-F
Mwanza 2005
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria:Not mentioned, either as an exclusion criteria or char-
acteristic of included participants
Clinical setting: Outpatient clinics
Country: Zambia (copper belt, Ndola and Kitwe)
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 119
Age: Inclusion criteria: adults and children aged over 60 months
Sex: Not reported, no mention of sex as inclusion or exclusion criteria
Co-morbidities and pregnancy: Not reported, no mention of these conditions as in-
clusion or exclusion criteria
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Mwanza 2005 (Continued)
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Hexagon Malaria
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants were all attending outpatient
clinics with fever, however the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Microscopy process is not described
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
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Mwanza 2005 (Continued)
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Nicastri 2009a
Clinical features and settings Presenting signs and symptoms: Fever over 38 °C for less than 10 days
Previous treatment for malaria: Participants with previous antimalarial treatment
(timescale not stated) were excluded
Clinical setting: Outpatient clinics at two peripheral hospitals
Country: Tanzania (Pemba Island and Iringa)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum
Participants Sample size: 336
Age: Inclusion criteria: adults and children aged over 12 months
Sex: Not reported, no mention of sex as inclusion or exclusion criteria
Co-morbidities and pregnancy: Excluded patients with signs of severe malaria, or with
diagnoses of mental illness, measles, chickenpox, otitis, infected wounds or pneumonia
Parasite density of microscopy positive cases: Not presented.
Study design Enrolment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Laboratory technician trained and supported with
blood slide reading
Microscopy setting: Hospital laboratory
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ParaHIT-f (Span Diagnostics Ltd, Surat, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Laboratory technician
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RDT setting: Hospital laboratory
Follow-up Not applicable
Notes Source of funding: Part of the activities carried out by the Programme Aid 8282 in
Tanzania, funded by the Italian Cooperation and Ministry of Foreign Affairs of Italy.
The American Society of Tropical Medicine and Hygiene assisted with the publication
expenses.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending an outpa-
tient department with fever, but the sam-
pling method was not described
Acceptable reference standard?
All tests
Unclear Skilled technicians viewed up to 200 high
powered fields before declaring negative;
however it is unclear how many observers
or repeats were used
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Yes There do not appear to be any uninter-
pretable results, as the number of partici-
pants recruited into the study is clearly pre-
sented and corresponds with the number
presented in the analysis
Withdrawals explained?
All tests
Yes There do not appear to be any withdrawals,
as the number of participants recruited into
the study is clearly presented and corre-
sponds with the number presented in the
analysis
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Nicastri 2009b
Clinical features and settings Presenting signs and symptoms: Fever over 38 °C for less than 10 days
Previous treatment for malaria: Participants with previous antimalarial treatment
(timescale not stated) were excluded
Clinical setting: Outpatient clinics at two peripheral hospitals
Country: Tanzania (Pemba Island and Iringa)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum
Participants Sample size: 336
Age: Inclusion criteria: adults and children aged over 12 months
Sex: Not reported, no mention of sex as inclusion or exclusion criteria
Co-morbidities and pregnancy: Excluded patients with signs of severe malaria, or with
diagnoses of mental illness, measles, chickenpox, otitis, infected wounds or pneumonia
Parasite density of microscopy positive cases: Not clear
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: PCR
Index and comparator tests Commerical name of RDT: ParaHIT-f (Span Diagnostics Ltd, Surat, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Laboratory technician
RDT setting: Hospital laboratory
Follow-up Not applicable
Notes Source of funding: Part of the activities carried out by the Programme Aid 8282 in
Tanzania, funded by the Italian Cooperation and Ministry of Foreign Affairs of Italy.
The American Society of Tropical Medicine and Hygiene assisted with the publication
expenses
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending an outpa-
tient department with fever, but the sam-
pling method was not described
Acceptable reference standard?
All tests
Yes Reference standard was PCR
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
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Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear There do not appear to be any uninter-
pretable results, as the number of partici-
pants recruited into the study is clearly pre-
sented and corresponds with the number
presented in the analysis
Withdrawals explained?
All tests
Yes There do not appear to be any withdrawals,
as the number of participants recruited into
the study is clearly presented and corre-
sponds with the number presented in the
analysis
Nigussie 2008a
Clinical features and settings Presenting signs and symptoms: Acutely febrile patients
Previous treatment for malaria: No exclusions based on previous treatment; 220 par-
ticipants were interviewed regarding previous antimalarial use and 24 of these (11%)
reported antimalarial use in the previous month
Clinical setting: Health centre outpatient departments
Country: Ethiopia (Wondo-Genet)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 460 enrolled, 452 received the test
Age: All ages eligible. Actual age range 1 to 60 years.
Sex: 242 males (52.6%), 218 females (47.4%)
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Two RDTs were tested in the study, these
are reported separately in this review.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Technicians who were members of the research
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team, and independent readers at a central laboratory
Microscopy setting: Health centres and Akilu Lemma Institute of Pathobiology para-
sitology laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two, one at the health centre and one at the central
laboratory
Resolution of discrepancies between observers: There were no discordant results
Index and comparator tests Commerical name of RDT:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Two well experienced technicians who were part of the
research team
RDT setting: Health centres
Follow-up Not applicable
Notes Source of funding: Paracheck Pf kits were provided by the Federal Democratic Republic
of Ethiopia Ministry of Health
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending health centre outpatient
departments with an acute fever
Acceptable reference standard?
All tests
Yes Two independent readers viewed at least
100 high power fields before declaring a
slide negative. One reader was based at a
central laboratory, and there were no dis-
cordant results between readers.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
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Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Yes Eight participants were excluded due either
to incomplete information on either the
Paracheck test or the malaria slide
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study is clearly stated and corresponds to
the number presented in the analysis minus
the number reported to have invalid test
results or incomplete data
Nigussie 2008b
Clinical features and settings Presenting signs and symptoms: Acutely febrile patients
Previous treatment for malaria: No exclusions based on previous treatment; 220 par-
ticipants were interviewed regarding previous antimalarial use and 24 of these (11%)
reported antimalarial use in the previous month
Clinical setting: Health centre outpatient departments
Country: Ethiopia (Wondo-Genet)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 259 received RDT, although 460 were enrolled in the study
Age: All ages eligible. Actual age range 1 to 60 years.
Sex: Males and females eligible for the study, actual numbers who received Parascreen
not presented
Co-morbidities and pregnancy: No exclusions criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Two RDTs were tested in the study, these
are reported separately in this review
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Technicians who were members of the research
team, and independent readers at a central laboratory
Microscopy setting: Health centres and Akilu Lemma Institute of Pathobiology para-
sitology laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two, one at the health centre and one at the central
laboratory
Resolution of discrepancies between observers: There were no discordant results
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Nigussie 2008b (Continued)
Index and comparator tests Commerical name of RDT:
Parascreen Pan/Pf (Zephyr Biomedical, Verna, Goa, India)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated Type: Type 3
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Two well experienced technicians who were part of the
research team
RDT setting: Health centres
Follow-up Not applicable
Notes Source of funding:TheGlobal Fund to fight AIDS, TB andMalaria through the Federal
Democratic Republic Ethiopian Ministry of Health
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Due to a shortage of test kits, only 259 of
the 460 participants enrolled in the study
received this RDT test, and it is not clear
how these participants were selected
Acceptable reference standard?
All tests
Yes Two independent readers viewed at least
100 high power fields before declaring a
slide negative. One reader was based at a
central laboratory and there were no dis-
cordant results between readers.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Yes Eight participants were excluded due either
to incomplete information on either the
Paracheck test or the malaria slide
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Yes The number of participants enrolled in the
study is clearly stated and corresponds to
the number presented in the analysis minus
the number reported to have invalid test
results or incomplete data
Nwuba 2001
Clinical features and settings Presenting signs and symptoms: Fever 38 °C or above, or other symptoms indicative
of malaria
Previous treatment for malaria: No exclusions based on previous treatment. Approx-
imately 60% of participants had taken antimalarial drugs one day to three weeks prior
to the hospital visit.
Clinical setting: Paediatric outpatient clinic, University College Hospital
Country: Nigeria, Ibadan
Malaria endemicity: Not stated
Malaria endemic species: Not stated
Participants Sample size: 77
Age: Children only. Age range not stated.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Stated as “workers”
Microscopy setting: Hospital laboratory
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent microscopists
Resolution of discrepancies between observers: Not stated
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described.
Person(s) performing RDT: Not stated
RDT setting: Paediatric outpatient clinic
Follow-up Not applicable
Notes Source of funding: Not stated
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Nwuba 2001 (Continued)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear The study included 77% of children pre-
senting to an outpatient clinic during the
study period with fever or other symptoms
of malaria; the method of selection of these
patients was not described
Acceptable reference standard?
All tests
Yes The independent microscopists viewed at
least 200 high power fields before declar-
ing a slide negative. Level of training of
the “two workers” is not described, but mi-
croscopy was undertaken in a major hospi-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report stated that themicroscopists had no
knowledge of the RDT test results
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
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Omar 1999
Clinical features and settings Presenting signs and symptoms: Febrile or other commonly associated malaria symp-
toms
Previous treatment for malaria: Not mentioned either as an exclusion criteria or char-
acteristic of included participants
Clinical setting: Outpatient clinic at a Primary Healthcare Centre
Country: Saudi Arabia
Malaria endemicity: Not stated
Malaria endemic species: 90% P. falciparum
Participants Sample size: 38
Age: Included participants aged 7 to 80 years
Sex: Male:Female ratio 3:1
Co-morbidities and pregnancy: Not mentioned
Parasite density of microscopy positive cases:Mean 7476 parasites per µl
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Person(s) performing microscopy:Microscopist checked by consultant
Microscopy setting: Parasitology laboratory
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Two observers but unclear whether they worked inde-
pendently
Resolution of discrepancies between observers: Not stated
Index and comparator tests Commerical nameofRDT:ParaSIght-F (BecktonDickinson, Franklin Lakes,NJ,USA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described.
Person(s) performing RDT: Two investigators
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participantswere attending outpatient clin-
icswith fever or other symptomsofmalaria,
but the samplingmethodwas not described
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Unclear Unclear how many high power fields were
examined before declaring a slide negative




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
Pandya 2001
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment and no
data presented on previous treatment
Clinical setting: Regional Health and Family Welfare Office Malaria Clinic
Country: India (Gujarat)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 468
Age: 10 aged under 5 years, 458 aged 5 and older
Sex: 298 males, 170 females
Co-morbidities and pregnancy:No exclusions due to co-morbidities or pregnancy, and
actual numbers of participants with these conditions not presented
Parasite density of microscopy positive cases: Not presented
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Pandya 2001 (Continued)
Study design Enrollment appeared to be consecutive, but may have been based only on those for
whom a blood slide had been taken (criteria for taking blood slide unclear). Enrollment
was prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck-Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described.
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were children attending a








Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
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No One enrolled individual ismissing from the
results table. The reason for this is unclear.
Withdrawals explained?
All tests
No One enrolled individual ismissing from the
results table. The reason for this is unclear.
Pattanasin 2003
Clinical features and settings Presenting signs and symptoms: Fever or history of fever and suspected diagnosis of
uncomplicated malaria
Previous treatment for malaria: No mention of previous treatment for malaria, either
as an exclusion criteria or a characteristic of included participants
Clinical setting: Not stated
Country: Thailand (Mae Sod)
Malaria endemicity: Not stated, peak transmission season
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 271
Age: Children aged under 2 years were excluded. The study included participants aged
two to 81 years; 71% were aged under 15 years.
Sex: Male: female ratio was 1.7:1
Co-morbidities and pregnancy: Pregnant women were excluded
Parasite density of microscopy positive cases: Not presented
Study design Enrolment was prospective. The sampling method was not described. Two RDTs were
evaluated, the vast majority of participants received both RDTs.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood film
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:
Paracheck-Pf (Orchid Biomedical Systems, Goa, India)
OptiMAL-IT (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect:
Paracheck-Pf - P. falciparum
OptiMAL-IT - P. falciparum or mixed infection, non-falciparum species only
Designated Type:
Paracheck-Pf - Type 1
OptiMAL-IT - Type 4
Batch numbers: Not stated
Transport and storage conditions: Kept at room temperature and opened just before
performing the test to avoid humidity
Person(s) performing RDT: Not stated
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Pattanasin 2003 (Continued)
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants had a fever and suspected
malaria, but the exact clinical setting and
the sampling method were not described
Acceptable reference standard?
All tests
Unclear No details of the microscopy process given
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Yes Test resultswere recordedwithout reference
to the microscopy results
Uninterpretable results reported?
All tests




Unclear Almost all participants were reported to re-
ceive the same index and reference tests
(271 participants in total: 266 received
OptMAL, 269 received Paracheck-Pf ); the
numbers presented in the analysis corre-
spond
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Rakotonirina 2008
Clinical features and settings Presenting signs and symptoms: Fever over 37.5 °C or history of fever in the previous
24 h
Previous treatment for malaria: Participants with recent antimalarial use were not
excluded from the study; 34% of participants declared antimalarial use
Clinical setting: Two primary health centres
Country:Madagascar (Tsiroanomandidy on the west foothill areas of the Highlands)
Malaria endemicity: Low and predominantly seasonal
Malaria endemic species: P. falciparum (80%) and P. vivax
Participants Sample size: 313
Age: All age groups were eligible for inclusion; the actual age range of the included
participants was 6 months to 79 years (median age 10 years)
Sex: Male: Famale ratio was 1.2:1
Co-morbidities and pregnancy: Pregnant women were excluded, as were people with
signs of severe or complicated malaria
Parasite density of microscopy positive cases: Range 32 to 52,750 parasites per µl,
mean 4104, Standard Deviation 7894
Study design Enrolment was consecutive and prospective. Two RDTs were evaluated; all participants
received both RDTs.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: PCR
Index and comparator tests Commerical name of RDT:
OptiMAL-IT (DiaMed AG, Cressier, Switzerland)
PALUTOP
Parasite(s) designed to detect:
OptiMAL-IT - P. falciparum or mixed infection, non-falciparum species only
PALUTOP - P. falciparum, P.vivax and other malaria types
Designated Type:
OptiMAL-IT - Type 4




Transport and storage conditions: Transported and maintained at the study sites (pri-
mary health centres) at room temperature and opened just before use to avoid humidity
damage
Person(s) performing RDT: Trained technician
RDT setting: Primary health centres
Follow-up Not applicable
Notes Source of funding: Global Fund Project for Madagascar, Round 3
Table of Methodological Quality
Item Authors’ judgement Description
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Yes Participants were a consecutive sample of
patients attending primary health centres




Yes Reference standard was PCR
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Stated that the PCR operator was blind to
the results of the other tests performed
Index test results blinded?
All tests
Yes Stated that the test readers were blind to
the results of the other tests performed
Uninterpretable results reported?
All tests
Yes There were no test failures with either RDT
Withdrawals explained?
All tests
Yes The number of participants enrolled in the
study is clearly stated and corresponds to
the number presented in the analysis
Ratsimbasoa 2007
Clinical features and settings Presenting signs and symptoms: Fever over 37.5 °C or history of fever in the previous
24 h, with typical malaria symptoms. Patients with signs of severe or complicated malaria
were excluded.
Previous treatment for malaria: Participants with recent antimalarial use were not
excluded from the study; 17% of participants reported antimalarial use
Clinical setting: Primary health centres
Country:Madagascar. Rural areas of Mahasolo (western foothills areas of the highlands)
and Saharevo (eastern foothills areas of the highlands).
Malaria endemicity: Low and predominantly seasonal in both areas
Malaria endemic species: Predominantly P. falciparum; some P. vivax
Participants Sample size: 194
Age: All groups eligible for inclusion not stated; actual age range of the included partic-
ipants was 1 to 79 years (mean age 15.2 years); 12.9% were under five years of age
Sex: Male: female ratio was 0.98:1
Co-morbidities and pregnancy: Pregnant women were excluded, as were people with
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Ratsimbasoa 2007 (Continued)
signs of severe or complicated malaria
Parasite density of microscopy positive cases: Range 16 to 233,600 parasites per µl,
mean 6564, Standard Deviation 26,553
Study design Enrolment was prospective. The sampling method was not described. Two RDTs were
evaluated, all participants received both RDTs.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: An experienced technician
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:
CareStart Malaria Pf/Pan (Access Bio Inc., Monmouth Junction, NJ, USA)
SD Malaria Antigen Bioline Pf/Pan (Standard Diagnostics, Suwon City, South Korea)
OptiMAL-IT (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated Type: Type 4
Batch numbers:
CareStart Malaria - J25IL, J35IL, J45IL, J55IL
SD Malaria Antigen Bioline - T5001, T5002, T5003, T5004
OptiMAL-IT - 46110.73.01, 46110.74.01, 46110.75.01
Transport and storage conditions: Transported and maintained at the study sites (pri-
mary health centres) at room temperature and opened just before use to avoid humidity
damage
Person(s) performing RDT: A technician
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Global Fund Project for Madagascar, Round 3. The manufacturers
supplied the test kits.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending primary
health centres with fever and symptoms of




No An expert technician viewed 200 high
power fields before declaring a slide nega-
tive; however their findings were not veri-
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Ratsimbasoa 2007 (Continued)
fied by a second independent reader
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “Analyzed without reference to the RDT
results”
Index test results blinded?
All tests




Unclear The number recruited into the study was
clearly stated, and corresponded with the
number presented in the analysis
Withdrawals explained?
All tests
Yes The number recruited into the study was
clearly stated, and corresponded with the
number presented in the analysis
Ratsimbasoa 2008
Clinical features and settings Presenting signs and symptoms: Fever or fever in the previous 24 h with typical malaria
symptoms
Previous treatment for malaria: Participants with recent antimalarial use were not
excluded from the study; 13% of participants declared antimalarial use
Clinical setting: Primary Health Centre
Country:Madagascar (Ampasimpotsy, Central Highlands)
Malaria endemicity: Transmission is low and predominantly seasonal. This study was
carried out in the low season.
Malaria endemic species: P. falciparum (approximately 75%) and P. vivax
Participants Sample size: 200
Age: Eligible age range not stated; actual age range of the included participants was 6
months to 73 years (40% under 5 years, 26.5% 5 to 15 years)
Sex: Male:female ratio was 1.2:1
Co-morbidities and pregnancy: Pregnant women were excluded, as were people with
signs of severe or complicated malaria
Parasite density of microscopy positive cases: Range 16 to 285,00 parasites per µl,
mean 16,757, Standard Deviation 42,631
Study design Enrolment was prospective. The sampling method was not described. Two RDTs were
evaluated, all participants received both RDTs.
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Ratsimbasoa 2008 (Continued)
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: PCR
Index and comparator tests Commerical name of RDT:
SD Bioline Malaria Ag Pf (Standard Diagnostics Inc., Suwon City, South Korea) (ex-
cluded as required data could not be extracted)
SD Bioline Malaria Ag Pf/Pan (Standard Diagnostics Inc., Suwon City, South Korea)
Parasite(s) designed to detect:
SD Bioline Malaria Ag Pf - P. falciparum
SD Bioline Malaria Ag Pf/Pan - P. falciparum or mixed infection, non-falciparum species
only
Designated Type:
SD Bioline Malaria Ag Pf - Type 1
SD Bioline Malaria Ag Pf/Pan - Type 3
Batch numbers:
SD Bioline Malaria Ag Pf - 05FK50
SD Bioline Malaria Ag Pf/Pan - 05FK60
Transport and storage conditions: All tests were kept at room temperature and opened
just before use to avoid humidity damage.
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Kozone, representing Standard Diagnostics Inc in Madagascar
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants were all attending a health cen-
tre with fever and typical symptoms of




Yes The reference standard was PCR
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes PCR was carried out by technicians blind
to the results of RDT testing
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Ratsimbasoa 2008 (Continued)
Index test results blinded?
All tests
Yes RDTs were undertaken before the results
of PCR were known
Uninterpretable results reported?
All tests
Yes Uninterpretable results are reported and ex-
cluded from the analysis. There were 2 in-




No There was one participantmissing from the
analysis for Bioline Pf/Pan, with no expla-
nation
Sayang 2009
Clinical features and settings Presenting signs and symptoms: Fever or history of fever in the previous 24 h, and
nurse’s suspicion of malaria
Previous treatment for malaria: Patients who reported taking antimalarial drugs in the
previous two weeks were excluded
Clinical setting: Primary health centre
Country: Yoaunde, Cameroon
Malaria endemicity: Reported to be high
Malaria endemic species: P. falciparum
Participants Sample size: 153
Age: Both adults and children were included; there is no indication of the proportion
of adults and children in the sample
Sex: Not mentioned either as an exclusion criteria or a characteristic of included partic-
ipants
Co-morbidities and pregnancy: Not mentioned either as an exclusion criteria or a
characteristic of included participants
Parasite density of microscopy positive cases: Range 40 to 125,000 parasites per µl.
Geometric mean: age 0-2 = 2869; age 3-5 = 6440; age 6-10 = 1580; age over 11 = 1535
Study design Enrollment was prospective. The samplingmethod was initially consecutive, fromwhich
a random sample of patients assigned to RDTs. One RDTs was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy
Person(s) performing microscopy: Not stated
Microscopy setting: Laboratory not further described
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Not stated
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Diaspot cassette device (Acumen Diagnostics Inc, USA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
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Sayang 2009 (Continued)
Transport and storage conditions: Not described
Person(s) performing RDT: Nurses trained in the use of the device
RDT setting: Primary Health Centre
Follow-up Not applicable
Notes Source of funding: Supported by the Service de Cooperation et d’Action Culturelle of
the French Embassy in Yaounde, European Union (READ-UP project, STREP, contract
no. 018602) and the Centre de Formation et Recherche en Medicine et Sante Tropicale,
Marseille, France
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were all attending health cen-
tre, had fever and a nurse suspected that
they might have malaria. Enrolment into
the main study was consecutive, and allo-
cation to RDT study was random.
Acceptable reference standard?
All tests
Unclear No details given of number of high power
fields viewed before declaring negative, or
number of observers or repeats
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Microscopy undertaken at a different site
to RDTs
Index test results blinded?
All tests
Yes RDTs undertaken before microscopy, and
at a different site
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any exclusions due to invalid test results
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not clearly stated,
therefore it is unclear whether there were
any withdrawals
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Sharew 2009
Clinical features and settings Presenting signs and symptoms: Febrile patients, clinically suspected for malaria
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but actual data not provided.
Clinical setting: Outpatient departments of two health centres
Country: Ethiopia (Southern - Wondo Genet)
Malaria endemicity: Takes place throughout the year
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 668
Age: All age groups eligible. Actual age range 6 months to 75 years.
Sex: 361 (54%) males, 307 (46%) females
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Two different RDTs were evaluated, and
each participant received both tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced malaria technicians
Microscopy setting: Not stated, but in the Wondo Genet area
Number of high power fields examined before declaring negative: 100
Number of observer or repeats:Two independent technicians, also checked by the team
leader
Resolution of discrepancies between observers: All discordant results between mi-
croscopy and RDTs were repeated
Index and comparator tests Commerical name of RDT:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
CareStart Malaria Pf/Pv Combo test (Access Bio Inc., New Jersey, USA)
Parasite(s) designed to detect: P. falciparum
Paracheck Pf - P. falciparum
CareStart Malaria Pf/Pv Combo test - P. falciparum, P. vivax or mixed infection
Designated Type:
Paracheck Pf - Type 1
CareStart Malaria Pf/Pv Combo test - Type 5
Batch numbers: Not stated
Transport and storage conditions: As per the instructions of the manufacturer
Person(s) performing RDT: Not stated
RDT setting: Two health centres
Follow-up Not applicable
Notes Source of funding: School of Graduate Studies of the Addis Adaba University through
the Graduate Programme in Tropical and Infectious Diseases, Aklilu Lemma Institute
of Pathobiology and from the Federal Ministry of Health of Ethiopia. Federal Ministry
of Health of Ethiopia and Access Bio Inc. donated the test kits.
175Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sharew 2009 (Continued)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of




Yes Two experienced microscopists indepen-
dently viewed 100 high power fields before
declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Not described
Index test results blinded?
All tests








Yes The number of participants enrolled in the
study was clearly stated and corresponds to
the number included in the analysis; there-
fore there were no withdrawals
Sharma 1999
Clinical features and settings Presenting signs and symptoms: Clinical symptoms of malaria
Previous treatment for malaria: No exclusions based on previous treatment. Informa-
tion on previous treatment collected, but actual data not provided except in the case of
false positive results.
Clinical setting: Malaria Clinics
Country: Orissa, India
Malaria endemicity: Not stated
Malaria endemic species: Mainly P. falciparum, some P. vivax
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Sharma 1999 (Continued)
Participants Sample size: 125
Age: Not mentioned either as an inclusion criteria or characteristic of the included
participants
Sex: Not mentioned either as an inclusion criteria or characteristic of the included
participants
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Range 40 to 36,000 parasites per µl
Study design Enrollment was prospective. Random sampling was used, but exact method used to
obtain a random sample was not stated. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Results discordant between microscopy and RDTwere
re-examined for confirmation of the results
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Various clinic staff
RDT setting: Malaria clinics
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a random sample of peo-




Unclear Discordant results between RDTs and mi-
croscopy were re-examined; however it is
unclear how many high power fields were
viewed before declaring a slide negative
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Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “Evaluation was double blind”
Index test results blinded?
All tests
Yes “Evaluation was double blind”
Uninterpretable results reported?
All tests
Yes There were five uninterpretable test results;
these were excluded from the analysis
Withdrawals explained?
All tests
Yes The numbers enrolled in the study and the
numbers with data presented for them cor-
respond, with the exception of the five ex-
cluded from the analysis due to uninter-
pretable test results
Singh 1997 (a)
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment. Data was
collected on previous treatment, but was only presented in the case of false positive
results.
Clinical setting: Field workers in villages
Country: India (Maldla District, Central India)
Malaria endemicity: Seasonal
Malaria endemic species: P. falciparum and P. vivax, but during the seasons the study
was undertaken, mainly P. falciparum
Participants Sample size: 353
Age: Not mentioned either as an inclusion criteria or characteristic of the included
participants
Sex: Not mentioned either as an inclusion criteria or characteristic of the included
participants
Co-morbidities and pregnancy: Not mentioned either as an exclusion criteria or char-
acteristic of the included participants
Parasite density of microscopy positive cases: Range 60 to 7,000 parasites per µl
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
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Singh 1997 (a) (Continued)
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy:Microscopist at central research centre
Microscopy setting: Blood films were prepared in villages and examined by at the
Malaria Research Centre in Delhi
Number of high power fields examined before declaring negative: Not stated; 250
WBCs were examined before classifying a slide as negative. All negative slides were re-
examined by counting up to 2500 WBCs.
Number of observer or repeats: One, although intimally negative slides were re-exam-
ined
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Field workers
RDT setting: Villages (actual setting not well described)
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear It is unclear as to whether passive or active




No Only one observer was used, and the num-
ber of high power fields viewed before
declaring a slide negative was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “without reference to the result of the ICT”
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Singh 1997 (a) (Continued)
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
Singh 1997 (b)
Clinical features and settings Presenting signs and symptoms: Fever
Previous treatment for malaria: No exclusions based on previous treatment. No data
presented on numbers who had previously been treated, although this information was
recorded for each participant.
Clinical setting: Malaria clinic established within a Primary Health Centre specifically
for the study
Country: India (Maldla District, Central India)
Malaria endemicity: Seasonal
Malaria endemic species: P. falciparum and P. vivax, but during the seasons the study
was undertaken, mainly P. falciparum
Participants Sample size: 1231
Age: Not mentioned either as an inclusion criteria or characteristic of the included
participants
Sex: Not mentioned either as an inclusion criteria or characteristic of the included
participants
Co-morbidities and pregnancy: Not mentioned either as exclusion criteria or as char-
acteristics of the included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and was prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy:Microscopist
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated. 1000
white blood cells were initially counted before declaring negative, with a repeat looking
at 4000 WBCs if initially negative
Number of observer or repeats: Negative slides were checked by another observer.
Resolution of discrepancies between observers: Not described.
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Singh 1997 (b) (Continued)
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, US)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Two independent technicians
RDT setting: Malaria clinic
Follow-up Not applicable
Notes Source of funding: WHO Special Program for Research and Training in Tropical Dis-
eases
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people attending a malaria clinic with fever
Acceptable reference standard?
All tests
No Only one observer was used for slides ini-
tially found positive. Unclear whether 100
high power fields viewed before declaring
negative, although an alternative criteria of
4000 WBCs was used
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
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Singh 1997 (b) (Continued)
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
Singh 2000 (a)
Clinical features and settings Presenting signs and symptoms: Clinically suspected malaria, including fever
Previous treatment for malaria: No exclusions based on previous treatment, and no
data reported; however the study was undertaken in a remote area with little access to
malaria treatment
Clinical setting: Mobile field clinic and laboratory
Country: India
Malaria endemicity: epidemic-prone forest villages in Madhya Pradesh, central India
Malaria endemic species: P. falciparum (83.7% of positives) and P. vivax
Participants Sample size: 526
Age: All age groups eligible. Adults and children included, but actual age profile of
participant population not presented.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy:Microscopists
Microscopy setting: Mobile laboratory
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: One, but negative blood smears were re-examined if
the corresponding RDT result was positive or if P. vivax was diagnosed
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT:Determinemalaria P.f. (Abbott Laboratories, Tokyo, Japan)
Parasite(s) designed to detect: P. falciparum
Designated type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Members of the field team of the malaria research centre
undertook the test after receiving one hour of training. A technician interpreted all the
test results.
RDT setting: Mobile laboratory
182Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Singh 2000 (a) (Continued)
Follow-up Not applicable
Notes Source of funding: Not stated. DP Medical Diagnostics (Ahmedaba Gujarat) supplied
the RDTs free of charge.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of
people with clinically suspected malaria,




No Microscopy was undertaken by a single
microscopist. There was no report of the
number of high power fields viewed before
declaring a slide negative.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Study report states that microscopists were
blinded to the RDT results
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
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Singh 2000 (c)
Clinical features and settings Presenting signs and symptoms: Fever suspected to be malaria
Previous treatment for malaria: There were no exclusions based on previous treatment,
and no information presented; this was an outbreak in a rural area
Clinical setting: Mobile field laboratory
Country: India (forest villages in Chhindwara, central India)
Malaria endemicity: Outbreak situation
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 344
Age: All age groups eligible. Actual age range 6 months to 65 years.
Sex: Both males and females eligible. Actual proportions of males and females in the
participant population not stated.
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy. No details of the frequency of these conditions in the participant population is
presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood film
Person(s) performing microscopy: Experienced microscopist for all slides; expert mi-
croscopist for re-examined slides
Microscopy setting: Mobile field laboratory for all slides; Malaria Research Centre at
Jabalur for re-examined slides
Number of high power fields examined before declaring negative: Not stated. How-
ever, 200 WBCs were counted as an alternative indicator; or 500 WBCs for slides that
were re-examined.
Number of observer or repeats: One, but negative blood smears were re-examined if
the patient was having severe symptoms, the corresponding RDT result was positive, or
if P. vivax was diagnosed
Resolution of discrepancies between observers: Not described, most likely accepted
the findings of second microscopist
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv (AMRAD, Australia)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 2
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Field laboratory assistants
RDT setting: Mobile field laboratory
Follow-up Not applicable
Notes Source of funding:BectonDickinson provided financial support and supplied the RDTs
free of charge
Table of Methodological Quality
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Singh 2000 (c) (Continued)
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes All participants were attending an ambu-
latory setting with fever suspected to be
malaria, and enrolment was consecutive
Acceptable reference standard?
All tests
No Microscopy was undertaken by one micro-
scopist only; and the number of high power
fields viewed was unclear (200 WBCs)
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “Blood films were examined...without ref-
erence to the results of ICT”
Index test results blinded?
All tests
Yes “All specimens were tested...who were




Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
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Singh 2003a
Clinical features and settings Presenting signs and symptoms: Fever or history of fever
Previous treatment for malaria: No explicit exclusions based on previous treatment,
and no data reported
Clinical setting: Hospital malaria clinic
Country: India, Jabalpur
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax in roughly equal proportions
Participants Sample size: 80
Age: All age groups eligible. Adults and children included; mean age 27.7 (SD 16.42)
for males and 29 (SD 12.8) for females
Sex: Both males and females eligible; included 28 males and 18 females
Co-morbidities and pregnancy: No explicit exclusion criteria based on co-morbidities
or pregnancy.Nodetails of the frequency of these conditions in the participant population
is presented.
Parasite density of microscopy positive cases: Range 40 to 370,574 parasites per µl
for P. falciparum and 318 to 9970 for P. vivax
Study design Enrollment was prospective. The sampling method was not described. Only one RDT
was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Hospital laboratory
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: If the results of the OptiMAL conflicted with that of
microscopy for any sample, the blood smear was re-examined by a different technician
Resolution of discrepancies between observers: If the re-examination of discordant
results gave a different result to the first examination, the second result was confirmed
by yet another technician
Index and comparator tests Commerical name of RDT: OptiMAL
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: A technician
RDT setting: Hospital clinic or laboratory
Follow-up Not applicable
Notes Source of funding: Not stated.
Table of Methodological Quality
Item Authors’ judgement Description
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Unclear Participants were all attending a clinic with
fever or history of fever, but the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Discordant results between RDT and mi-
croscopy were re-examined; however the
number of high power fields viewed before
declaring a sample negative was not stated
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Yes Technicans were blinded to the results of
the blood smear examination
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
Singh 2003b
Clinical features and settings Presenting signs and symptoms: Fever and chills of several days’ duration
Previous treatment for malaria: No explicit exclusions based on previous treatment,
and no data reported
Clinical setting: Field clinics
Country: India, villages in the Jabalpur district
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax in roughly equal proportions
Participants Sample size: 75
Age: All age groups eligible. Adults and children included; mean age 20.4 (SD 17.00)
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Singh 2003b (Continued)
for males and 25.9 (SD 17.9) for females
Sex: Both males and females eligible; included 25 males and 32 females
Co-morbidities and pregnancy: No explicit exclusion criteria based on co-morbidities
or pregnancy.Nodetails of the frequency of these conditions in the participant population
is presented.
Parasite density of microscopy positive cases: Range 100 to 90,000 parasites per µl
for P. falciparum, 835 to 4320 for P. vivax
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood films
Person(s) performing microscopy: Not stated
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: If the results of the OptiMAL conflicted with that of
microscopy for any sample, the blood smear was re-examined by a different technician
Resolution of discrepancies between observers: If the re-examination of discordant
results gave a different result to the first examination, the second result was confirmed
by yet another technician
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated type: Type 4
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Not stated
Follow-up Not applicable
Notes Source of funding: Not stated.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending a field clinic
with fever and chills of several days’ dura-




Unclear Discordant results between RDT and mi-
croscopy were re-examined; however the
number of high power fields viewed before
declaring a sample negative was not stated
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Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
Stephens 1999
Clinical features and settings Presenting signs and symptoms: Unclear; participants were selected by triage from
people presenting themselves at a hospital
Previous treatment for malaria: No exclusions based on previous treatment; data pre-
sented on previous treatment only covers false positive cases
Clinical setting: Hospital outpatient clinic
Country: Thailand (North West - Mae Hong Son)
Malaria endemicity: Perennial with seasonal peaks
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 301 enrolled, 296 received RDT
Age: All age groups eligible. Actual age range from less than one month to 81 years
Sex: Male: female ratio 6:4
Co-morbidities and pregnancy: No explicit exclusion criteria based on co-morbidities
or pregnancy.Nodetails of the frequency of these conditions in the participant population
is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
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Stephens 1999 (Continued)
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy:Microscopists
Microscopy setting: Hospital laboratory
Number of high power fields examined before declaring negative: Not stated
Number of observer or repeats: Two; one viewed the thick film and another viewed the
thin film. The two microscopists worked independently and their findings compared at
the end of the study.
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: ParaSight-F (Becton Dickinson Tropical Disease Diagnos-
tics, Sparks, MD, US)
Parasite(s) designed to detect: P. falciparum
Designated type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Hospital clinic or laboratory
Follow-up Not applicable
Notes Source of funding: Supported by Dr Surang Tanpridist, Director, Malaria Division,
Ministry for PublicHealth,Nonthaburi, andDr SomsakPrajakwongse,Director,Malaria
Region 2, Chiang Mai, Thailand, and the DFID-funded Malaria Work Programme of
the Liverpool School of Tropical Medicine
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests




Unclear No details of the number of high power
fields viewed before declaring a slide nega-
tive, and no information on how the find-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
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Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Unclear Blinding not described
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes Five of the participants originally enrolled
did not received RDTs. With the excep-
tion of these five, the number of partici-
pants originally enrolled in the study was
clearly stated and the number presented in
the analysis corresponded.
Stow 1999
Clinical features and settings Presenting signs and symptoms: Symptoms suggestive of malaria
Previous treatment for malaria: Not mentioned
Clinical setting: Hospital outpatient department
Country: Kenya
Malaria endemicity: Catchment area varied from holoendemic to seasonally endemic
Malaria endemic species: P. falciparum
Participants Sample size: 164
Age: Not mentioned either as an inclusion criteria or characteristic of included partici-
pants
Sex: Males and females included
Co-morbidities and pregnancy: Not reported, no mention of these conditions as in-
clusion or exclusion criteria
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Expert microscopist
Microscopy setting: Westmead Hospital, Sydney, Australia
Number of high power fields examined before declaring negative:Not stated (exam-
ined for ten minutes)
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
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Stow 1999 (Continued)
Index and comparator tests Commerical name of RDT: ICT Malaria Pf (ICT Diagnostics, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Hospital outpatient department
Follow-up Not applicable
Notes Source of funding: Not stated.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants had symptoms suggestive




No Only one microscopist was used, and the
number of high power fields viewed before




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report stated that microscopists were blind
to the results of the ICT test
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
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Stow 1999 (Continued)
responded; therefore there were no with-
drawals
Tagbo 2007
Clinical features and settings Presenting signs and symptoms: History of fever and body temperature 37.5 °C or
higher
Previous treatment for malaria:No exclusions based on previous antimalarial use, and
no data presented on the numbers that previously used antimalarials
Clinical setting: Outpatient department of all small private hospital for children
Country: Nigeria
Malaria endemicity: Holoendemic
Malaria endemic species: P. falciparum
Participants Sample size: 89
Age: Children only, mean age 3.6 years, range 2 weeks to 14 years
Sex: 50 males and 39 females
Co-morbidities and pregnancy:No exclusion criteria based on co-morbidities or preg-
nancy; 83 of the 89 included participants had a clinical diagnosis of malaria, the remain-
ing 6 had other infections diagnosed clinically. Of the 83 with diagnosed malaria, 29
had acute respiratory infection, 4 had gastroenteritis and 4 had otitis media.
Parasite density of microscopy positive cases:Mean 9058 parasites per µl
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Certified medical laboratory scientists
Microscopy setting: Nigeria Institute for Medical Research at Lagos
Number of high power fields examined before declaring negative: at least 100
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: 32037E
Transport and storage conditions: Stored at room temperatures within the range of 4
°C and 30 °C recommended by the manufacturers
Person(s) performing RDT: The study authors
RDT setting: Outpatient clinic
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
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Tagbo 2007 (Continued)
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive sample of




No Certified microscopists viewed at least 100
high power fields before declaring a slide
negative, however their resultswere not ver-
ified by a second independent reader
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Reports that the laboratory was blinded to
the results of the RDT
Index test results blinded?
All tests




Unclear The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no exclu-
sions due to uninterpretable test results
Withdrawals explained?
All tests
Yes The number of participants originally en-
rolled in the study was clearly stated and
the number presented in the analysis cor-
responded; therefore there were no with-
drawals
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Tjitra 1999
Clinical features and settings Presenting signs and symptoms: Symptomatic with a presumptive clinical diagnosis of
malaria: fever or history of fever in the last 24 h and no other obvious cause of fever
Previous treatment for malaria: Prior use of antimalarials was not an exclusion criteria.
Approximately half of the participants reported use of antimalarials within the previous
4 weeks.
Clinical setting: Primary health centre
Country: Indonesia (Laratama sub district, West Sumba, East Nusa Tenggara Province,
Eastern Indonesia)
Malaria endemicity: Infection rate in children 0 to 9 years of 5.1%
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 560
Age: All ages eligible. Actual age range of the participants 0 to 80 years.
Sex: Males and females eligible; 289 males and 271 females included
Co-morbidities: Not mentioned either as an exclusion criteria or a characteristic of the
included participants
Parasite density of microscopy positive cases: P. vivax mean 7157 parasites per µl
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Expert microscopists with over 20 years experience
each
Microscopy setting: One local (exact setting not stated); cross-checking was done in
Darwin, Australia
Number of high power fields examined before declaring negative: At least 100 for
all slides, at least 200 for those cross-checked
Number of observer or repeats: One observer for the majority of slides; discordant
results between microscopy and RDT and 20% of slides with concordant results were
cross-checked by a second microscopist, blind to the results of first microscopy and RDT
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: ICT Malaria Pf/Pv
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated Type: Type 2
Batch numbers: 100088 for the first 393 tests, and 041388 for the remaining 167 tests
Transport and storage conditions: Not described
Person(s) performing RDT: Performed by trained health workers and read by a study
physician blinded to the microscopy results
RDT setting: Primary health centre
Follow-up Not applicable
Notes Source of funding: Financial assistance received from the Northern Territory Govern-
ment 50th Anniversary of Indonesian Independence Malaria-Tuberculosis Research Fel-
lowships. ICT Pf/Pv kits and some logistical costs were supported by AMRAD-ICT
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Tjitra 1999 (Continued)
Sydney, New South Wales, Australia.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Participants were all attending a primary
health care centre with fever and symptoms




Yes All slides were read by an experienced mi-
croscopist viewing at least 100 high power
fields, and results discordant with RDT




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “The microscopist was unaware of the im-
munochromatographic test result”
Index test results blinded?
All tests
Yes “The results were read by a study physician
who was blinded to themicroscopy results”
Uninterpretable results reported?
All tests
Unclear The number of participants enrolled in the
study was clearly stated and corresponded
to the number presented in the analysis;




Yes The number of participants enrolled in the
study was clearly stated and corresponded
to the number included in the analysis;
therefore there were no withdrawals
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Valecha 2003
Clinical features and settings Presenting signs and symptoms: Fever or history of fever
Previous treatment for malaria: Not mentioned, either as an exclusion criteria or a
characteristic of included participants
Clinical setting: Malaria clinics and village health workers
Country: India (Delhi, Nadiad, Jabalpur and Sonapur)
Malaria endemicity: Four sites of different endemicities
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 699
Age: All ages eligible; age range of included participants 1 to 75 years (mean 22.8)
Sex: Included 395 males and 304 females
Co-morbidities: Not mentioned, either as an exclusion criteria or a characteristic of
included participants
Parasite density of microscopy positive cases: P. vivax range 40 to 44,000 parasites per
µl, median 1020; P. falciparum range 120 to 68,480 parasites per µl, median 2000
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy
Person(s) performing microscopy:Microscopist
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: One for most slides. All results discordant with RDT
results and 20% of concordant results were cross-checked. Negative slides which tested
positive by kit were re-examined by counting up to 2000 WBCs.
Resolution of discrepancies between observers: In the case of initially negative slides
looked at in more detail because of discordant results, the second reading was taken as
true
Index and comparator tests Commerical name of RDT: OptiMAL (DiaMed AG, Cressier, Switzerland)
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated Type: Type 4
Batch numbers: 46050.24.05
Transport and storage conditions: Stored below 30 °C
Person(s) performing RDT: Not stated
RDT setting: At the study sites (clinic and villages)
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
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Unclear All participants were all attending clinics
or approaching village health workers with
fever or history of fever, but the sampling
method was not described
Acceptable reference standard?
All tests
Unclear Microscopists viewed100high power fields
before declaring a slide negative, and results
discordant with RDTs were cross-checked.
However, it is not clear whether the per-
son doing the cross-checking was a differ-
ent microscopist working independently
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “Microscopists were blinded to the rapid
test results”
Index test results blinded?
All tests
Yes The RDT was done before the microscopy
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is unclear whether there were




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it is unclear whether there were
any withdrawals
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Van den Broek 2006
Clinical features and settings Presenting signs and symptoms:Newepisode of suspectedmalaria, which could include
fever, history or other complaints indicating possible malaria infection
Previous treatment for malaria: Excluded if malaria confirmed (treated or untreated)
within the previous four weeks
Clinical setting: Malaria outpatient centre
Country: Colombia
Malaria endemicity: Hypoendemic, annual parasite rate 2% to 5%
Malaria endemic species: P. vivax (54%), P. falciparum (46%)
Participants Sample size: 896
Age: All ages eligible. Actual numbers of children and adults not stated, although the
report mentions that many workers were included.
Sex: Both males and females eligible. Most of the participants were male (646, 79%)
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Geometric mean approximately 2300
parasites per µl for both P. falciparum and P. vivax
Study design Enrollment was prospective. The sampling method was not described. Three RDTs were
tested. All individuals received all three tests.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy:Well trained, experienced microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: At least 200
Number of observer or repeats:One, except for about one third of the slides (especially
lowdensity parasitaemias andmixed infections). In this case, anothermicroscopist viewed
the slide and discordant results between microscopists or between slides and RDTs were
sent to the University of Antioquia for external cross-checking.
Resolution of discrepancies between observers: Disagreements between the internal
and external results were sent to a third laboratory: the National Health Institute in
Bogota. In cases where both external laboratories disagreed with the internal laboratory,
results were corrected accordingly.
Index and comparator tests Commerical name of RDT:
Paracheck Pf (Orchid Biomedical Systems, Goa, India)
OptiMAL-IT (Diamed AG, Switzerland)
NOWMalaria ICT (Binax, Portland, USA)
Parasite(s) designed to detect:
Paracheck Pf - P. falciparum
OptiMAL-IT - P. falciparum or mixed infection, non-falciparum species only
NOWMalaria ICT - P. falciparum or mixed infection, non-falciparum species only
Designated Type:
Paracheck Pf - Type 1
OptiMAL - IT - Type 4
Now Malaria ICT - Type 2
Batch numbers: Not stated
Transport and storage conditions: Not described
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Van den Broek 2006 (Continued)
Person(s) performing RDT: A bacteriologist. Where the result was ambiguous, two
bacteriologists read the test results.
RDT setting: At the malaria centre
Follow-up Not applicable
Notes Source of funding: Medicins Sans Frontieres and its donors. The American Society of
Tropical Medicine and Hygiene assisted with publication expenses.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were patients presenting
with suspected malaria, but the sampling
method was not described
Acceptable reference standard?
All tests
No Microscopists viewed at least 200 high
power fields before declaring a slide nega-
tive; however the findings were only veri-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that microscopists were
blinded to the results of RDTs
Index test results blinded?
All tests
Yes Report states that RDTs were blinded to
the results of microscopy
Uninterpretable results reported?
All tests
Yes There were no uninterpretable results; and
weak lines were scored as positive
Withdrawals explained?
All tests
Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it was not possible to assess
whether there were any withdrawals
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Verle 1996
Clinical features and settings Presenting signs and symptoms: Fever or history of fever in previous days
Previous treatment for malaria: No exclusion criteria based on prior antimalarial drug
use. Data collected and reported only for participants who were found to be false positive
or true negative (5 out of 6 false positives, 11 out of 65 true negatives)
Clinical setting: Community health centre. Villagers who felt ill during a malaria epi-
demic were invited to attend.
Country: Vietnam (Ha Giang Province Northern Vietnam)
Malaria endemicity:Mostly hypoendemic, but there is contact with focal areas endemic
for malaria, and the study was undertaken during an epidemic
Malaria endemic species: P. vivax and P. falciparum
Participants Sample size: 93
Age: All ages eligible. Actual numbers of children and adults not stated.
Sex: Both males and females eligible. Actual numbers of males and females not stated.
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: P. falciparum geometric mean 6457
parasites per µl, range 2240 to 33,160
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick blood smears
Person(s) performing microscopy: An experienced technician
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: One
Resolution of discrepancies between observers: Not applicable
Index and comparator tests Commerical name of RDT: ParaSight-F (Beckton Dickinson, Franklin Lakes, NJ, SA)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not described
Person(s) performing RDT: Not stated
RDT setting: Community health centre
Follow-up Not applicable
Notes Source of funding: Belgian Agency for Development Co-operation and the Compagnie
Maritime Belge
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-
tients attending a health centre with fever
during a malaria epidemic
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No The microscopist was experienced and
viewed at least 100 high power fields, how-




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Report states that microscopy was under-
taken by a technician unaware of the results
of the RDT
Index test results blinded?
All tests
Yes The RDT was undertaken straight away at




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it was not possible to assess




Unclear The number of participants originally en-
rolled in the study was not explicitly stated;
therefore it was not possible to assess
whether there were any withdrawals
Willcox 2009a
Clinical features and settings Presenting signs and symptoms: Symptoms of uncomplicated malaria, primarily fever
Previous treatment for malaria: No exclusion criteria based on previous antimalarial
use, and no data presented on the numbers that previously used antimalarials
Clinical setting: Village healthworker
Country:Mali
Malaria endemicity: Mesoendemic
Malaria endemic species: Mainly P. falciparum
Participants Sample size: 158 under the age of five years (301 total)
Age: All ages eligible for the study. Refers only to the analysis including children under
the age of five years.
Sex: Both males and females eligible.
Co-morbidities and pregnancy: No exclusions criteria based on co-morbidities. No
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Willcox 2009a (Continued)
details of the frequency of these conditions in the participant population are presented.
Parasite density of microscopy positive cases: Geometric mean 2323 parasites per µl,
95% CI 1492 to 3616
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Field laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two independent microscopists
Resolution of discrepancies between observers:Cross checkeduntil bothmicroscopists
agreed.
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at room temperatures of up to 40 °C.
Person(s) performing RDT: A clinician and a laboratory technician from the research
team
RDT setting: Field laboratory
Follow-up Not applicable
Notes Source of funding: Swiss Agency for Development and Co-operation. Orchid Biomed-
ical Systems supplied the Paracheck Pf tests free of charge.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-
tients presenting with suspected malaria
Acceptable reference standard?
All tests
Yes Two independent experienced micro-
scopists viewed 100 high power fields be-
fore declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
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Willcox 2009a (Continued)
Reference standard results blinded?
All tests
Yes Reported that microscopists were blinded
to the results of the RDTs
Index test results blinded?
All tests
Yes Dipsticks were labelled with random num-
bers so that the people recording the results




Yes There were no uninterpretable test results
(the control line was positive in all cases)
Withdrawals explained?
All tests
Yes The number of participants enrolled was
explicitly stated and corresponded to the
number presented in the analysis; therefore
there were no withdrawals
Willcox 2009b
Clinical features and settings Presenting signs and symptoms: Symptoms of uncomplicated malaria, primarily fever
Previous treatment for malaria: No exclusion criteria based on previous antimalarial
use, and no data presented on the numbers that previously used antimalarials
Clinical setting: Village health worker
Country:Mali
Malaria endemicity: Mesoendemic
Malaria endemic species: mainly P. falciparum
Participants Sample size: 143 aged five or over (301 total)
Age: All ages included in the study. Refers only to the analysis of participants over the
age of five years.
Sex: Both males and females eligible.
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Geometric mean 267 parasites per µl,
95% CI 172 to 413
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Field laboratory
Number of high power fields examined before declaring negative: 100
Number of observer or repeats: Two independent microscopists
Resolution of discrepancies between observers:Cross checkeduntil bothmicroscopists
agreed.
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Willcox 2009b (Continued)
Index and comparator tests Commerical name of RDT: Paracheck Pf (Orchid Biomedical Systems, Goa, India)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Stored at room temperatures of up to 40°C
Person(s) performing RDT: A clinician and a laboratory technician from the research
team
RDT setting: Field laboratory
Follow-up Not applicable
Notes Source of funding: Swiss Agency for Development and Co-operation. Orchid Biomed-
ical Systems supplied the Paracheck Pf tests free of charge.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of pa-
tients presenting with suspected malaria
Acceptable reference standard?
All tests
Yes Two experiencedmicroscopists viewed 100




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes Reported that microscopists were blinded
to the results of the RDTs
Index test results blinded?
All tests
Yes Dipsticks were labelled with random num-
bers so that the people recording the results




Yes There were no uninterpretable test results
(the control line was positive in all cases)
Withdrawals explained?
All tests
Yes The number of participants enrolled was
explicitly stated and corresponded to the
number presented in the analysis; therefore
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there were no withdrawals
Wolday 2001
Clinical features and settings Presenting signs and symptoms: Self-referred to a malaria clinic
Previous treatment for malaria:No exclusions based on previous antimalarial use; data
recorded on previously used antimalarials, but not presented for the sample
Clinical setting: Malaria clinic
Country: Ethiopia (Debre Zeit, Addis Ababa)
Malaria endemicity: Parasite prevalence approximately 40%
Malaria endemic species: P. falciparum and P. vivax. The study was undertaken in the
season when P. vivax predominated.
Participants Sample size: 306
Age: All ages included in the study. Range 1 to 70 years, mean age 15.2 years
Sex: 112 (36.6%) females
Co-morbidities and pregnancy: No exclusion criteria based on co-morbidities. No
details of the frequency of these conditions in the participant population is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. One RDT was tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Experienced technicians and parasitologists
Microscopy setting: Malaria laboratory
Number of high power fields examined before declaring negative: 300
Number of observer or repeats: Two technicians confirmed by two parasitologists
Resolution of discrepancies between observers: Not stated
Index and comparator tests Commerical name of RDT: Rapid test malaria (Quorum Diagnostics Inc., Vancouver,
BC, Canada)
Parasite(s) designed to detect: P. falciparum
Designated Type: Type 1
Batch numbers: Not stated
Transport and storage conditions: Not stated
Person(s) performing RDT: Person doing the test not stated. Dipstick readings were
done by three independent observers
RDT setting: Field laboratory
Follow-up Not applicable
Notes Source of funding: “We thank Quorum Diagnostics Inc (Vancouver, BC, Canada) for
the support of this project”
Table of Methodological Quality
Item Authors’ judgement Description
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Yes Participants were a consecutive series of pa-




Yes Two independent, experienced micro-
scopists viewed at least 300 high power
fields before declaring a slide negative
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes The blood smears were read before the
RDTs
Index test results blinded?
All tests
Yes Report states that blinding was undertaken
Uninterpretable results reported?
All tests
Unclear The number of participants originally en-
rolled was not explicitly stated; therefore
it was not possible to assess whether there




Unclear The number of participants originally en-
rolled was not explicitly stated; therefore
it was not possible to assess whether there
were any withdrawals
Wongsrichanalai 1999
Clinical features and settings Presenting signs and symptoms: Symptomatic patients self-referring for initial malaria
diagnosis
Previous treatment for malaria: Participants were excluded if they were known to have
taken antimalarial drugs within the last 15 days
Clinical setting: District malaria clinic and hospital outpatients
Country: Thailand, on the international borders
Malaria endemicity: Hypoendemic, with seasonal variation
Malaria endemic species: P. falciparum 50% to 60%, P. vivax 40% to 50%
Participants Sample size: 309
Age: All age groups eligible. Mean age 29 years.
Sex: Both males and females eligible. 245 males and 64 females included.
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Wongsrichanalai 1999 (Continued)
Co-morbidities and pregnancy:No stated exclusion criteria based on co-morbidities or
pregnancy. No details of the frequency of these conditions in the participant population
is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was consecutive and prospective. Only one RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood films
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Armed Forces Research Institute of Medical Sciences
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent microscopists
Resolution of discrepancies between observers: By a third microscopist, who had the
final say
Index and comparator tests Commerical name of RDT: ICT test (AMARD/ ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated type: Type 1
Batch numbers: Not stated
Trasport and storage conditions: Not described
Person(s) performing RDT: Laboratory staff
RDT setting: The study sites
Follow-up Not applicable
Notes Source of funding:Half of the RDTs were supplied free of charge by the manufacturer.
No other source of funding described.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants were a consecutive series of
symptomatic new patients self-referring for
diagnosis of malaria in an endemic area
Acceptable reference standard?
All tests
Yes Two independent experienced micro-
scopists examined at least 200 high power
fields before declaring a slide negative. Dis-
cordant results were resolved by a third mi-
croscopist in a double-blind manner.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
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Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes RDTs and microscopy were undertaken at
different locations
Index test results blinded?
All tests




Yes One RDT failed due to operator error.




Yes The number of participants originally en-
rolled was explicitly stated and corre-
sponded with the number included in
the analysis; therefore there were no with-
drawals
Wongsrichanalai 2003
Clinical features and settings Presenting signs and symptoms: Oral temperature over 38 °C, headache or a history
of fever in the previous 72 h
Previous treatment for malaria:No exclusions based on previous episodes or treatment
for malaria; no data presented on recent antimalarial use in the children
Clinical setting: Malaria clinics
Country: Thailand (Maesod)
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax.
Participants Sample size: 246
Age: Inclusion criteria stipulated over 20 years old
Sex: Both males and females were eligible
Co-morbidities and pregnancy:Not mentioned, either as an exclusion criteria or char-
acteristic of the included participants
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The sampling method was not described. One RDT was
tested.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy thick and thin blood smears
Person(s) performing microscopy: Experienced microscopists
Microscopy setting: Armed Forces Research Institute of Medical Sciences
Number of high power fields examined before declaring negative: 200
Number of observer or repeats: Two independent observers, blinded to each others
findings
Resolution of discrepancies between observers: Resolved by a third expert micro-
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Wongsrichanalai 2003 (Continued)
scopist, whose reading was accepted as final. Where there was species discrepancy be-
tween microscopy and NOW ICT, PCR was conducted.
Index and comparator tests Commerical name of RDT: NOW ICT Malaria Pf/Pv
Parasite(s) designed to detect: P. falciparum or mixed infection, non-falciparum species
only
Designated Type: Type 2
Batch numbers: 030611
Transport and storage conditions: Not described
Person(s) performing RDT: Technician
RDT setting: Armed Forces Research Institute of Medical Sciences
Follow-up Not applicable
Notes Source of funding: US Army Medical Material Development Activity
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear All participants were attending malaria
clinics with temperature over 38 °C,
headache or a history of fever in the pre-




Yes Two independent microscopists at a re-
search laboratory viewed at least 200 high




Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Yes “read by two microscopists blinded to.. the
NOW ICT results”
Index test results blinded?
All tests




Yes The RDTs had to be repeated in 39 of 285
assays. A successful testwas eventually com-
pleted for each sample.
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Yes The number of participants enrolled in the
study was clearly stated and corresponded
with the number included in the analysis,
indicating no withdrawals
Yadav 1997
Clinical features and settings Presenting signs and symptoms: Participants who attended at malaria clinic or who
were selected from the villages based on clinical condition
Previous treatment for malaria: No explicit exclusion criteria based on antimalarial
use, and no relevant data presented for included participants
Clinical setting: Malaria clinic and in the field
Country: Gujarat, India
Malaria endemicity: Not stated
Malaria endemic species: P. falciparum and P. vivax
Participants Sample size: 148
Age: All age groups eligible. Sample included 79 children and 69 adults.
Sex: 73 males and 75 females included
Co-morbidities and pregnancy:No stated exclusion criteria based on co-morbidities or
pregnancy. No details of the frequency of these conditions in the participant population
is presented.
Parasite density of microscopy positive cases: Not presented
Study design Enrollment was prospective. The selection and sampling methods were not described.
One RDT was evaluated.
Target condition and reference standard(s) Target condition: Malaria parasitaemia
Reference standard: Microscopy
Person(s) performing microscopy:Microscopists
Microscopy setting: Not stated
Number of high power fields examined before declaring negative: Not stated. The
microscopist counted 300 WBCs before declaring a slide negative. A negative slide that
tested positive by RDT was re-examined, counting up to 2000 WBCs.
Number of observer or repeats: A negative slide that tested positive by RDT was re-
examined, counting up to 2000 WBCs. A positive slide that tested negative by RDT
was re-examined and confirmed by another person by staining the duplicate film.
Resolution of discrepancies between observers: Not described
Index and comparator tests Commerical name of RDT: ICT test (AMARD/ ICT, Sydney, Australia)
Parasite(s) designed to detect: P. falciparum
Designated type: Type 1
Batch numbers: Not stated
Trasport and storage conditions: Test kits were carried into the field under cold con-
ditions in the containers that are commonly used for carrying vaccines.
Person(s) performing RDT: Not states
RDT setting: Malaria clinic and in the field in villages
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Yadav 1997 (Continued)
Follow-up Not applicable
Notes Source of funding: Not stated
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear The selection criteria and sampling meth-
ods were not described; however all partic-
ipants had either identified symptoms of
malaria or were attending a malaria clinic
Acceptable reference standard?
All tests
No Microscopists did not explicitly view 100
high power fields before declaring a slide
negative. However, they had an alternative
criteria of 300 WBCs. Re-examination by
a second microscopist was done for results
discordant for RDT and microscopy.
Partial verification avoided?
All tests
Yes All participants who received the index test
also received the reference test
Differential verification avoided?
All tests
Yes The same reference test was used regardless
of the index test results
Incorporation avoided?
All tests
Yes The index test does not form part of the
reference standard
Reference standard results blinded?
All tests
Unclear Blinding not described
Index test results blinded?
All tests
Yes The ICT test was performed “blind”
Uninterpretable results reported?
All tests
Unclear The number of participants originally in-
cluded in the analysis was not explicitly
stated; therefore it was not possible to assess
whether any participantsmay have been ex-




Unclear The number of participants originally in-
cluded in the analysis was not explicitly
stated; therefore it was not possible to assess
whether there were any withdrawals
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
A-Elgayoum 2009 (b) Not a study of rapid diagnostic tests (compared usual with expert microscopy)
Abul 2000 Participants had cerebral malaria
Afzaal 2001 Review or narrative
Ahmad 2003 Eligibility unclear due to lack of published information
Anonymous 2005 Review or narrative
Ansah 2008 Eligibility unclear due to lack of published information
Araz 2000 Some participants did not have symptoms of malaria
Arcanjo 2007 European foreign language study
Arora 2003 Participants have severe or complicated malaria
Arrospide 2004 European foreign language study
Arrospide 2004 (a) Majority of participants have no symptoms of malaria
Arrospide 2006 European foreign language study
Ashley 2009 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Aslan 2001 Participants were hospital inpatients
Assal 1999 Not rapid immunochromatographic tests
Avila 2002 Participants were travellers returning from an endemic to a non-endemic region
Azazy 2004 Only participants with malaria positive blood films by microscopy received the RDT
Babacar 2008 Not a diagnostic test accuracy study
Bartoloni 1998 Single case study
Bassene 2009 Not a diagnostic test accuracy study
Bassett 1991 Not a diagnostic test accuracy study
Beadle 1994 Majority of participants did not have symptoms of malaria
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(Continued)
Beg 2005 All participants were positive for malaria by microscopy
Belizario 2005 Participants were recruited by active case finding
Bell 2005 Not a consecutive sample: excluded a random sample of participants who were negative for malaria by
microscopy
Bell 2006 Review or narrative
Bellagra 1998 Participants are travellers returning from an endemic to a non-endemic area
Bendezu 2008 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Berens-Riha 2009 Participants were dead
Bhandari 2008 All participants were positive for malaria by microscopy
Bhatt 1994 Review or narrative
Birku 1999 Participants had severe or complicated malaria
Bisoffi 2009 Not a diagnostic test accuracy study
Bisoffi 2009a Review or narrative
Biswas 2004 Not a diagnostic test accuracy study
Biswas 2006 Not an immunochromatographic test
Bouchaud 2000 Participants were travellers returning from endemic to non-endemic areas
Brenier-Pinchart 2000 Participants were travellers returning from endemic to non-endemic areas
Bruxvoort 2008 Participants were recruited by active case finding
Bualombai 2003 No usable data for P. falciparum malaria
Bualombai 2006 Eligibility unclear due to lack of published information
Buchachart 2004 Participants are hospital in-patients
Bujanover 2002 Not a diagnostic test accuracy study
Cabezas 2004 Not a diagnostic test accuracy study (compares ’field’ and laboratory RDT results)
Cavallo 1997 Participants are travellers returning from an endemic to a non-endemic area
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(Continued)
Chatterjee 2008 Eligibility unclear due to lack of published information
Cheng 2006 Review or narrative
Chilton 2006 Not a diagnostic test accuracy study
Chiodini 1998 Review or narrative
Chiodini 2005 Not a diagnostic test accuracy study
Cho 2001 Not undertaken in a malaria endemic area
Coleman 2002a Majority of participants did not have symptoms of malaria
Coleman 2002b Majority of participants did not have symptoms of malaria
Cong Le 2002 Article written in Russian only
Craig 1997 Tested blood films with artificially cultured and diluted malaria parasites
Craig 2002 The participants were positive for malaria by microscopy
Cropley 2000 Participants were travellers returning from endemic to non-endemic areas
Cuadros 2007 Participants were travellers returning from endemic to non-endemic areas
De Carsalade 2009 European foreign language study
De Dominguez 1996 Not a diagnostic test accuracy study
De Monbrison 2004 Participants were travellers returning from endemic to non-endemic areas
Delaunay 2008 Review or narrative
Deletoille 1987 Participants are travellers returning from an endemic to a non-endemic area
Di Perry 1997 All participants were positive for malaria by microscopy
Dietze 1995 Some participants did not have symptoms of malaria
Drakeley 2009 Review or narrative
Dubarry 1990 Not evaluating an immunochromatographic rapid diagnostic test
Durand 2005 Participants were travellers returning from endemic to non-endemic areas
Durand 2005a Review or narrative
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Dyer 2000 All participants were positive for malaria by microscopy
Eisen 2000 Not undertaken in a malaria endemic area
El-Moamly 2007 Participants were travellers returning from a malaria endemic to a non-endemic area
Elmardi 2009 Not a diagnostic test accuracy study
Endeshaw 2008 Majority of participants did not have symptoms of malaria
Fan 2000 Written in Chinese only
Farcas 2003 Participants were travellers returning from endemic to non-endemic areas
Farcas 2004 Not an immunochromatographic test
Ferro 2002 Participants were travellers returning from an endemic area to a non-endemic area
Figueiredo 2003 All participants were positive for malaria by microscopy
Fogg 2008 No usable data for P. falciparum malaria
Fryauff 1997 Eligibility unclear due to lack of published information
Fryauff 2000 Participants did not have symptoms of malaria
Funk 1999 Participants were travellers returning from endemic to non-endemic areas
Garavelli 2002 Participants were travellers returning from endemic to non-endemic areas
Garcia 1996 Eligibility unclear due to lack of published information
Gatti 2002 Participants were travellers returning from endemic to non-endemic areas
Gatti 2007 Participants were travellers returning from endemic to non-endemic areas
Ghanchi 2009 Not a diagnostic test accuracy study
Gillet 2009 (a) Participants were travellers returning from endemic to non-endemic areas
Gillet 2009 (b) Not a diagnostic test accuracy study
Gillet 2009 (c) Participants were travellers returning from an endemic to a non-endemic area
Gogtay 1999 Participants had severe or complicated malaria
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(Continued)
Gogtay 2003 Participants were all positive for malaria by blood smear
Gonzales-Ceron 2005 Evaluates P. vivax only
Grobusch 1999 Not undertaken in a malaria endemic area
Grobusch 2002 Not undertaken in a malaria endemic area
Grobusch 2003 Participants were travellers returning from endemic to non-endemic areas
Grobusch 2003b Participants were travellers returning from endemic to non-endemic areas
Gupta 2001 Some participants had severe or complicated malaria
Gutierrez 2005 Not a diagnostic test accuracy study
Haditsch 2004 Review or narrative
Hance 2005 Review or narrative
Hanscheid 1999 Review or narrative
Happi 2004 All participants were positive for malaria by microscopy
Hashizume 2006 Participants were displaced persons from mainly very low endemicity areas
Hernandes 2001 Participants were travellers returning from endemic to non-endemic areas
Holmberg 1992 Not a diagnostic test accuracy study
Hossain 2008 Participants had severe or complicated malaria
Houze 2009 All participants were positive for malaria by microscopy
Humar 1997 Participants were travellers returning from endemic to non-endemic areas
Huong 2002 Not based on a consecutive sample; included a groupmalaria positive by microscopy, and an asymptomatic
malaria negative control group
Iqbal 2000 Not a consecutive sample: participants were selected to have a high risk of rheumatoid factor
Iqbal 2001 Participants were travellers returning from endemic to non-endemic areas
Iqbal 2002 Participants were travellers returning from endemic to non-endemic areas
Iqbal 2004 All participants were positive for malaria by microscopy
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Jelinek 1996 Does not evaluate an immunochromatographic rapid diagnostic test for malaria
Jelinek 1999 Participants were travellers returning from endemic to non-endemic areas
Jelinek 2000 Participants were travellers returning from endemic to non-endemic areas
Jelinek 2001 Participants were travellers returning from endemic to non-endemic areas
Jeurissen 1999 Review or narrative
John 1998 All participants were positive for malaria by microscopy
Joshi 2004 Not evaluating an immunochromatographic rapid diagnostic test
Kaewsonthi 1996 Not a diagnostic test accuracy study
Kahama-Maro 2008 Eligibility unclear due to lack of published information
Kakkilaya 2003 Review or narrative
Kamugisha 2008 Majority of participants did not have symptoms of malaria
Karbwang 1996 All participants were positive for malaria by microscopy
Kaur 2000 All participants had cerebral malaria
Kaushal 1995 Tested for P. knowlesi infection in monkeys
Kaushal 1997 Review or narrative
Kawai 2009 Tested for P. knowlesi infection in monkeys
Keating 2009 Majority of participants did not have symptoms of malaria
Khairnar 2009 Participants were travellers returning from an endemic to a non-endemic area
Khan 2004 Participants were hospital inpatients
Kilian 1997 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Kim 2008 Includes a symptomatic group with malaria infection identified by microscopy, and an asymptomatic
group with no malaria infection by microscopy
Knappik 2002 Participants were travellers returning from endemic to non-endemic areas
Kodisinghe 1997 Some participants did not have symptoms of malaria
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Kumar 2000 Participants were migrants from a very low endemicity area
Lee 1999 Some participants did not have symptoms of malaria
Lee 2008 Participants were soldiers usually residing in non-endemic areas
Lema 1999 Some participants were attending for follow-up of a previously diagnosed and treated case of malaria
Lepere 2004 Not a diagnostic test accuracy study
Lim 2001 Half the participants had malaria confirmed by microscopy before enrolment
Llanos Zavalaga 2000 Not a diagnostic test accuracy study
Llanos-Zavalaga 2002 European foreign language study
Mahajan 2000 Participants were hospital inpatients
Makler 1998 Review or narrative
Makler 2009 Review or narrative
Malik 2004 Study was based at a tertiary referral centre with a high percentage of patients with complicated malaria
Mankhambo 2002 Majority of participants did not have symptoms of malaria
Mason 2002 Some participants did not have symptoms of malaria
Mayxay 2004 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
McCutchan 2008 Review or narrative
Meena 2009 Participants were all hospital inpatients
Menan 1996 Not a study of rapid diagnostic tests
Mendoza 2007 Eligibility unclear due to lack of published information
Mengesha 1999 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Metzger 2008 Participants were recruited by active case finding
Mharakurwa 1997 Participants had all been recently treated for malaria
Miller 2001 Letter
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Miller 2008 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Mills 1999 Participants were travellers returning from endemic to non-endemic areas
Mills 2007 Eligibility unclear due to lack of published information
Mills 2009 Not a consecutive sample; selected HIV positive participants only
Minodier 2005 Review or narrative
Mishra 1999 Not a consecutive sample; comprised a malaria positive group by microscopy, and negative control groups
Mishra 2007 Eligibility unclear due to lack of published information
Mohanty 1999 Eligibility unclear due to lack of published information
Montoya 2008 European foreign language study
Moody 2000 Participants were travellers returning from endemic to non-endemic areas
Moody 2002 Review or narrative
Moody 2002a RDTs tested on artificially cultured blood samples
Moonasar 2007 Not a diagnostic test accuracy study
Moulin 2009 Review or narrative
Mueller 2007 Participants not representative of people presenting to ambulatory care setting with symptoms of malaria
Munier 2009 European foreign language study
Murray 2003 Review or narrative
Murray 2008 Review or narrative
Myjak 2004 Participants were travellers returning from endemic to non-endemic areas
Naing 2002 No usable data for P. falciparum malaria
Nema 2004 All participants were positive for malaria by microscopy
Neumann 2008 Majority of participants did not have symptoms of malaria
Ochola 2006 Review or narrative
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OMS 1999 Not a diagnostic test accuracy study
Onile 2005 Review or narrative
Ozbilge 2006 Not an immunochromatographic test
Pabon 2007 European foreign language study
Palmer 1998 Eligibility unclear due to lack of published information
Palmer 1999 All participants were positive for malaria by microscopy
Palmer 2003 Participants were travellers returning from endemic to non-endemic areas
Pammenter 1988 Review or narrative
Pandey 1995 Review or narrative
Park 2003 Not a consecutive sample; included a known malaria group and negative control group by microscopy
Park 2006 Written in Korean only
Parra 1991 Not a diagnostic test accuracy study
Penhalbel 2005 Not a consecutive sample; included a known malaria group and negative control group by microscopy
Perez 2007 Review or narrative
Peyron 1999 Review or narrative
Pica 2005 Review or narrative
Pieroni 1998 Participants were travellers returning from endemic to non-endemic areas
Pinto 1999 All participants had previously tested negative for malaria and had symptoms that meant complicated
malaria could not be ruled out
Piper 1999 Half the participants lived in non-endemic areas
Pividal 1994 Not a diagnostic test accuracy study (blood samples from one patient were serially diluted and tested)
Planche 2001 Review or narrative
Playford 2002 Participants were travellers returning from endemic to non-endemic areas
Popov 2000 Written in Russian only
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Popov 2004 Written in Russian only
Premji 1994 Participants did not have symptoms of malaria
Prou 1988 Not an immunochromatographic test
Proux 2001 Majority of participants did not have symptoms of malaria
Quintana 1998 Eligibility unclear due to lack of published information
Rabinovich 2006 Written in Russian only
Radrianasolo 2007 European foreign language study
Rahim 2002 All participants were positive for malaria by microscopy
Rajendran 2006 Eligibility unclear due to lack of published information
Ratnawati 2008 Many participants were recruited by active case finding
Rehlis 2004 Written in Polish only
Reyburn 2007 Not a diagnostic test accuracy study
Ricci 2000 Participants were travellers returning from endemic to non-endemic areas
Richardson 2002 Participants were travellers returning from endemic to non-endemic areas
Richter 2004 Review or narrative
Richter 2004a Participants were travellers returning from endemic to non-endemic areas
Roche 1995 Not an immunochromatographic test
Rodriguez-Iglesias 2005 Review or narrative
Rodulfo 2007 Some of the participants did not have symptoms of malaria
Rolland 2006 Not a diagnostic test accuracy study
Rubio 2001 Participants were travellers returning from endemic to non-endemic areas
Ryan 2002 Not a diagnostic test accuracy study
Samal 1998 Not an immunochromatographic test
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Saranya 2003 Review or narrative
Schmidt 2003 Review or narrative
Seidahmed 2008 Not a diagnostic test accuracy study
Sezibera 2009 Not a diagnostic test accuracy study
Shah 2004 All participants were positive for malaria by microscopy
Shamsi 1999 Eligibility unclear due to lack of published information
Sharma 2008 Some participants did not have symptoms of malaria
She 2007 Not undertaken in a malaria endemic area
Shenoi 1996 Eligibility unclear due to lack of published information
Shiff 1993 Some participants did not have symptoms of malaria
Shillcutt 2008 Not a diagnostic test accuracy study
Shirayama 2008 Not a diagnostic test accuracy study
Shujatullah 2006 Participants had severe or complicated malaria
Shujatullah 2009 Participants were hospital inpatients
Singer 2004 Majority of participants did not have symptoms of malaria
Singh 2000 (b) Some participants did not have symptoms of malaria
Singh 2001 Participants were recruited by active case finding
Singh 2002 Majority of participants did not have symptoms of malaria
Singh 2002(b) All participants were positive for malaria by microscopy
Singh 2004 Participants had severe or complicated malaria
Singh 2005 (a) Majority of participants did not have symptoms of malaria
Singh 2005 (b) Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Singh 2005c Some participants did not have symptoms of malaria
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Singh 2007 Majority of participants did not have symptoms of malaria
Skarbinski 2009 Not a diagnostic test accuracy study
Smego 2000 Review or narrative
Sotimehin 2007 Majority of participants did not have symptoms of malaria
Srinivasan 2000 Participants were travellers returning from endemic to non-endemic areas
Stauffer 2005 Participants were refugees from an endemic to a non-endemic country
Stauffer 2006 Participants were travellers returning from endemic to non-endemic areas
Stauffer 2009 Participants were all travellers returning from an endemic to a non-endemic area
Sturenburg 2009 Review or narrative
Susi 2005 Participants were all travellers returning from an endemic to a non-endemic area
Swarthout 2007 All participants were positive for malaria by microscopy
Tagbor 2008 Majority of participants did not have symptoms of malaria
Tarazona 2004 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Tarimo 1999 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Tarimo 2001 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Taylor 2002 All participants were positive for malaria by microscopy
Tham 1999 Participants were all travellers returning from an endemic to a non-endemic area
Thepsamarn 1997 All participants were positive for malaria by microscopy
Tietche 1996 Not a diagnostic test accuracy study (study of the probability of malaria in febrile children)
Tjitra 2001a All participants were positive for malaria by microscopy
Tjitra 2001b All participants were positive for malaria by microscopy
Trachsler 1999 Not a diagnostic test accuracy study
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Uguen 1995 Participants were travellers returning from endemic to non-endemic areas
Uneke 2008 Not a diagnostic test accuracy study
Uneke 2008a Review or narrative
Uzuchukwu 2009 No usable data for P. falciparum malaria
Valea 2009 No usable data for P. falciparum malaria
Valecha 1998 Eligibility unclear due to lack of published information
Valecha 2002 Participants were recruited by active case finding
Van den Ende 1998 Participants were travellers returning from endemic to non-endemic areas
Van der Palen 2009 Participants were travellers returning from endemic to non-endemic areas
Van Dijk 2009 Participants are travellers returning from an endemic to a non-endemic area
Van Hellemond 2009 Not a diagnostic test accuracy study
VanderJagt 2005 Majority of participants had no symptoms of malaria
Venkatesh 2007 Participants had severe or complicated malaria
Voller 1993 Review or narrative
Waltz 2007 Review or narrative
Wang J-Y 2007 Not a commercial test kit
Wanji 2008 Participants did not have symptoms of malaria
WHO 1996 Review or narrative
Wiese 2006 Participants were travellers returning from endemic to non-endemic areas
Williams 2008 Not a diagnostic test accuracy study
Win 2001 Review or narrative
Wongsrichanalai 2001 Review or narrative
Wongsrichanalai 2007 Review or narrative
Wu 2005 Not an immunochromatographic rapid diagnostic test kit
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Yavo 2002 European foreign language study
Zakai 2003 Review or narrative
Zerpa 2007 Not able to extract or calculate absolute numbers of true positives, false positives, false negatives and true
negatives
Zheng 1999 Written in Chinese only
Zhu 1998 Written in Chinese only
Zikusooka 2008 Not a diagnostic test accuracy study
Zurovac 2008 Not a diagnostic test accuracy study
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Presented below are all the data for all of the tests entered into the review.






1 Paracheck-Pf 27 22319
2 ParaSight-F 17 12521
3 ICT Malaria Pf 16 2955
4 ParaHIT-F 4 1119
5 PATH 2 378
6 Determine Malaria Pf 1 526
7 Rapid Test Malaria 1 306
8 Diaspot Malaria 1 153
9 New Pf-1 mini 1 10
10 Hexagon Malaria 1 119
11 Type 1 (All) 65 40062
12 CareStart Malaria Pf/Pan 2 537
13 ICT Malaria Pf/Pv 6 2255
14 NOWmalaria ICT 2 1142
15 Type 2 (All) 8 3397
16 SD Malaria Antigen Bioline 2 224
17 First Response Malaria 1 291
18 OptiMAL/ OptiMAL 48 10 3393
19 Parascreen 2 443
20 Type 3 (All) 5 958
21 OptiMAL-IT 3 1356
22 Parabank 2 7918
23 Type 4 (All) 16 13010
24 Carestart Pf/Pv 2 908
25 ParaSight Pf/Pv 1 869
26 Type 5 (All) 3 1777
27 HRP-2 based tests 75 43307
28 pLDH based tests 19 14787
29 Type 1 (paired comparison
with Type 4)
7 9764
30 Type 4 (paired comparison
with Type 1)
7 9761
31 PCR adjusted microscopy,
Type 1, Paracheck-PF (All)
1 7000
32 PCR adjusted microscopy,
Type 4, Parabank (All)
1 7000
33 PCR, Type 1, ParaSight-F 1 520
34 PCR, Type 1, ParaHIT-F 1 336
35 PCR, Type 1 (All) 2 856
36 PCR, Type 3, SD Malaria
Antigen (All)
1 198
37 HRP-2 based tests paired data 9 10626
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38 pLDH based tests paired data 9 10623
71 PCR, Type 6, PALUTOP (All) 1 313




Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 1 Paracheck-Pf
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
A-Elgayoum 2009 28 0 0 382 1.00 [ 0.88, 1.00 ] 1.00 [ 0.99, 1.00 ]
Abeku 2008a 554 220 55 408 0.91 [ 0.88, 0.93 ] 0.65 [ 0.61, 0.69 ]
Abeku 2008b 9 1 1 989 0.90 [ 0.55, 1.00 ] 1.00 [ 0.99, 1.00 ]
De Oliveira 2009 163 65 25 1574 0.87 [ 0.81, 0.91 ] 0.96 [ 0.95, 0.97 ]
Dev 2004 21 0 0 9 1.00 [ 0.84, 1.00 ] 1.00 [ 0.66, 1.00 ]
Gerstl 2009 167 44 2 130 0.99 [ 0.96, 1.00 ] 0.75 [ 0.68, 0.81 ]
Guthmann 2002 412 38 11 280 0.97 [ 0.95, 0.99 ] 0.88 [ 0.84, 0.91 ]
Hopkins 2007 274 47 15 582 0.95 [ 0.92, 0.97 ] 0.93 [ 0.90, 0.94 ]
Hopkins 2008a 2626 1245 77 3052 0.97 [ 0.96, 0.98 ] 0.71 [ 0.70, 0.72 ]
Kumar 2004 837 161 34 1859 0.96 [ 0.95, 0.97 ] 0.92 [ 0.91, 0.93 ]
Mboera 2006a 15 4 2 287 0.88 [ 0.64, 0.99 ] 0.99 [ 0.97, 1.00 ]
Mboera 2006b 16 6 3 63 0.84 [ 0.60, 0.97 ] 0.91 [ 0.82, 0.97 ]
Mboera 2006c 31 6 1 190 0.97 [ 0.84, 1.00 ] 0.97 [ 0.93, 0.99 ]
Mboera 2006d 147 16 3 140 0.98 [ 0.94, 1.00 ] 0.90 [ 0.84, 0.94 ]
Mboera 2006e 13 1 7 43 0.65 [ 0.41, 0.85 ] 0.98 [ 0.88, 1.00 ]
Mendiratta 2006 75 5 6 357 0.93 [ 0.85, 0.97 ] 0.99 [ 0.97, 1.00 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 56 3 4 121 0.93 [ 0.84, 0.98 ] 0.98 [ 0.93, 0.99 ]
Msellem 2009 279 82 26 618 0.91 [ 0.88, 0.94 ] 0.88 [ 0.86, 0.91 ]
Nigussie 2008a 147 72 5 228 0.97 [ 0.92, 0.99 ] 0.76 [ 0.71, 0.81 ]
Pandya 2001 98 2 15 352 0.87 [ 0.79, 0.92 ] 0.99 [ 0.98, 1.00 ]
Pattanasin 2003 52 10 5 202 0.91 [ 0.81, 0.97 ] 0.95 [ 0.91, 0.98 ]
Sharew 2009 167 16 1 484 0.99 [ 0.97, 1.00 ] 0.97 [ 0.95, 0.98 ]
Tagbo 2007 11 4 15 59 0.42 [ 0.23, 0.63 ] 0.94 [ 0.85, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
(Continued . . . )
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Van den Broek 2006 137 4 15 740 0.90 [ 0.84, 0.94 ] 0.99 [ 0.99, 1.00 ]
Willcox 2009a 135 3 11 9 0.92 [ 0.87, 0.96 ] 0.75 [ 0.43, 0.95 ]
Willcox 2009b 83 5 34 21 0.71 [ 0.62, 0.79 ] 0.81 [ 0.61, 0.93 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 2. ParaSight-F.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 2 ParaSight-F
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Banchongaksorn 1996a 226 12 16 659 0.93 [ 0.89, 0.96 ] 0.98 [ 0.97, 0.99 ]
Banchongaksorn 1997 598 20 21 2722 0.97 [ 0.95, 0.98 ] 0.99 [ 0.99, 1.00 ]
Bojang 1999 82 5 3 49 0.96 [ 0.90, 0.99 ] 0.91 [ 0.80, 0.97 ]
Caraballo 1996 268 8 41 1081 0.87 [ 0.82, 0.90 ] 0.99 [ 0.99, 1.00 ]
Dev 2004 26 1 0 17 1.00 [ 0.87, 1.00 ] 0.94 [ 0.73, 1.00 ]
Forney 2001 541 346 37 2057 0.94 [ 0.91, 0.95 ] 0.86 [ 0.84, 0.87 ]
Gaye 1998 31 2 3 30 0.91 [ 0.76, 0.98 ] 0.94 [ 0.79, 0.99 ]
Kar 1998 45 0 0 48 1.00 [ 0.92, 1.00 ] 1.00 [ 0.93, 1.00 ]
Kilian 1999 635 89 44 558 0.94 [ 0.91, 0.95 ] 0.86 [ 0.83, 0.89 ]
Mharakurwa 1997a 54 12 3 67 0.95 [ 0.85, 0.99 ] 0.85 [ 0.75, 0.92 ]
Mharakurwa 1997b 53 11 4 28 0.93 [ 0.83, 0.98 ] 0.72 [ 0.55, 0.85 ]
Mharakurwa 1997c 20 16 2 175 0.91 [ 0.71, 0.99 ] 0.92 [ 0.87, 0.95 ]
Murahwa 1999 31 12 2 52 0.94 [ 0.80, 0.99 ] 0.81 [ 0.70, 0.90 ]
Omar 1999 9 0 3 26 0.75 [ 0.43, 0.95 ] 1.00 [ 0.87, 1.00 ]
Singh 1997 (b) 354 64 28 785 0.93 [ 0.90, 0.95 ] 0.92 [ 0.90, 0.94 ]
Stephens 1999 55 39 7 195 0.89 [ 0.78, 0.95 ] 0.83 [ 0.78, 0.88 ]
Verle 1996 19 9 0 65 1.00 [ 0.82, 1.00 ] 0.88 [ 0.78, 0.94 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. ICT Malaria Pf.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 3 ICT Malaria Pf
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bechem 1999 98 17 2 82 0.98 [ 0.93, 1.00 ] 0.83 [ 0.74, 0.90 ]
Dev 2004 85 0 0 12 1.00 [ 0.96, 1.00 ] 1.00 [ 0.74, 1.00 ]
Durrheim 1998 68 4 1 191 0.99 [ 0.92, 1.00 ] 0.98 [ 0.95, 0.99 ]
Gaye 1998 32 0 2 32 0.94 [ 0.80, 0.99 ] 1.00 [ 0.89, 1.00 ]
Ghosh 2000 15 3 0 63 1.00 [ 0.78, 1.00 ] 0.95 [ 0.87, 0.99 ]
Kumar 1996 21 1 0 76 1.00 [ 0.84, 1.00 ] 0.99 [ 0.93, 1.00 ]
Kyabayinze 2008 136 62 3 156 0.98 [ 0.94, 1.00 ] 0.72 [ 0.65, 0.77 ]
Mohapatra 1996 53 2 0 45 1.00 [ 0.93, 1.00 ] 0.96 [ 0.85, 0.99 ]
Moonasar 2009 190 8 1 206 0.99 [ 0.97, 1.00 ] 0.96 [ 0.93, 0.98 ]
Murahwa 1999 33 21 0 63 1.00 [ 0.89, 1.00 ] 0.75 [ 0.64, 0.84 ]
Nwuba 2001 27 2 2 46 0.93 [ 0.77, 0.99 ] 0.96 [ 0.86, 0.99 ]
Sharma 1999 54 1 2 63 0.96 [ 0.88, 1.00 ] 0.98 [ 0.92, 1.00 ]
Singh 1997 (a) 201 22 0 130 1.00 [ 0.98, 1.00 ] 0.86 [ 0.79, 0.91 ]
Stow 1999 21 6 5 132 0.81 [ 0.61, 0.93 ] 0.96 [ 0.91, 0.98 ]
Wongsrichanalai 1999 69 10 8 222 0.90 [ 0.81, 0.95 ] 0.96 [ 0.92, 0.98 ]
Yadav 1997 60 1 11 76 0.85 [ 0.74, 0.92 ] 0.99 [ 0.93, 1.00 ]
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Test 4. ParaHIT-F.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 4 ParaHIT-F
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chitkara 2004 135 5 2 531 0.99 [ 0.95, 1.00 ] 0.99 [ 0.98, 1.00 ]
Dev 2004 7 0 0 3 1.00 [ 0.59, 1.00 ] 1.00 [ 0.29, 1.00 ]
Devi 2002 16 2 0 82 1.00 [ 0.79, 1.00 ] 0.98 [ 0.92, 1.00 ]
Nicastri 2009a 15 3 17 301 0.47 [ 0.29, 0.65 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 5. PATH.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 5 PATH
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gaye 1999 122 4 5 51 0.96 [ 0.91, 0.99 ] 0.93 [ 0.82, 0.98 ]
Labbe 2001 51 10 2 133 0.96 [ 0.87, 1.00 ] 0.93 [ 0.88, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 6. Determine Malaria Pf.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 6 Determine Malaria Pf
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Singh 2000 (a) 257 35 5 229 0.98 [ 0.96, 0.99 ] 0.87 [ 0.82, 0.91 ]
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Test 7. Rapid Test Malaria.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 7 Rapid Test Malaria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Wolday 2001 35 11 1 259 0.97 [ 0.85, 1.00 ] 0.96 [ 0.93, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 8. Diaspot Malaria.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 8 Diaspot Malaria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Sayang 2009 45 16 18 74 0.71 [ 0.59, 0.82 ] 0.82 [ 0.73, 0.89 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 9. New Pf-1 mini.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 9 New Pf-1 mini
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Dev 2004 6 0 0 4 1.00 [ 0.54, 1.00 ] 1.00 [ 0.40, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 10. Hexagon Malaria.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 10 Hexagon Malaria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Mwanza 2005 32 30 0 57 1.00 [ 0.89, 1.00 ] 0.66 [ 0.55, 0.75 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 11. Type 1 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 11 Type 1 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
A-Elgayoum 2009 28 0 0 382 1.00 [ 0.88, 1.00 ] 1.00 [ 0.99, 1.00 ]
Abeku 2008a 554 220 55 408 0.91 [ 0.88, 0.93 ] 0.65 [ 0.61, 0.69 ]
Abeku 2008b 9 1 1 989 0.90 [ 0.55, 1.00 ] 1.00 [ 0.99, 1.00 ]
Banchongaksorn 1996a 226 12 16 659 0.93 [ 0.89, 0.96 ] 0.98 [ 0.97, 0.99 ]
Banchongaksorn 1997 598 20 21 2722 0.97 [ 0.95, 0.98 ] 0.99 [ 0.99, 1.00 ]
Bechem 1999 98 17 2 82 0.98 [ 0.93, 1.00 ] 0.83 [ 0.74, 0.90 ]
Bojang 1999 82 5 3 49 0.96 [ 0.90, 0.99 ] 0.91 [ 0.80, 0.97 ]
Caraballo 1996 268 8 41 1081 0.87 [ 0.82, 0.90 ] 0.99 [ 0.99, 1.00 ]
Chitkara 2004 135 5 2 531 0.99 [ 0.95, 1.00 ] 0.99 [ 0.98, 1.00 ]
De Oliveira 2009 163 65 25 1574 0.87 [ 0.81, 0.91 ] 0.96 [ 0.95, 0.97 ]
Dev 2004 21 0 0 9 1.00 [ 0.84, 1.00 ] 1.00 [ 0.66, 1.00 ]
Devi 2002 16 2 0 82 1.00 [ 0.79, 1.00 ] 0.98 [ 0.92, 1.00 ]
Durrheim 1998 68 4 1 191 0.99 [ 0.92, 1.00 ] 0.98 [ 0.95, 0.99 ]
Forney 2001 541 346 37 2057 0.94 [ 0.91, 0.95 ] 0.86 [ 0.84, 0.87 ]
Gaye 1998 31 2 3 30 0.91 [ 0.76, 0.98 ] 0.94 [ 0.79, 0.99 ]
Gaye 1999 122 4 5 51 0.96 [ 0.91, 0.99 ] 0.93 [ 0.82, 0.98 ]
Gerstl 2009 167 44 2 130 0.99 [ 0.96, 1.00 ] 0.75 [ 0.68, 0.81 ]
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ghosh 2000 15 3 0 63 1.00 [ 0.78, 1.00 ] 0.95 [ 0.87, 0.99 ]
Guthmann 2002 412 38 11 280 0.97 [ 0.95, 0.99 ] 0.88 [ 0.84, 0.91 ]
Hopkins 2007 274 47 15 582 0.95 [ 0.92, 0.97 ] 0.93 [ 0.90, 0.94 ]
Hopkins 2008a 2626 1245 77 3052 0.97 [ 0.96, 0.98 ] 0.71 [ 0.70, 0.72 ]
Kar 1998 45 0 0 48 1.00 [ 0.92, 1.00 ] 1.00 [ 0.93, 1.00 ]
Kilian 1999 635 89 44 558 0.94 [ 0.91, 0.95 ] 0.86 [ 0.83, 0.89 ]
Kumar 1996 21 1 0 76 1.00 [ 0.84, 1.00 ] 0.99 [ 0.93, 1.00 ]
Kumar 2004 833 165 34 1859 0.96 [ 0.95, 0.97 ] 0.92 [ 0.91, 0.93 ]
Kyabayinze 2008 136 62 3 156 0.98 [ 0.94, 1.00 ] 0.72 [ 0.65, 0.77 ]
Labbe 2001 51 10 2 133 0.96 [ 0.87, 1.00 ] 0.93 [ 0.88, 0.97 ]
Mboera 2006a 15 4 2 287 0.88 [ 0.64, 0.99 ] 0.99 [ 0.97, 1.00 ]
Mboera 2006b 16 6 3 63 0.84 [ 0.60, 0.97 ] 0.91 [ 0.82, 0.97 ]
Mboera 2006c 31 6 1 190 0.97 [ 0.84, 1.00 ] 0.97 [ 0.93, 0.99 ]
Mboera 2006d 147 16 3 140 0.98 [ 0.94, 1.00 ] 0.90 [ 0.84, 0.94 ]
Mboera 2006e 13 1 7 43 0.65 [ 0.41, 0.85 ] 0.98 [ 0.88, 1.00 ]
Mendiratta 2006 75 5 6 357 0.93 [ 0.85, 0.97 ] 0.99 [ 0.97, 1.00 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 56 3 4 121 0.93 [ 0.84, 0.98 ] 0.98 [ 0.93, 0.99 ]
Mharakurwa 1997a 54 12 3 67 0.95 [ 0.85, 0.99 ] 0.85 [ 0.75, 0.92 ]
Mharakurwa 1997b 53 11 4 28 0.93 [ 0.83, 0.98 ] 0.72 [ 0.55, 0.85 ]
Mharakurwa 1997c 20 16 2 175 0.91 [ 0.71, 0.99 ] 0.92 [ 0.87, 0.95 ]
Mohapatra 1996 53 2 0 45 1.00 [ 0.93, 1.00 ] 0.96 [ 0.85, 0.99 ]
Moonasar 2009 190 8 1 206 0.99 [ 0.97, 1.00 ] 0.96 [ 0.93, 0.98 ]
Msellem 2009 279 82 26 618 0.91 [ 0.88, 0.94 ] 0.88 [ 0.86, 0.91 ]
Murahwa 1999 31 12 2 52 0.94 [ 0.80, 0.99 ] 0.81 [ 0.70, 0.90 ]
Mwanza 2005 32 30 0 57 1.00 [ 0.89, 1.00 ] 0.66 [ 0.55, 0.75 ]
Nicastri 2009a 15 3 17 301 0.47 [ 0.29, 0.65 ] 0.99 [ 0.97, 1.00 ]
Nigussie 2008a 147 72 5 228 0.97 [ 0.92, 0.99 ] 0.76 [ 0.71, 0.81 ]
Nwuba 2001 27 2 2 46 0.93 [ 0.77, 0.99 ] 0.96 [ 0.86, 0.99 ]
Omar 1999 9 0 3 26 0.75 [ 0.43, 0.95 ] 1.00 [ 0.87, 1.00 ]
Pandya 2001 98 2 15 352 0.87 [ 0.79, 0.92 ] 0.99 [ 0.98, 1.00 ]
Pattanasin 2003 52 10 5 202 0.91 [ 0.81, 0.97 ] 0.95 [ 0.91, 0.98 ]
Sayang 2009 45 16 18 74 0.71 [ 0.59, 0.82 ] 0.82 [ 0.73, 0.89 ]
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Sharew 2009 167 16 1 484 0.99 [ 0.97, 1.00 ] 0.97 [ 0.95, 0.98 ]
Sharma 1999 54 1 2 63 0.96 [ 0.88, 1.00 ] 0.98 [ 0.92, 1.00 ]
Singh 1997 (a) 201 22 0 130 1.00 [ 0.98, 1.00 ] 0.86 [ 0.79, 0.91 ]
Singh 1997 (b) 354 64 28 785 0.93 [ 0.90, 0.95 ] 0.92 [ 0.90, 0.94 ]
Singh 2000 (a) 257 35 5 229 0.98 [ 0.96, 0.99 ] 0.87 [ 0.82, 0.91 ]
Stephens 1999 55 39 7 195 0.89 [ 0.78, 0.95 ] 0.83 [ 0.78, 0.88 ]
Stow 1999 21 6 5 132 0.81 [ 0.61, 0.93 ] 0.96 [ 0.91, 0.98 ]
Tagbo 2007 11 4 15 59 0.42 [ 0.23, 0.63 ] 0.94 [ 0.85, 0.98 ]
Van den Broek 2006 137 4 15 740 0.90 [ 0.84, 0.94 ] 0.99 [ 0.99, 1.00 ]
Verle 1996 19 9 0 65 1.00 [ 0.82, 1.00 ] 0.88 [ 0.78, 0.94 ]
Willcox 2009a 135 3 11 9 0.92 [ 0.87, 0.96 ] 0.75 [ 0.43, 0.95 ]
Willcox 2009b 83 5 34 21 0.71 [ 0.62, 0.79 ] 0.81 [ 0.61, 0.93 ]
Wolday 2001 35 11 1 259 0.97 [ 0.85, 1.00 ] 0.96 [ 0.93, 0.98 ]
Wongsrichanalai 1999 69 10 8 222 0.90 [ 0.81, 0.95 ] 0.96 [ 0.92, 0.98 ]
Yadav 1997 60 1 11 76 0.85 [ 0.74, 0.92 ] 0.99 [ 0.93, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 12. CareStart Malaria Pf/Pan.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 12 CareStart Malaria Pf/Pan
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gerstl 2009 168 7 1 167 0.99 [ 0.97, 1.00 ] 0.96 [ 0.92, 0.98 ]
Ratsimbasoa 2007 67 12 4 111 0.94 [ 0.86, 0.98 ] 0.90 [ 0.84, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 13. ICT Malaria Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 13 ICT Malaria Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bell 2001a 103 64 3 180 0.97 [ 0.92, 0.99 ] 0.74 [ 0.68, 0.79 ]
Bell 2001b 24 14 4 71 0.86 [ 0.67, 0.96 ] 0.84 [ 0.74, 0.91 ]
Fernando 2004 24 0 0 304 1.00 [ 0.86, 1.00 ] 1.00 [ 0.99, 1.00 ]
Harani 2006 32 9 4 515 0.89 [ 0.74, 0.97 ] 0.98 [ 0.97, 0.99 ]
Singh 2000 (c) 155 5 4 180 0.97 [ 0.94, 0.99 ] 0.97 [ 0.94, 0.99 ]
Tjitra 1999 236 32 11 281 0.96 [ 0.92, 0.98 ] 0.90 [ 0.86, 0.93 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 14. NOWmalaria ICT.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 14 NOW malaria ICT
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Van den Broek 2006 144 70 8 674 0.95 [ 0.90, 0.98 ] 0.91 [ 0.88, 0.93 ]
Wongsrichanalai 2003 38 8 0 200 1.00 [ 0.91, 1.00 ] 0.96 [ 0.93, 0.98 ]
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Test 15. Type 2 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 15 Type 2 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bell 2001a 103 64 3 180 0.97 [ 0.92, 0.99 ] 0.74 [ 0.68, 0.79 ]
Bell 2001b 24 14 4 71 0.86 [ 0.67, 0.96 ] 0.84 [ 0.74, 0.91 ]
Fernando 2004 24 0 0 304 1.00 [ 0.86, 1.00 ] 1.00 [ 0.99, 1.00 ]
Harani 2006 32 9 4 515 0.89 [ 0.74, 0.97 ] 0.98 [ 0.97, 0.99 ]
Singh 2000 (c) 155 5 4 180 0.97 [ 0.94, 0.99 ] 0.97 [ 0.94, 0.99 ]
Tjitra 1999 236 32 11 281 0.96 [ 0.92, 0.98 ] 0.90 [ 0.86, 0.93 ]
Van den Broek 2006 144 70 8 674 0.95 [ 0.90, 0.98 ] 0.91 [ 0.88, 0.93 ]
Wongsrichanalai 2003 38 8 0 200 1.00 [ 0.91, 1.00 ] 0.96 [ 0.93, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 16. SD Malaria Antigen Bioline.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 16 SD Malaria Antigen Bioline
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Dev 2004 17 0 0 13 1.00 [ 0.80, 1.00 ] 1.00 [ 0.75, 1.00 ]
Ratsimbasoa 2007 61 7 10 116 0.86 [ 0.76, 0.93 ] 0.94 [ 0.89, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 17. First Response Malaria.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 17 First Response Malaria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bharti 2008 69 12 3 207 0.96 [ 0.88, 0.99 ] 0.95 [ 0.91, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 18. OptiMAL/ OptiMAL 48.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 18 OptiMAL/ OptiMAL 48
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chayani 2004 93 0 3 136 0.97 [ 0.91, 0.99 ] 1.00 [ 0.97, 1.00 ]
Cooke 1999 131 13 13 244 0.91 [ 0.85, 0.95 ] 0.95 [ 0.92, 0.97 ]
Dev 2004 69 0 16 54 0.81 [ 0.71, 0.89 ] 1.00 [ 0.93, 1.00 ]
Iqbal 2003 111 3 20 796 0.85 [ 0.77, 0.90 ] 1.00 [ 0.99, 1.00 ]
Kolaczinski 2004 24 1 6 468 0.80 [ 0.61, 0.92 ] 1.00 [ 0.99, 1.00 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 58 3 2 121 0.97 [ 0.88, 1.00 ] 0.98 [ 0.93, 0.99 ]
Singh 2003a 23 0 1 56 0.96 [ 0.79, 1.00 ] 1.00 [ 0.94, 1.00 ]
Singh 2003b 43 2 1 29 0.98 [ 0.88, 1.00 ] 0.94 [ 0.79, 0.99 ]
Valecha 2003 190 5 26 478 0.88 [ 0.83, 0.92 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 19. Parascreen.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 19 Parascreen
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Mens 2007b 60 9 0 115 1.00 [ 0.94, 1.00 ] 0.93 [ 0.87, 0.97 ]
Nigussie 2008b 110 52 0 97 1.00 [ 0.97, 1.00 ] 0.65 [ 0.57, 0.73 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 20. Type 3 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 20 Type 3 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bharti 2008 69 12 3 207 0.96 [ 0.88, 0.99 ] 0.95 [ 0.91, 0.97 ]
Dev 2004 17 0 0 13 1.00 [ 0.80, 1.00 ] 1.00 [ 0.75, 1.00 ]
Mens 2007b 60 9 0 115 1.00 [ 0.94, 1.00 ] 0.93 [ 0.87, 0.97 ]
Nigussie 2008b 110 52 0 97 1.00 [ 0.97, 1.00 ] 0.65 [ 0.57, 0.73 ]
Ratsimbasoa 2007 61 7 10 116 0.86 [ 0.76, 0.93 ] 0.94 [ 0.89, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 21. OptiMAL-IT.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 21 OptiMAL-IT
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Pattanasin 2003 50 19 7 190 0.88 [ 0.76, 0.95 ] 0.91 [ 0.86, 0.94 ]
Ratsimbasoa 2007 64 4 7 119 0.90 [ 0.81, 0.96 ] 0.97 [ 0.92, 0.99 ]
Van den Broek 2006 127 13 25 731 0.84 [ 0.77, 0.89 ] 0.98 [ 0.97, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 22. Parabank.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 22 Parabank
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Hopkins 2007 254 0 35 629 0.88 [ 0.84, 0.91 ] 1.00 [ 0.99, 1.00 ]
Hopkins 2008a 2385 358 318 3939 0.88 [ 0.87, 0.89 ] 0.92 [ 0.91, 0.92 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 23. Type 4 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 23 Type 4 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chayani 2004 93 0 3 136 0.97 [ 0.91, 0.99 ] 1.00 [ 0.97, 1.00 ]
Cooke 1999 131 13 13 244 0.91 [ 0.85, 0.95 ] 0.95 [ 0.92, 0.97 ]
Dev 2004 69 0 16 54 0.81 [ 0.71, 0.89 ] 1.00 [ 0.93, 1.00 ]
Gerstl 2009 168 7 1 167 0.99 [ 0.97, 1.00 ] 0.96 [ 0.92, 0.98 ]
Hopkins 2007 254 0 35 629 0.88 [ 0.84, 0.91 ] 1.00 [ 0.99, 1.00 ]
Hopkins 2008a 2385 358 318 3939 0.88 [ 0.87, 0.89 ] 0.92 [ 0.91, 0.92 ]
Iqbal 2003 111 3 20 796 0.85 [ 0.77, 0.90 ] 1.00 [ 0.99, 1.00 ]
Kolaczinski 2004 24 1 6 468 0.80 [ 0.61, 0.92 ] 1.00 [ 0.99, 1.00 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 58 3 2 121 0.97 [ 0.88, 1.00 ] 0.98 [ 0.93, 0.99 ]
Pattanasin 2003 50 19 7 190 0.88 [ 0.76, 0.95 ] 0.91 [ 0.86, 0.94 ]
Ratsimbasoa 2007 67 12 4 111 0.94 [ 0.86, 0.98 ] 0.90 [ 0.84, 0.95 ]
Singh 2003a 23 0 1 56 0.96 [ 0.79, 1.00 ] 1.00 [ 0.94, 1.00 ]
Singh 2003b 43 2 1 29 0.98 [ 0.88, 1.00 ] 0.94 [ 0.79, 0.99 ]
Valecha 2003 190 5 26 478 0.88 [ 0.83, 0.92 ] 0.99 [ 0.98, 1.00 ]
Van den Broek 2006 127 13 25 731 0.84 [ 0.77, 0.89 ] 0.98 [ 0.97, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 24. Carestart Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 24 Carestart Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Mekonnen 2010 54 0 2 184 0.96 [ 0.88, 1.00 ] 1.00 [ 0.98, 1.00 ]
Sharew 2009 167 10 1 490 0.99 [ 0.97, 1.00 ] 0.98 [ 0.96, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 25. ParaSight Pf/Pv.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 25 ParaSight Pf/Pv
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Forney 2003 169 46 7 647 0.96 [ 0.92, 0.98 ] 0.93 [ 0.91, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 26. Type 5 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 26 Type 5 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Forney 2003 169 46 7 647 0.96 [ 0.92, 0.98 ] 0.93 [ 0.91, 0.95 ]
Mekonnen 2010 54 0 2 184 0.96 [ 0.88, 1.00 ] 1.00 [ 0.98, 1.00 ]
Sharew 2009 167 10 1 490 0.99 [ 0.97, 1.00 ] 0.98 [ 0.96, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 27. HRP-2 based tests.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 27 HRP-2 based tests
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
A-Elgayoum 2009 28 0 0 382 1.00 [ 0.88, 1.00 ] 1.00 [ 0.99, 1.00 ]
Abeku 2008a 554 220 55 408 0.91 [ 0.88, 0.93 ] 0.65 [ 0.61, 0.69 ]
Abeku 2008b 9 1 1 989 0.90 [ 0.55, 1.00 ] 1.00 [ 0.99, 1.00 ]
Banchongaksorn 1996a 226 12 16 659 0.93 [ 0.89, 0.96 ] 0.98 [ 0.97, 0.99 ]
Banchongaksorn 1997 598 20 21 2722 0.97 [ 0.95, 0.98 ] 0.99 [ 0.99, 1.00 ]
Bechem 1999 98 17 2 82 0.98 [ 0.93, 1.00 ] 0.83 [ 0.74, 0.90 ]
Bell 2001a 103 64 3 180 0.97 [ 0.92, 0.99 ] 0.74 [ 0.68, 0.79 ]
Bell 2001b 24 14 4 71 0.86 [ 0.67, 0.96 ] 0.84 [ 0.74, 0.91 ]
Bharti 2008 69 12 3 207 0.96 [ 0.88, 0.99 ] 0.95 [ 0.91, 0.97 ]
Bojang 1999 82 5 3 49 0.96 [ 0.90, 0.99 ] 0.91 [ 0.80, 0.97 ]
Caraballo 1996 268 8 41 1081 0.87 [ 0.82, 0.90 ] 0.99 [ 0.99, 1.00 ]
Chitkara 2004 135 5 2 531 0.99 [ 0.95, 1.00 ] 0.99 [ 0.98, 1.00 ]
De Oliveira 2009 163 65 25 1574 0.87 [ 0.81, 0.91 ] 0.96 [ 0.95, 0.97 ]
Dev 2004 21 0 0 9 1.00 [ 0.84, 1.00 ] 1.00 [ 0.66, 1.00 ]
Devi 2002 16 2 0 82 1.00 [ 0.79, 1.00 ] 0.98 [ 0.92, 1.00 ]
Durrheim 1998 68 4 1 191 0.99 [ 0.92, 1.00 ] 0.98 [ 0.95, 0.99 ]
Fernando 2004 24 0 0 304 1.00 [ 0.86, 1.00 ] 1.00 [ 0.99, 1.00 ]
Forney 2001 541 346 37 2057 0.94 [ 0.91, 0.95 ] 0.86 [ 0.84, 0.87 ]
Gaye 1998 31 2 3 30 0.91 [ 0.76, 0.98 ] 0.94 [ 0.79, 0.99 ]
Gaye 1999 122 4 5 51 0.96 [ 0.91, 0.99 ] 0.93 [ 0.82, 0.98 ]
Gerstl 2009 167 44 2 130 0.99 [ 0.96, 1.00 ] 0.75 [ 0.68, 0.81 ]
Ghosh 2000 15 3 0 63 1.00 [ 0.78, 1.00 ] 0.95 [ 0.87, 0.99 ]
Guthmann 2002 412 38 11 280 0.97 [ 0.95, 0.99 ] 0.88 [ 0.84, 0.91 ]
Harani 2006 32 9 4 515 0.89 [ 0.74, 0.97 ] 0.98 [ 0.97, 0.99 ]
Hopkins 2007 274 47 15 582 0.95 [ 0.92, 0.97 ] 0.93 [ 0.90, 0.94 ]
Hopkins 2008a 2626 1245 77 3052 0.97 [ 0.96, 0.98 ] 0.71 [ 0.70, 0.72 ]
Kar 1998 45 0 0 48 1.00 [ 0.92, 1.00 ] 1.00 [ 0.93, 1.00 ]
Kilian 1999 635 89 44 558 0.94 [ 0.91, 0.95 ] 0.86 [ 0.83, 0.89 ]
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(Continued . . . )
243Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kumar 1996 21 1 0 76 1.00 [ 0.84, 1.00 ] 0.99 [ 0.93, 1.00 ]
Kumar 2004 833 165 34 1859 0.96 [ 0.95, 0.97 ] 0.92 [ 0.91, 0.93 ]
Kyabayinze 2008 136 62 3 156 0.98 [ 0.94, 1.00 ] 0.72 [ 0.65, 0.77 ]
Labbe 2001 51 10 2 133 0.96 [ 0.87, 1.00 ] 0.93 [ 0.88, 0.97 ]
Mboera 2006a 15 4 2 287 0.88 [ 0.64, 0.99 ] 0.99 [ 0.97, 1.00 ]
Mboera 2006b 16 6 3 63 0.84 [ 0.60, 0.97 ] 0.91 [ 0.82, 0.97 ]
Mboera 2006c 31 6 1 190 0.97 [ 0.84, 1.00 ] 0.97 [ 0.93, 0.99 ]
Mboera 2006d 147 16 3 140 0.98 [ 0.94, 1.00 ] 0.90 [ 0.84, 0.94 ]
Mboera 2006e 13 1 7 43 0.65 [ 0.41, 0.85 ] 0.98 [ 0.88, 1.00 ]
Mendiratta 2006 75 5 6 357 0.93 [ 0.85, 0.97 ] 0.99 [ 0.97, 1.00 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 56 3 4 121 0.93 [ 0.84, 0.98 ] 0.98 [ 0.93, 0.99 ]
Mharakurwa 1997a 54 12 3 67 0.95 [ 0.85, 0.99 ] 0.85 [ 0.75, 0.92 ]
Mharakurwa 1997b 53 11 4 28 0.93 [ 0.83, 0.98 ] 0.72 [ 0.55, 0.85 ]
Mharakurwa 1997c 20 16 2 175 0.91 [ 0.71, 0.99 ] 0.92 [ 0.87, 0.95 ]
Mohapatra 1996 53 2 0 45 1.00 [ 0.93, 1.00 ] 0.96 [ 0.85, 0.99 ]
Moonasar 2009 190 8 1 206 0.99 [ 0.97, 1.00 ] 0.96 [ 0.93, 0.98 ]
Msellem 2009 279 82 26 618 0.91 [ 0.88, 0.94 ] 0.88 [ 0.86, 0.91 ]
Murahwa 1999 31 12 2 52 0.94 [ 0.80, 0.99 ] 0.81 [ 0.70, 0.90 ]
Mwanza 2005 32 30 0 57 1.00 [ 0.89, 1.00 ] 0.66 [ 0.55, 0.75 ]
Nicastri 2009a 15 3 17 301 0.47 [ 0.29, 0.65 ] 0.99 [ 0.97, 1.00 ]
Nigussie 2008a 147 72 5 228 0.97 [ 0.92, 0.99 ] 0.76 [ 0.71, 0.81 ]
Nigussie 2008b 110 52 0 97 1.00 [ 0.97, 1.00 ] 0.65 [ 0.57, 0.73 ]
Nwuba 2001 27 2 2 46 0.93 [ 0.77, 0.99 ] 0.96 [ 0.86, 0.99 ]
Omar 1999 9 0 3 26 0.75 [ 0.43, 0.95 ] 1.00 [ 0.87, 1.00 ]
Pandya 2001 98 2 15 352 0.87 [ 0.79, 0.92 ] 0.99 [ 0.98, 1.00 ]
Pattanasin 2003 52 10 5 202 0.91 [ 0.81, 0.97 ] 0.95 [ 0.91, 0.98 ]
Ratsimbasoa 2007 61 7 10 116 0.86 [ 0.76, 0.93 ] 0.94 [ 0.89, 0.98 ]
Sayang 2009 45 16 18 74 0.71 [ 0.59, 0.82 ] 0.82 [ 0.73, 0.89 ]
Sharew 2009 167 16 1 484 0.99 [ 0.97, 1.00 ] 0.97 [ 0.95, 0.98 ]
Sharma 1999 54 1 2 63 0.96 [ 0.88, 1.00 ] 0.98 [ 0.92, 1.00 ]
Singh 1997 (a) 201 22 0 130 1.00 [ 0.98, 1.00 ] 0.86 [ 0.79, 0.91 ]
Singh 1997 (b) 354 64 28 785 0.93 [ 0.90, 0.95 ] 0.92 [ 0.90, 0.94 ]
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Singh 2000 (a) 257 35 5 229 0.98 [ 0.96, 0.99 ] 0.87 [ 0.82, 0.91 ]
Singh 2000 (c) 155 5 4 180 0.97 [ 0.94, 0.99 ] 0.97 [ 0.94, 0.99 ]
Stephens 1999 55 39 7 195 0.89 [ 0.78, 0.95 ] 0.83 [ 0.78, 0.88 ]
Stow 1999 21 6 5 132 0.81 [ 0.61, 0.93 ] 0.96 [ 0.91, 0.98 ]
Tagbo 2007 11 4 15 59 0.42 [ 0.23, 0.63 ] 0.94 [ 0.85, 0.98 ]
Tjitra 1999 236 32 11 281 0.96 [ 0.92, 0.98 ] 0.90 [ 0.86, 0.93 ]
Van den Broek 2006 137 4 15 740 0.90 [ 0.84, 0.94 ] 0.99 [ 0.99, 1.00 ]
Verle 1996 19 9 0 65 1.00 [ 0.82, 1.00 ] 0.88 [ 0.78, 0.94 ]
Willcox 2009a 135 3 11 9 0.92 [ 0.87, 0.96 ] 0.75 [ 0.43, 0.95 ]
Willcox 2009b 83 5 34 21 0.71 [ 0.62, 0.79 ] 0.81 [ 0.61, 0.93 ]
Wolday 2001 35 11 1 259 0.97 [ 0.85, 1.00 ] 0.96 [ 0.93, 0.98 ]
Wongsrichanalai 1999 69 10 8 222 0.90 [ 0.81, 0.95 ] 0.96 [ 0.92, 0.98 ]
Wongsrichanalai 2003 38 8 0 200 1.00 [ 0.91, 1.00 ] 0.96 [ 0.93, 0.98 ]
Yadav 1997 60 1 11 76 0.85 [ 0.74, 0.92 ] 0.99 [ 0.93, 1.00 ]
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Test 28. pLDH based tests.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 28 pLDH based tests
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chayani 2004 93 0 3 136 0.97 [ 0.91, 0.99 ] 1.00 [ 0.97, 1.00 ]
Cooke 1999 131 13 13 244 0.91 [ 0.85, 0.95 ] 0.95 [ 0.92, 0.97 ]
Dev 2004 69 0 16 54 0.81 [ 0.71, 0.89 ] 1.00 [ 0.93, 1.00 ]
Forney 2003 169 46 7 647 0.96 [ 0.92, 0.98 ] 0.93 [ 0.91, 0.95 ]
Gerstl 2009 168 7 1 167 0.99 [ 0.97, 1.00 ] 0.96 [ 0.92, 0.98 ]
Hopkins 2007 254 0 35 629 0.88 [ 0.84, 0.91 ] 1.00 [ 0.99, 1.00 ]
Hopkins 2008a 2385 358 318 3939 0.88 [ 0.87, 0.89 ] 0.92 [ 0.91, 0.92 ]
Iqbal 2003 111 3 20 796 0.85 [ 0.77, 0.90 ] 1.00 [ 0.99, 1.00 ]
Kolaczinski 2004 24 1 6 468 0.80 [ 0.61, 0.92 ] 1.00 [ 0.99, 1.00 ]
Mekonnen 2010 54 0 2 184 0.96 [ 0.88, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 58 3 2 121 0.97 [ 0.88, 1.00 ] 0.98 [ 0.93, 0.99 ]
Pattanasin 2003 50 19 7 190 0.88 [ 0.76, 0.95 ] 0.91 [ 0.86, 0.94 ]
Ratsimbasoa 2007 67 12 4 111 0.94 [ 0.86, 0.98 ] 0.90 [ 0.84, 0.95 ]
Sharew 2009 167 10 1 490 0.99 [ 0.97, 1.00 ] 0.98 [ 0.96, 0.99 ]
Singh 2003a 23 0 1 56 0.96 [ 0.79, 1.00 ] 1.00 [ 0.94, 1.00 ]
Singh 2003b 43 2 1 29 0.98 [ 0.88, 1.00 ] 0.94 [ 0.79, 0.99 ]
Valecha 2003 190 5 26 478 0.88 [ 0.83, 0.92 ] 0.99 [ 0.98, 1.00 ]
Van den Broek 2006 127 13 25 731 0.84 [ 0.77, 0.89 ] 0.98 [ 0.97, 0.99 ]
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Test 29. Type 1 (paired comparison with Type 4).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 29 Type 1 (paired comparison with Type 4)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gerstl 2009 167 44 2 130 0.99 [ 0.96, 1.00 ] 0.75 [ 0.68, 0.81 ]
Hopkins 2007 274 47 15 582 0.95 [ 0.92, 0.97 ] 0.93 [ 0.90, 0.94 ]
Hopkins 2008a 2626 1245 77 3052 0.97 [ 0.96, 0.98 ] 0.71 [ 0.70, 0.72 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 56 3 4 121 0.93 [ 0.84, 0.98 ] 0.98 [ 0.93, 0.99 ]
Pattanasin 2003 52 10 5 202 0.91 [ 0.81, 0.97 ] 0.95 [ 0.91, 0.98 ]
Van den Broek 2006 137 4 15 740 0.90 [ 0.84, 0.94 ] 0.99 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 30. Type 4 (paired comparison with Type 1).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 30 Type 4 (paired comparison with Type 1)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gerstl 2009 168 7 1 167 0.99 [ 0.97, 1.00 ] 0.96 [ 0.92, 0.98 ]
Hopkins 2007 254 0 35 629 0.88 [ 0.84, 0.91 ] 1.00 [ 0.99, 1.00 ]
Hopkins 2008a 2385 358 318 3939 0.88 [ 0.87, 0.89 ] 0.92 [ 0.91, 0.92 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 58 3 2 121 0.97 [ 0.88, 1.00 ] 0.98 [ 0.93, 0.99 ]
Pattanasin 2003 50 19 7 190 0.88 [ 0.76, 0.95 ] 0.91 [ 0.86, 0.94 ]
Van den Broek 2006 127 13 25 731 0.84 [ 0.77, 0.89 ] 0.98 [ 0.97, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 31. PCR adjusted microscopy, Type 1, Paracheck-PF (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 31 PCR adjusted microscopy, Type 1, Paracheck-PF (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Hopkins 2008b 3454 417 34 3095 0.99 [ 0.99, 0.99 ] 0.88 [ 0.87, 0.89 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 32. PCR adjusted microscopy, Type 4, Parabank (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 32 PCR adjusted microscopy, Type 4, Parabank (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Hopkins 2008b 2707 36 284 3973 0.91 [ 0.89, 0.92 ] 0.99 [ 0.99, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 33. PCR, Type 1, ParaSight-F.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 33 PCR, Type 1, ParaSight-F
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Banchongaksorn 1996b 153 2 14 351 0.92 [ 0.86, 0.95 ] 0.99 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
248Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Test 34. PCR, Type 1, ParaHIT-F.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 34 PCR, Type 1, ParaHIT-F
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Nicastri 2009b 18 0 7 311 0.72 [ 0.51, 0.88 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 35. PCR, Type 1 (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 35 PCR, Type 1 (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Banchongaksorn 1996b 153 2 14 351 0.92 [ 0.86, 0.95 ] 0.99 [ 0.98, 1.00 ]
Nicastri 2009b 18 0 7 311 0.72 [ 0.51, 0.88 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 36. PCR, Type 3, SD Malaria Antigen (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 36 PCR, Type 3, SD Malaria Antigen (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ratsimbasoa 2008 95 8 6 89 0.94 [ 0.88, 0.98 ] 0.92 [ 0.84, 0.96 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 37. HRP-2 based tests paired data.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 37 HRP-2 based tests paired data
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gerstl 2009 167 44 2 130 0.99 [ 0.96, 1.00 ] 0.75 [ 0.68, 0.81 ]
Hopkins 2007 274 47 15 582 0.95 [ 0.92, 0.97 ] 0.93 [ 0.90, 0.94 ]
Hopkins 2008a 2626 1245 77 3052 0.97 [ 0.96, 0.98 ] 0.71 [ 0.70, 0.72 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 58 3 2 121 0.97 [ 0.88, 1.00 ] 0.98 [ 0.93, 0.99 ]
Pattanasin 2003 52 10 5 202 0.91 [ 0.81, 0.97 ] 0.95 [ 0.91, 0.98 ]
Ratsimbasoa 2007 61 7 10 116 0.86 [ 0.76, 0.93 ] 0.94 [ 0.89, 0.98 ]
Sharew 2009 167 16 1 484 0.99 [ 0.97, 1.00 ] 0.97 [ 0.95, 0.98 ]
Van den Broek 2006 137 4 15 740 0.90 [ 0.84, 0.94 ] 0.99 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 38. pLDH based tests paired data.
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 38 pLDH based tests paired data
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gerstl 2009 168 7 1 167 0.99 [ 0.97, 1.00 ] 0.96 [ 0.92, 0.98 ]
Hopkins 2007 254 0 35 629 0.88 [ 0.84, 0.91 ] 1.00 [ 0.99, 1.00 ]
Hopkins 2008a 2385 358 318 3939 0.88 [ 0.87, 0.89 ] 0.92 [ 0.91, 0.92 ]
Mens 2007a 3 0 0 151 1.00 [ 0.29, 1.00 ] 1.00 [ 0.98, 1.00 ]
Mens 2007b 56 3 4 121 0.93 [ 0.84, 0.98 ] 0.98 [ 0.93, 0.99 ]
Pattanasin 2003 50 19 7 190 0.88 [ 0.76, 0.95 ] 0.91 [ 0.86, 0.94 ]
Ratsimbasoa 2007 67 12 4 111 0.94 [ 0.86, 0.98 ] 0.90 [ 0.84, 0.95 ]
Sharew 2009 167 10 1 490 0.99 [ 0.97, 1.00 ] 0.98 [ 0.96, 0.99 ]
Van den Broek 2006 127 13 25 731 0.84 [ 0.77, 0.89 ] 0.98 [ 0.97, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
250Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Test 71. PCR, Type 6, PALUTOP (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 71 PCR, Type 6, PALUTOP (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Rakotonirina 2008 86 7 5 215 0.95 [ 0.88, 0.98 ] 0.97 [ 0.94, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 72. PCR, Type 4, OptiMAL-IT (All).
Review: Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries
Test: 72 PCR, Type 4, OptiMAL-IT (All)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Rakotonirina 2008 66 2 25 220 0.73 [ 0.62, 0.81 ] 0.99 [ 0.97, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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A P P E N D I C E S
Appendix 1. Appendix 1. Search strategy
Search set MEDLINE EMBASE





3 Malaria ti, ab Malaria ti, ab
4 1 or 2 or 3 1 or 2 or 3








7 RDT ti, ab RDT ti, ab
8 Dipstick* ti, ab Dipstick$ ti, ab




10 MRDD ti, ab MRDD ti, ab
11 OptiMal ti, ab OptiMal ti, ab
12 Binax NOW ti, ab Binax NOW ti, ab













17 Combo card test* ti,
ab
Combo card test$ ti,
ab
252Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
















21 Rapid test* ti, ab Rapid test$ ti, ab
22 Card test* ti, ab Card test$ ti, ab
23 Rapid AND (detec-
tion* or diagnos*) ti,
ab
Rapid AND (detec-
tion$ or diagnos$) ti,
ab
24 5 or 6 or 7 or 8 or 9 or
10 or 11 or 12 or 13
or 14 or 15 or 16 or
17 or 18 or 19 or 20
or 21 or 22 or 23
5 or 6 or 7 or 8 or 9 or
10 or 11 or 12 or 13
or 14 or 15 or 16 or
17 or 18 or 19 or 20
or 21 or 22 or 23
25 4 and 19 4 and 19
26 Limit 20 to Humans Limit 20 to Human
Search set Web of Science LILACS Medion African Index medi-
cus
IndMed








3 1 or 2 1 or 2 1 or 2 1 or 2
4 Rapid diagnostic test*
(topic)
Rapid diagnostic test$ Diagnos* Diagnos*
5 RDT (topic) RDT dipstick dipstick





Card test Card test
253Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
8 Parasight (topic) Parasight parasight parasight
9 Dipstick (topic) Dipstick RDT RDT
10 Binax (topic) Binax 4 or 5 or 6 or 7 or 8 or
9
4 or 5 or 6 or 7 or 8 or
9
11 4 or 5 or 6 or 7 or 8 or
9 or 10
4 or 5 or 6 or 7 or 8 or
9 or 10
3 and 10 3 and 10
12 3 and 11 3 and 11
Appendix 2. Data extraction: characteristic of included studies
Study ID First author, year of publication
Clinical features and settings Presenting signs and symptoms, previous treatments for malaria, clinical setting
Participants Sample size, age, sex, co-morbidities or pregnancy, country and locality, P. falciparum malaria en-
demicity, endemic malaria species, average parasite density in microscopy positive cases
Study design Were consecutive patients enrolled retrospectively or prospectively?
Whether the sampling method was consecutive or random, or whether the method was not described
but consecutive sampling was most probable
If the study evaluated more than one RDT, how were tests allocated to individuals, or did each
individual receive all the tests?
Target condition Malaria parasitaemia
Reference standard The reference standard test(s) used
If microscopy was used, who performed it, and where?
If microscopy was used, how many high power fields were looked at?
If microscopy was used, how many observers or repeats were used?
If microscopy was used, how were discrepancies between observers resolved?
Index tests The parasite species the test was designed to detect, the commercial name, and the type of test. Batch
numbers if provided. Transport and storage conditions. Details of the test operators, including any
special training provided.
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(Continued)
Notes Source of funding.
Appendix 3. Data extraction and criteria for judgement: methodological quality
Quality Indicator Notes
Was the spectrum of patients representative of the spectrum of
patients who will receive the test in practice?
’Yes’ if the inclusion criteria clearly stipulated people attending an
ambulatory healthcare setting with symptoms of malaria, and the
sampling method was consecutive or random.
’No’ if the sample was unrepresentative of people with uncom-
plicated malaria in general (for example, if the majority of par-
ticipants also had some other presenting health problem, such as
pneumonia). Where a proportion of potential participants were
excluded due to recent antimalarial use, well defined co-morbidi-
ties or pregnancy, the sample could be classed as representative,
because these groups may also be excluded from testing as normal
clinical practice, depending on local policy and practice.
’Unclear’ if the source or characteristics of participants was not ad-
equately described; or if the sampling method was not described.
Is the reference standard likely to correctly identify the target con-
dition?
’Yes’ if microscopy was undertaken by experienced microscopists
with adequate laboratory facilities. Laboratory facilities were as-
sumed to be adequate unless the study report indicated otherwise.
Slides were viewed by at least two independent observers, either
for all slides or for those where there were discordant results be-
tween the index and the reference test. At least 100 microscopic
fields were viewed before declaring a slide negative.
’Yes’ if reference standard was PCR.
’No’ if microscopy was undertaken by insufficiently trained indi-
viduals, by one individual only, or in a situation with inadequate
equipment, or if they viewed less than 100 microscopic fields be-
fore declaring negative.
’Unclear’ if insufficient information was provided.
Is partial verification avoided? ’Yes’ if all participants who received the index test also received
the reference test.
’No’ if not all the participants who received the index test also
received the reference test.
’Unclear’ if insufficient information was provided to assess this.
If not all participants received the reference test, we reported how
many did not.
Is differential verification avoided? ’Yes’ if the same reference test was used regardless of the index test
results.
’No’ if different reference tests were used depending on the results
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(Continued)
of the index test.
’Unclear’ if insufficient information was provided.
If any participants received a different reference test, we reported
the reasons stated for this, and how many participants were in-
volved.
Is incorporation avoided? (the index test does not form part of the
reference standard)
Should be ‘Yes’ for all studies, as the reference standard is defined
in the inclusion criteria as microscopy or PCR.
Are the reference standard test results blinded? ’Yes’ if the person undertaking the reference test did not know the
results of the index tests, if the two tests were carried out in dif-
ferent places, or it was clear that the reference test was undertaken
and the results recorded before the index test.
’No’ if the same person performed both tests, or if the results of the
index tests were known to the person undertaking the reference
tests.
’Unclear’ if insufficient information was provided.
Are the index test results blinded? ’Yes’ if the person undertaking the index test did not know the
results of the reference tests, or if the two tests were carried out in
different places, or it was clear that the index test was undertaken
and the results recorded before the reference test.
’No’ if the same person performed both tests, or if the results of the
index tests were known to the person undertaking the reference
tests.
’Unclear’ if insufficient information was provided.
Were uninterpretable results reported? ’Yes’ if the paper stated whether there were any uninterpretable or
invalid results, and how those were handled; for example whether
they were repeated until a valid result was obtained, or excluded
from the analysis.
’No’ if the number of participants presented in the analysis did not
match the number of participants originally enrolled in the study,
and insufficient explanation was provided for any discrepancy.
’Unclear’ if uninterpretable or invalid test results were not men-
tioned, but the number of participants presented in the analysis
corresponded to the number of participants reported to be orig-
inally recruited into the study, or if insufficient information was
given to permit this judgement; for example if the original num-
ber of participants recruited into the study was unclear.
We reported how many results were uninterpretable (of the total)
, and how these were handled in the analysis.
Were any withdrawals explained? ’Yes’ if it was clear that no participants were excluded from the
analysis (the number of participants originally enrolled was clearly
stated, and corresponded to the number presented in the analysis)
or if exclusions were adequately described.
’No’ if there were participants missing or excluded from the analy-
sis and there was no explanation given; usually where the number
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(Continued)
of participants reported to have been enrolled and the number
presented in the analysis did not correspond.
’Unclear’ if not enough information was given to assess whether
any participants were excluded from the analysis; for example if
the original number of participants recruited into the study was
unclear.
We reported how many participants were excluded from the anal-
ysis.
Appendix 4. Extra figures
Estimates of average sensitivity and specificity for Type 1 RDT brands (Figure 8)
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Figure 8. Summary estimates of Type 1 RDTs plotted in ROC space (by RDT brand)
Estimates of average sensitivity and specificity for Type 4 RDT brands (Figure 9)
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Figure 9. Summary estimates of Type 4 RDTs plotted in ROC space (by RDT brand)
ROC plot of study results for Type 2, 3 and 5 RDT brands (Figure 10)
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Figure 10. Study results of Type 2, 3 and 5 RDTs plotted in ROC space (by RDT brand)
Study results and estimates of average sensitivity and specificity for Type 2 RDTs (Figure 11)
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Figure 11. Summary estimates of Type 2 RDTs and study results plotted in ROC space (by RDT brand)
Study results and estimates of average sensitivity and specificity for Type 3 RDTs (Figure 12)
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Figure 12. Summary estimates of Type 3 RDTs and study results plotted in ROC space
Study results and estimates of average sensitivity and specificity for Type 5 RDTs (Figure 13)
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Figure 13. Summary estimates of Type 5 RDTs and study results plotted in ROC space
ROC plot of paired results which compare Type 1 and Type 4 RDT brands (Figure 14)
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Figure 14. Paired comparison of Type 1 and Type 4 RDTs. Connecting lines link the direct comparison of
pairs of tests in each study.
ROC plot of paired results which compare HRP-2-based tests and pLDH-based tests(Figure 15)
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Figure 15. Paired comparison of HRP-2-based tests and pLDH-based tests. Connecting lines link the direct
comparison of pairs of tests in each study.
Appendix 5. Type 1 RDT brands evaluated in more than 1000 participants
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Ratio of sensitivity
(95% CI)
P value for comparison
Ratio of specificity
(95% CI)
P value for comparison
Paracheck-Pf ParaSight-F ICT Malaria-Pf
Studies
(participants)













ParaSight-F 17 (12,591) 94.2 (90.1,96.7)
94.9 (91.0,97.1)
1.01 (0.96,1.06) P =
0.67
0.99 (0.95,1.03) P =
0.67
- -
ICT Malaria-Pf 16 (2955) 97.7 (95.5,98.8)
94.7 (90.7,97.1)
1.05 (1.01,1.08) P =
0.01
0.99 (0.95,1.03) P =
0.63
1.04 (1.00,1.07) P =
0.05
1.00 (0.97,1.03) P =
0.93
-
ParaHIT-F 4 (1119) 92.6 (74.3,98.2)
98.9 (94.4,99.8)




0.98 (0.88,1.10) P =
0.76
1.04 (1.01,1.08) P =
0.02
0.95 (0.85,1.06) P =
0.33
1.04 (1.01,1.08) P =
0.02
Appendix 6. Additional direct comparisons between test types
Sensitivity Specificity
TP/diseased P value change TN/not diseased P value change
Type 2 vs
Type 1
Type 2 Type 1 Type 2 Type 1
Van den
Broek 2006
144/152 137/152 P = 0.19 +4.6% (-
1.3% to
+10.5%)




Type 2 Type 4 Type 2 Type 4
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144/152 127/152 P = 0.003 +11.1%
(+4.3% to
+18.1%)




Type 3 Type 1 Type 3 Type 1
Mens 2007b 60/60 113/127 P = 0.006 +11.0%
(+5.6% to
+16.5%)
115/124 678/711 P = 0.26 -2.6% (-7.4% to
+2.2%)
Dev 2004 17/17 21/21 P = 1.00 0% (not es-
timable)
13/13 9/9 P = 1.00 0% (not estimable)
Type 3 vs
Type 4
Type 3 Type 4 Type 3 Type 4
Mens 2007b 60/60 58/60 P = 0.50 +3.3% (-
1.2% to
+7.9%)
115/124 121/124 P = 0.14 -4.8% (-10.1% to
+0.5%)
Dev 2004 17/17 69/85 P = 0.07 +18.8%
(+10.5% to
+27.1%)
13/13 54/54 P = 1.00 0% (not estimable)
Type 5 vs
Type 1
Type 5 Type 1 Type 5 Type 1
Sharew
2009
167/168 167/168 P = 1.00 0% (-1.6% to
1.6%)
490/500 484/500 P = 0.32 +1.2% (-0.8% to
+3.2%)
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Appendix 8. Comparison of local microscopy and RDTs verified with good quality microscopy
Study RDT Local microscopy RDT
Sensitivity Specificity Sensitivity Specificity
Kolaczinski 2004 OptiMAL 85.2 99.7 79.3 99.7
De Oliveira 2009 Paracheck-Pf 52.5 77.0 91.7 96.7
WH A T ’ S N E W
Last assessed as up-to-date: 13 January 2010.
Date Event Description
6 July 2011 Amended Plain language summary added.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We intended to consider RDTs for detecting all species of malaria in a single review. We subsequently decided to split the review into
two to make it more readable.
We had intended to handsearch reference lists of included articles, contact test manufacturers for any unpublished studies, handsearch
conference proceedings, and contact authors and other experts for information on ongoing and unpublished studies. However, due to
the number of citations returned by our search (over 4000), these activities were not required.
We added four further exclusion criteria: studies that used active case detection to recruit participants; studies that did not present
absolute numbers; studies not published in English; and studies not presenting sufficient information to enable a full assessment of
their eligibility.
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